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ABSTRACT 
 
CELL-SPECIFIC GENE EXPRESSION: PYLORUS MORPHOGENESIS AND 
HEDGEHOG-REGULATED ENHANCERS 
by 
Aaron Mark Udager 
 
 
Chair: Deborah L. Gumucio 
 
 
The precise spatiotemporal control of gene expression is integral to the survival of all 
organisms. Inappropriate gene expression can lead to developmental defects in newborns, 
such as Infantile Hypertrophic Pyloric Stenosis, in which hypertrophy of pyloric 
sphincter smooth muscle leads to gastric outlet obstruction. This thesis work analyzes the 
mechanisms and consequences of cell-specific gene expression in three systems: 
establishment of the epithelial gastro-duodenal (pyloric) border, development of smooth 
muscle structures at the pylorus, and transcriptional response to Hedgehog (Hh) signaling 
in Drosophila. 
 
 xiv 
Microarray is used to characterize the antral, pyloric, and duodenal transcriptomes at 
embryonic days (E) 14.5 and 16.5. At E16.5, hundreds of genes are upregulated 
specifically in duodenal epithelium. This event is termed intestinalization because the 
activated genes are associated with intestinal function. Several transcription factors (i.e., 
Tcfec, Creb3l3, and Hnf4) are upregulated in duodenal epithelium and levels of Hh 
signaling are downregulated in duodenal mesenchyme. In addition, novel pyloric genes 
are identified, including Gata3, which encodes a zinc finger transcription factor. 
 
A role for Gata3 during pylorus development is elucidated using a genetic model of 
Gata3 insufficiency. Gata3 and the homeodomain transcription factor Nkx2-5 co-localize 
with molecular markers of pyloric smooth muscle and are expressed in novel bilateral 
smooth muscle structures at the pylorus (i.e., the ventral pyloric cords). Loss of Gata3 
alters the shape of the pylorus and attenuates the pyloric constriction. The ventral pyloric 
cords and outer longitudinal smooth muscle at the pylorus are absent in Gata3 null 
embryos. Gata3 does not control Nkx2-5 expression at the pylorus. 
 
An in silico approach identifies Hh-regulated enhancers in Drosophila. Binding sites for 
the Hh transcriptional effector cubitus interruptus (Ci) are significantly clustered in the 
genomes of two divergent Drosophila species, but mutant Ci sites are not. Putative Hh-
regulated enhancers are identified by the comparison of orthologous regions of 
significant Ci clustering. Two of these enhancers (inv and rdx) are active in Hh-
responsive cells of the Drosophila larval imaginal wing disc. 
 
 xv 
These studies reveal novel gene expression patterns during pylorus morphogenesis and 
suggest an approach to identifying direct transcriptional targets of signaling pathways. 
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CHAPTER I 
 
INTRODUCTION 
 
Cell-specific gene regulation is essential for embryonic development and adult 
homeostasis: combinatorial patterns of gene expression establish and maintain cellular 
identity; unique spatiotemporal expression domains position genes to influence 
morphogenesis and function; and distinct transcriptional responses to cell-cell signaling 
integrate spatiotemporal position and cellular identity. This thesis explores the 
mechanisms and consequences of cell-specific gene regulation. 
 
In the first half of my thesis work I examined the patterning of the pylorus, the site of 
muscular sphincter that marks the boundary between the stomach and intestine (see 
Chapters II and III). To provide context for this part of the work, I will review the cellular 
and molecular basis of gut tube development and then focus specifically on what was 
known regarding the patterning of the pylorus at the beginning of my studies. 
 
The second half of my thesis work centers on one important cell-cell signaling program, 
the Hedgehog (Hh) pathway. To provide background for this part of the work, I will 
review the multiple patterning events that are controlled by Hh signals in the 
gastrointestinal (GI) tract and discuss the cellular targets of Hh signaling in this tissue. 
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Further mechanistic understanding of the developmental events that are controlled by Hh 
signaling, including patterning of the pylorus, requires identification of the molecular 
targets of Hh signals, but to date, few targets are known. I have developed a novel 
computational method for the prediction of cell-specific transcriptional targets of Hh 
signaling (see Chapter IV). To put this work in perspective, I will review existing tools 
for the recognition of signaling-regulated enhancers in genomic DNA and consider their 
strengths and weaknesses. 
 
I.1. Embryonic development of the early GI tract 
 
The GI tract is the primary site for digestion of food particles, absorption of nutrients, and 
excretion of solid waste. It extends from the mouth to the anus and includes both the 
tubular gut (i.e., esophagus, stomach, small intestine, and colon) and accessory digestive 
organs (i.e., pancreas and liver). The tubular gut is comprised of two concentric tissue 
layers, epithelium and mesenchyme, which are derived from endoderm and mesoderm, 
respectively. Epithelium lines the lumen of the gut tube and is responsible for its core 
digestive functions. Mesenchyme surrounds the epithelium, providing structural and 
vascular support and facilitating the flux of nutrients (i.e., motility) within the GI tract. 
Gut motility is partly controlled by innervations within the mesenchyme from the enteric 
nervous system, which is established via the migration of ectoderm-derived, neural crest 
cells. Here, I will outline the major events in early GI tract development and describe the 
expression of specific transcription factors and roles for signaling pathways. 
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Formation of the primitive gut 
The three primary germ layers (i.e., ectoderm, mesoderm, and endoderm) are established 
during gastrulation. In the mouse, beginning at embryonic day (E) 6.5 epiblast cells 
migrate through the primitive streak and, under the influence of cell-cell signaling, 
become specified as mesoderm or endoderm [1]. The endodermal cells intercalate into the 
extraembryonic visceral endoderm on the ventral-most surface of the embryo, forming 
the definitive endoderm. By E9.5 coordinated morphogenic movements convert this sheet 
of endoderm into the primitive gut tube. The anterior endoderm folds posteriorly and 
laterally to form the anterior intestinal portal (AIP), and in an analogous manner, the 
posterior endoderm folds anteriorly and laterally to establish the caudal intestinal portal 
(CIP). These folds create the primitive foregut and hindgut pockets, respectively. Lateral 
folding of the endoderm continues posteriorly from the AIP and anteriorly from the CIP 
until the endoderm forms a closed tube. 
 
Patterning of the primitive gut 
Closure of the gut tube is accompanied by the migration of its associated mesoderm. By 
E9.5 the primitive gut exists as a single-layered tube of endoderm surrounded by 
mesoderm. Elegant lineage tracing and microarray experiments, however, indicate that 
patterning of the gut is initiated well prior to gut tube formation [2, 3]. This partitioning 
of the GI tract into broad organ domains involves precise spatiotemporal control of 
transcription factor expression and signaling pathway activity. 
 
Transcription factors 
 4 
A number of transcription factors show restricted expression patterns in primitive gut 
endoderm and mesoderm. Hox genes are particularly notable because their expression 
extends along the entire anteroposterior (A-P) axis of the gut [4, 5]. Overlapping, 
combinatorial expression of Homeobox (Hox) transcription factors delineates specific GI 
regions (i.e., foregut) or organ territories (i.e., stomach), while tight expression 
boundaries between Hox genes often correspond to transitions between adjacent organs. 
This “gastrointestinal Hox code” is one of the earliest apparent patterns in the GI tract 
and influences subsequent organogenesis of the gut. 
 
As early as E8, there is clear A-P patterning of transcription factors in the endoderm. The 
forkhead box A (FoxA) subfamily and Sry-box containing gene 2 (Sox2) are expressed 
broadly in foregut endoderm, while caudal type homeobox 2 (Cdx2) expression 
demarcates midgut and hindgut endoderm [1]. Expression of pancreatic and duodenal 
homeobox 1 (Pdx1) spans the foregut-midgut boundary and delineates a unique domain 
from which a trio of accessory digestive organs (liver, gall bladder, and pancreas) later 
emerge. The Pdx1-positive area of the tubular gut gives rise to the pylorus as well as the 
surrounding distal antrum and proximal duodenum. 
 
The smooth muscle sphincters of the GI tract are critical structures during digestion and 
are associated with unique transcription factor expression. For example, NK2 
transcription factor related, locus 5 (Drosophila) (Nkx2-5) is expressed specifically in a 
narrow domain of mesoderm at the future site of the pyloric sphincter (see Chapter I.3) 
[6]. 
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Signaling pathways 
There are at least seven major developmental signaling pathways including: Bone 
morphogenetic protein (Bmp), Hh, Jak/Stat, Notch, nuclear receptor, receptor tyrosine 
kinase, and Wnt [7]. These pathways interact with organ-specific transcription factors to 
pattern the primitive gut and direct organogenesis within the GI tract. In the early gut 
tube, fibroblast growth factor (Fgf; a receptor tyrosine kinase ligand), Wnt, and retinoic 
acid (RA; a nuclear receptor ligand) facilitate the establishment of the A-P axis [1]. Fgf 
and Wnt directly activate Cdx genes in the hindgut, while RA signaling and active 
inhibition of Wnt limits their anterior expression boundaries in the foregut. Subsequent 
Fgf, Bmp, and RA signals subdivide the anterior gut into specific organ domains, while 
FGF and Wnt promote the elaboration of an intestinal domain in the posterior gut. 
 
Hh signaling acts at several points during patterning of the primitive gut, and loss of 
either sonic hedgehog (Shh) or Indian hedgehog (Ihh), genes encoding two of the three 
mouse Hh ligands, leads to GI defects [8]. Shh is required for proper dorsoventral (D-V) 
patterning of the anterior foregut. Loss of Shh disrupts separation of the trachea and 
esophagus, leading to trachea-esophageal fistulas, and causes alterations in antral as well 
as anal patterning [8, 9]. In contrast, specific downregulation of Shh is required for 
formation of the dorsal pancreatic bud [10]. In the intestine, Hh signaling controls Wnt 
and Bmp expression, in part via activation of FoxF and FoxL transcription factors, and is 
essential for epithelial and mesenchymal patterning later in gut development (see Chapter 
I.4) [11]. 
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I.2. Establishing epithelial identity and morphology in the foregut 
 
The foregut is comprised of a variety of organs with vastly different roles in digestion: 
the esophagus facilitates the transport of food and water from the mouth; the stomach 
breaks down food particles for digestion; and the duodenum begins the absorption of 
nutrients. These functions are carried out by specialized epithelia, each with unique tissue 
morphology, specific cell types, and distinct gene expression patterns. All of these 
regional or organ-specific attributes are initially patterned during primitive gut 
development. Here I will describe the role of specific transcription factors in establishing 
domains of organ-specific foregut epithelia. I will then summarize the morphological and 
temporal events accompanying differentiation of intestinal epithelium. 
 
Transcription factors pre-pattern foregut endoderm 
FoxA subfamily: endodermal competence 
Vertebrate Fox genes encode transcription factors that are related to the Drosophila 
melanogaster (D. melanogaster) gene fork head, and Fox proteins have a characteristic 
winged helix (“forkhead box”) DNA binding domain [12]. The FoxA subfamily members 
Foxa1, Foxa2, and Foxa3 were initially identified as liver transcription factors and termed 
hepatocyte nuclear factor-3 (Hnf3) alpha, beta, and gamma, respectively. The expression 
of FoxA genes, however, is not localized to the liver. Foxa1 and Foxa2 are expressed in 
the primitive streak, notochord, and endoderm throughout the primitive gut, while the 
expression of Foxa3 is restricted to a domain of endoderm from the posterior foregut to 
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the hindgut. The overlapping expression patterns of FoxA genes indicate the possibility 
of genetic redundancy or compensation, and neither Foxa1 nor Foxa3 is uniquely 
required during embryogenesis [13, 14]. Foxa2 null embryos, on the other hand, die by 
E11 due to loss of Shh expression in the notochord and significant non-endodermal 
defects [15]. 
 
Sophisticated genetic approaches have highlighted an important role for FoxA factors in 
the foregut. Endodermal loss of both Foxa1 and Foxa2 completely inhibits liver 
development, impairs differentiation of respiratory epithelium in the lung, and eliminates 
Pdx1 expression in pancreatic endoderm [16-18]. In a site-specific manner FoxA factors 
bind directly to histones and reduce local chromatin compaction near organ-specific 
genes [19]. This makes the endoderm poised (or “competent”) to respond to differentially 
expressed transcription factors. Thus, FoxA proteins act as “pioneer factors” for nuclear 
hormone receptors by facilitating their recruitment to cis-regulatory sequence of organ-
specific genes [20]. 
 
Sox2: anterior foregut cell fates 
Sox2 is a member of a large family of high mobility group (HMG) box transcription 
factors. There are twenty mouse Sox genes, which have been classified into nine 
subgroups [21]. Along with Sox1 and Sox3, Sox2 is a part of the SoxB1 subgroup of 
transcriptional activators. Sox3 is expressed in foregut endoderm as early as E9.5 and is 
known to genetically interact with Sox2 during formation of the second pharyngeal arch 
[22].  
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Sox2 is expressed in both A-P and D-V gradients. The highest expression is in the 
esophagus, anteriorly in the A-P gradient and dorsally in the D-V gradient [23]. Sox2 
levels also correlate with epithelial morphology: stratified squamous (high) and simple 
columnar (low). In the early gut tube, the posterior boundary of Sox2 expression occurs 
at the pylorus, where it abuts the anterior border of intestinal Cdx2 expression until at 
least E14.5 [3]. This boundary may be maintained by mutual transcriptional repression 
interactions between Sox2 and Cdx2 (see below). While Sox2 null mice die before 
gastrulation, mice carrying hypomorphic Sox2 alleles survive to birth and show 
significant foregut defects [23, 24]. Genetic reduction of Sox2 posteriorizes anterior 
foregut cell fates. For example, intestinal genes are misexpressed in the esophagus, and 
the anterior stomach displays the morphological characteristics of the posterior stomach 
[23]. Thus, while the FoxA family establishes a competence for subsequent organ-
specific gene expression in foregut endoderm, Sox2 induces specific foregut cell fates in 
a dosage-dependent manner. 
 
Cdx2: intestinal cell fate 
The vertebrate Cdx genes Cdx1, Cdx2, and Cdx4 encode transcription factors that are 
related to the D. melanogaster gene caudal, an essential gene for proper A-P patterning in 
flies [25]. Cdx1 and Cdx2 are expressed in overlapping patterns in the developing 
intestine. The anterior boundary of Cdx2 occurs at the pylorus and is maintained by 
mutual repressive interaction with Sox2 [3]. Cdx1 null mice have no apparent gut 
phenotype and Cdx2 null embryos die prior to gastrulation [26, 27]. Endoderm-specific 
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deletion of Cdx2 causes a conversion of the simple columnar intestinal epithelium of the 
ileum to esophagus-like stratified squamous epithelium [28]. Loss of Cdx2 is 
accompanied by upregulation of Sox2 and downregulation of Ihh. Conversely ectopic 
expression of Cdx2 in the stomach leads to intestinal metaplasia, wherein patches of 
intestine-like epithelium are found within a field of normal stomach epithelium [29]. 
Thus Cdx2 is a fundamental regulator of intestinal cell identity: it is required not only to 
activate intestinal gene expression, but repress anterior Sox2-dependent cell fates. 
 
Pdx1: pancreatic cell fate 
Pdx1 is expressed in a narrow domain of posterior foregut endoderm, beginning at E8.5 
[3]. Its expression extends from the distal stomach, across the pylorus, and into the 
proximal small intestine, and it does not adhere to the boundary formed by mutual Cdx2 
and Sox2 repression. The dorsal and ventral pancreatic buds emerge from the gut tube 
within this Pdx1 expression domain [1]. Pdx1 null embryos have a small rudimentary 
pancreas that lacks insulin-secreting -cells [30]. Loss of Pdx1 also disrupts the 
morphogenesis of the proximal small intestine: there is loss of villi, absence of Brunner’s 
glands, and conversion of intestinal to bile duct epithelium. Thus, Pdx1 specifies a unique 
domain of pancreatic progenitors and may contribute to the development of other 
specialized structures (i.e., Brunner’s glands) at the pylorus. 
 
Epithelial morphogenesis during villus emergence 
By E9.5 broad organ domains have been established in the primitive gut. From E9.5-
E14.5, the pancreatic, hepatic, and splenic anlagen emerge from a narrow region in the 
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distal foregut and undergo organ-specific morphogenic programs, while the stomach 
acquires its characteristic saclike shape [1]. At the same time, however, relatively minor 
changes occur in the epithelium of the tubular gut. 
 
After gut tube formation the number of cells in the endodermal layer increases 
dramatically, and the sheet of intestinal endoderm becomes either a multi-layer stratified 
or pseudo-stratified epithelium [31]. (Unpublished preliminary data from our lab suggest 
that it is pseudo-stratified.) This transformation nearly fills the gut tube lumen with 
endodermal cells and increases epithelial girth. Then over the course of two days, from 
E14-E16, this thick tube of intestinal epithelial cells is dramatically remodeled. While 
lumenal surface slowly expands throughout the intestinal epithelium, mesenchymal 
condensations (“clusters”) form at regularly spaced intervals beneath it [32]. As the 
epithelium is converted to a simple columnar epithelium, generating fingerlike 
projections known as villi, the clusters are enveloped by the forming villi and become the 
mesenchymal cores. Between these emerging villi is the proliferative intervillus 
epithelium, which will be remodeled postnatally to form the intestinal crypt. Thus 
concomitant with these changes in epithelial morphology is the primary establishment of 
the intestinal crypt-villus axis. The emergence of villi begins in the anterior intestine and 
continues posteriorly in a “wave” along the A-P axis [31]. By E16.5 the villi of the 
proximal duodenum have been formed and many of the differentiated cells types of the 
intestine are present: absorptive enterocytes, mucous-secreting goblet cells, and hormone-
secreting enteroendocrine cells. 
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Shortly after villus formation begins, another dramatic patterning event can be discerned: 
the establishment of a sharp anterior boundary for intestinal gene expression. This 
boundary was first noted while examining villin gene expression [33]. At E14.5 robust 
villin expression extends throughout intestinal endoderm and into distal stomach 
endoderm, where it gradually decreases in a posteroanterior gradient. Two days later after 
the endoderm has been remodeled into a simple columnar epithelium, a tight, one-cell-
thick anterior boundary of villin expression is discernable. This expression boundary 
corresponds to the transition between differentiated intestinal and gastric epithelial cell 
types along the GI tract.  
 
I.3. Regulation of nutrient transport within the GI tract 
 
Compartmentalization of organ-specific epithelia by sphincters of the GI tract facilitates 
the precise regulation of individual digestive functions, and malformation or dysfunction 
of these sphincters leads to significant human pathologies [34]. In the tubular GI tract 
sphincters control the passage of nutrients during digestion by adjusting the diameter of 
the lumen between adjacent organs (i.e., the stomach and intestine). There are six 
sphincters within the tubular GI tract: upper esophageal, lower esophageal, pyloric, 
ileocecal, internal anal, and external anal. All but the lower esophageal are anatomic (or 
“true”) sphincters, which have distinguishable muscular thickenings that adjust lumenal 
diameter in response to muscular tone. In contrast, the lower esophageal sphincter, which 
separates the esophagus from the acidic environment of the stomach, is “physiological”. 
It is not associated with an obvious muscular thickening, and its constriction is regulated 
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in part by differences in intrathoracic and intraabdominal pressure. The muscular control 
of anatomic sphincters is either voluntary (i.e., upper esophageal and external anal) or 
involuntary (i.e., pyloric, ilio-cecal, and internal anal). Here I will describe the structure, 
function, and development of the pylorus and its associated sphincter. 
 
Control of gastroduodenal flux by the pylorus 
Through its sphincter the pylorus regulates the timing of gastric emptying as well as the 
size of food particles that pass from the stomach into the duodenum [34]. It prevents the 
backflow of nutrients into the stomach during peristaltic contractions in the intestine and 
assists in the mechanical digestion of food by strong muscular contractions of the antrum. 
 
The pylorus, like other areas of the tubular GI tract, is fundamentally comprised of two 
basic tissue layers, epithelium and mesenchyme. At the pylorus there is an abrupt one-
cell-thick transition between differentiated gastric and intestinal epithelial cells (i.e., the 
epithelial pyloric border; see Chapter II) [33]. Directly surrounding the pyloric 
epithelium, the sub-mucosa is a layer of loose mesenchyme that contains myofibroblasts, 
smooth muscle cells (i.e., muscularis mucosa), blood vessels, and neurons [34]. 
Peripheral to the sub-mucosa, the thick smooth muscle of the muscularis externa defines 
the gross morphological shape of the pylorus. The serosa is a thin layer of mesothelial 
cells that comprises the outer surface of the tubular gut. There are numerous innervations 
throughout the pyloric mesenchyme, which control smooth muscle cell contraction and 
regulate the tone of the pyloric sphincer. 
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Muscularis externa 
Flanking the pylorus in the distal antrum and proximal duodenum, the muscularis externa 
has two discrete smooth muscle layers: inner circular and outer longitudinal [34]. The 
orientation of muscle fibers in the inner circular and outer longitudinal layers is 
perpendicular and parallel to the long axis of the gut tube, respectively. Throughout much 
of the tubular gut, the inner circular layer is thicker than the outer longitudinal layer. 
There are, however, organ-specific differences in the muscularis externa. For example, it 
is much thicker in the stomach than the intestine. 
 
Whereas the muscularis externa of the distal antrum and proximal duodenum is arranged 
in two discrete, continuous layers, the pyloric sphincter has a more complex muscular 
structure [34]. The inner circular layer of the pylorus is thicker than even the neighboring 
antral inner circular layer, and it is organized into fascicular bundles of fibers. These 
bundles are separated by dense connective tissue and travel at a slightly oblique angle to 
the long axis of the gut tube. In contrast the outer longitudinal layer of the pylorus is 
mostly continuous with the outer longitudinal layers of the distal antrum and proximal 
duodenum. This layer, however, is noticeably thicker at the pyloric sphincter, and many 
of its muscle fibers diverge and travel towards the epithelium, where they join muscle 
bundles of the inner circular layer. 
 
Innervations 
The entire GI tract is innervated by the enteric nervous system (ENS), a subdivision of 
the peripheral nervous system, which regulates the involuntary contractions of these 
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muscle layers during digestion [34]. There are two major types of neuronal ganglia in the 
ENS: myenteric (Auerbach’s) and sub-mucosal (Meissner’s) plexuses. Myenteric 
plexuses are located in the muscularis externa between the inner circular and outer 
longitudinal layers, where they integrate sympathetic and parasympathetic motor 
innervations to the GI tract to control peristaltic contractions necessary for the movement 
of food content. 
 
The muscular tone of the pyloric sphincter is under tight neural control. It is influenced 
by direct sympathetic and parasympathetic extrinsic innervations as well as intrinsic 
innervations and local neuropeptide release [34]. Extrinsic sympathetic and 
parasympathetic innervations are primarily via the splanchnic and vagus nerves, 
respectively. The majority of these innervations are afferent and relay information to the 
central nervous system from mucosal and muscle sense receptors. Mucosal receptors 
respond to changes in lumenal content (i.e., nutrient load), while muscle receptors detect 
the mechanical load on GI smooth muscle (i.e., stretch from distention). Short- or long-
range reflex pathways govern the pyloric response to these afferent stimuli. 
 
Contraction of the pyloric sphincter is stimulated by adrenergic and cholinergic 
neurotransmitter release from extrinsic efferent sympathetic and parasympathetic 
innervations, respectively, while inhibition occurs via release of a non-adrenergic, non-
cholingergic neurotransmitter, possibly vasoactive intestinal peptide (VIP) or nitric oxide 
(NO) from extrinsic efferent parasympathetic innervations [34]. In addition to extrinsic 
neuronal control, intrinsic neural pathways originating in the proximal duodenum and 
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distal antrum regulate the muscular tone of the pyloric sphincter and coordinate 
gastrointestinal responses to local stimuli. These intrinsic innervations affect adrenergic- 
and cholinergic-dependent extrinsic innervations via the release of neuropeptides 
including VIP, cholecystokinin, substance P, and neuropeptide Y. 
 
Infantile Hypertrophic Pyloric Stenosis 
Pyloric dysfunction has a tremendous impact on digestion and human health. Infantile 
Hypertrophic Pyloric Stenosis (IHPS) is one of the most common gastrointestinal 
disorders in newborns; the incidence is approximately 3 per 1,000 live births [35]. It is 
associated with significant hypertrophy of the pyloric sphincter muscle and narrowing of 
the pyloric lumen. These anatomical changes lead to gastric outlet obstruction, which 
results in characteristic projectile vomiting at 2-8 weeks of age. Without proper medical 
care children are unable to feed and rapidly become dehydrated. In the early 20
th
 century 
IHPS was often fatal, but today IHPS can be effectively treated by pyloromyotomy 
surgery, during which the hypertrophied muscle is cut by a longitudinal incision in the 
anterior wall of the pylorus. 
 
The precise etiology of IHPS is unknown. In biopsies of hypertrophied pyloric sphincter 
muscle from IHPS patients, the distribution of neuronal subtypes is significantly altered 
[35]. It is unclear, however, whether this neuronal phenotype is a cause or result of the 
muscular hypertrophy. Interestingly mice that lack neuronal nitric oxide synthase (nNOS) 
display hypertrophy of the pyloric sphincter, and a similar pyloric phenotype was 
obtained in newborn rats by administering L-NAME, an chemical inhibitor of nitric oxide 
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synthase, to pregnant dams [36, 37]. Given the potential role for NO in mediating 
relaxation of the pyloric sphincter muscle, this suggests that the muscular hypertrophy in 
IHPS patients may be due in part to decreased NO signaling. However no clear genetic 
cause has been identified for IHPS [35]. 
 
Embryonic development of the pylorus 
The genetic network of pylorus development is well conserved across vertebrates, despite 
tremendous variation in GI tract morphology [38]. The mouse has two different types of 
stomach epithelium. The anterior stomach, which is also known as the forestomach, has 
stratified squamous epithelium and is similar to the esophagus. The posterior stomach, on 
the other hand, has simple columnar epithelium that is organized into deep glands. Within 
this region of glandular stomach epithelium, there are distinct domains with specialized 
functions, cell types, and gene expression. Cells of the anterior glandular epithelial region 
(i.e., the corpus) secrete digestive enzymes and acid, while those of the posterior 
glandular epithelial region (i.e., the antrum) secrete mucus and regulatory hormones (e.g., 
gastrin). The pylorus, the most distal part of the posterior stomach, is the site of the 
pyloric sphincter, and pyloric epithelium is similar to that of the antrum. 
 
Unique gene expression domains in the posterior foregut mesoderm, site of the future 
pylorus 
Above, I summarized the establishment of organ-specific gene expression in posterior 
foregut endoderm (see Chapter I.2). Similarly, distinctive gene expression patterns 
emerge in the posterior stomach and presumptive pyloric mesoderm: the transcription 
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factor BarH-like homeobox 1 (Barx1) is expressed throughout the stomach; the secreted 
signaling molecules Wnt5a and Bmp4 are restricted to the anterior glandular stomach; 
and the transcription factors sine oculis-related homeobox 2 homolog (Drosophila) (Six2) 
and NK3 homeobox 2 (Nkx3-2/Bapx1) are localized to the posterior glandular stomach 
[38]. On the other hand Bmp4 and Nkx2-3 are expressed in the intestine. This leaves a 
domain in the posterior glandular stomach that is devoid of Bmp4, and in this region, 
Bmp4 expression may be inhibited by Bapx1 and/or Six2 [39, 40]. This domain 
corresponds precisely with the expression of bone morphogenetic protein receptor, type 
1A (Bmpr1a) [38]. Gremlin (Grem1), a secreted inhibitor of Bmp signaling, is expressed 
specifically at the pylorus [41]. The expression of gremlin, coupled with the expression of 
Bmpr1a in the posterior glandular stomach and pylorus, suggests that Bmp signaling 
from the surrounding tissue may be important for patterning the posterior glandular 
stomach and/or the pylorus. 
 
Molecular mechanisms of pylorus development 
Activation of Bmp4 in the mesenchyme of the intestine by secreted Hh from foregut 
endoderm is one of the earliest events in pylorus development [42]. Secreted Bmp4 
ligand binds to BMP receptors (including Bmpr1a) in the posterior stomach and 
subsequent BMP pathway activity cell-autonomously activates Nkx2-5 and Sox9 [43, 44]. 
Since misexpression of Nkx2-5 does not affect Sox9 expression (and vice versa), it 
appears that these two pathways are independently activated by Bmp [41, 43]. 
 
In the chicken, the posterior glandular stomach is called the gizzard, and gizzard 
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epithelium can be distinguished from more posterior pyloric epithelium by its histological 
appearance. Misexpression of Bmp4, Bmpr1b, Nkx2-5 or Sox9 in gizzard mesoderm 
converts the overlying endoderm to pyloric epithelium-type histology [6, 41, 43, 44]. 
Conversely pyloric endoderm can be converted to gizzard-type epithelium by 
misexpression of dominant-negative forms of Nkx2-5 (enrepNkx2-5) or Sox9 
(Sox9 Cter) in pyloric mesoderm (although epithelial conversion by enrepNkx2-5 is 
incomplete) [41, 44]. 
 
Misexpression of gremlin in gizzard mesoderm yields a similar epithelial phenotype to 
Bmp4, Bmpr1b, Nkx2-5 or Sox9 misexpression, suggesting that Nkx2-5 and/or Sox9 may 
specify pyloric epithelium indirectly through regulation of gremlin expression [41]. In 
support of this hypothesis, misexpression of Sox9 or Sox9 Cter in stomach mesoderm 
expands or reduces gremlin expression, respectively. Since Nkx2-5 does not regulate 
Sox9 and a regulatory relationship between Nkx2-5 and gremlin is unclear, the 
mechanism by which Nkx2-5 controls pyloric epithelial phenotype remains unresolved. 
 
In the mouse, pyloric Nkx2-5 expression first appears around E9.5 in discrete, bilateral 
mesodermal domains that flank the primitive gut tube [45]. A day later at E10.5 these 
domains expand to form a complete, circumferential ring around the gut at the site of the 
future pylorus. This domain also gives rise to the spleen. A condensation of splenic 
precursor cells (SPCs) that express Nkx2-5 arises on the dorsal side of the pyloric band. 
From E10.5-E14.5 SPCs migrate anteriorly through the gastric mesothelium, along the 
greater curvature of the stomach. After E14.5 the migration of SPCs ends, and there are 
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distinct pyloric and splenic domains of Nkx2-5 expression. 
 
A number of genetic mouse models exist for the study of pyloric development. Nkx2-5 
null embryos have significant heart defects and die by E10, while Sox9 heterozygous 
mice display skeletal abnormalities and die perinatally [46, 47]. Thus in the absence of 
appropriate conditional genetic models the lethality of these mutations has precluded a 
functional analysis of either Nkx2-5 or Sox9 during mouse pylorus development. Gremlin 
null mice show significant limb defects and die perinatally, but a pyloric phenotype has 
not been reported [48]. In contrast, mutant mouse models for Six2, Bapx1, and Barx1 are 
all associated with loss of the pyloric constriction [39, 49, 50]. While neither loss of Six2 
nor Bapx1 significantly alters Nkx2-5 expression, the expression of Sox9 in pyloric 
mesenchyme is almost completely lost in Six2 null embryos [39, 50]. In addition loss of 
Six2 is associated with an expansion of Bmp4 expression into posterior stomach 
mesoderm [39]. 
 
These data indicate that the genetic network of pylorus development is largely conserved 
between chicken and mouse. Still many questions remain about the molecular details of 
pylorus patterning. To address this issue, a part of my thesis work involved a microarray 
analysis of pylorus development (see Chapter II). From these studies we uncovered many 
more genes with exquisitely precise patterning at the pylorus and focused on the 
functional role of one of these, the zinc finger transcription factor GATA binding protein 
3 (Gata3), in pylorus development. This study successfully revealed changes in several 
signaling pathways during pylorus development. One of the most dramatic changes was 
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the downregulation of Hh signaling in the intestine, but not the stomach. Previous studies 
in the Xenopus model had shown that a reduced level of Hh signaling in the intestine is 
required for proper cytodifferentiation of that organ [51]. While Hh is downregulated in 
intestine at this time, it is not extinguished, and Hh signaling continues to play important 
roles in smooth muscle development, lipid absorption, and inflammatory signaling in the 
adult intestine. 
 
The fact that Hh signals are centrally involved in both embryonic and adult gut 
morphogenesis and function led me to further examine the molecular targets through 
which Hh signals impact gene expression. In the following sections, I will first review the 
roles of Hh in gut tube patterning. Second, I will discuss what is known about Hh-
regulated transcriptional enhancers. Finally, I will analyze current in silico tools for 
detection of signaling-regulated enhancers. 
 
I.4. Hh signaling in the late embryonic and adult GI tract 
 
Throughout embryonic and adult life from the antrum to the colon, Hh signaling is 
exclusively paracrine: Hh ligands are secreted from the epithelium and signal to the 
surrounding mesenchyme [52]. Hh signaling is essential for the development and 
maintenance of mesenchymal and epithelial cell types in the gut; mice with perturbed Hh 
signaling have significant GI defects [8]. In much of the GI tract, Hh signals pattern the 
mesenchyme directly but epithelium indirectly. 
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Distinct mesenchymal cell populations in the gut transduce Hh signals [52]. For example, 
smooth muscle cells of the muscularis externa, muscularis muscosa, and villus core as 
well as mesothelial cells of the serosa respond to Hh signals, while neurons of the enteric 
nervous system do not. Myeloid cell populations in the colon, including dendritic cells 
and macrophages, can also directly respond to Hh signals [53]. Here I will summarize the 
molecular components of the Hh signaling pathway. Then, I will describe late 
developmental roles for Hh signaling in stomach and intestine and a homeostatic function 
for Hh in adult intestine. 
 
The Hh pathway is highly conserved in eukaryotes 
Invertebrates: Hh signaling in D. melanogaster 
Components of the Hh pathway were first identified during a forward genetic screen for 
embryonic lethal mutations in D. melanogaster [54]. Genetic mutants for hedgehog (Hh), 
the sole D. melanogaster Hh ligand, or its transmembrane receptor patched (Ptc) have 
characteristic larval cuticle patterns arising from segmentation defects in the early 
embryo. In the absence of Hh ligand, Ptc inhibits the activation of the transmembrane 
protein smoothened (Smo). When Smo activation is inhibited, the downstream 
transcriptional effector cubitus interruptus (Ci) is proteolytically-cleaved to a repressor 
form (Ci
R
) [55]. Upon binding of Hh to Ptc, Smo is activated and prevents formation of 
Ci
R
. At high levels of Hh binding, Smo facilitates the production of activator Ci (Ci
A
). 
 
Vertebrates: Hh signaling in the mouse 
With a few notable exceptions Hh signaling in vertebrates is directly analogous to D. 
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melanogaster. In the mouse there are three ligands [i.e., Shh, Ihh, and desert hedgehog 
(Dhh)], two receptors [i.e., patched homolog 1 (Ptch1) and Ptch2], and three intracellular 
transcriptional effectors [i.e., GLI-Kruppel family member GLI1 (Gli1), Gli2, and Gli3] 
[55]. In the absence of Hh ligand, Ptch1 inhibits smoothened homolog (Smo) 
(orthologous to D. melanogaster Smo), and Gli2 and Gli3 are converted to repressor 
forms (Gli
R
). Hh ligand binding to Ptch1 releases its inhibition of Smo activation and 
promotes formation of activated Gli2 and Gli3 (Gli
A
). Gli1 is an obligate transcriptional 
activator. Gli1 levels are not directly regulated by Smo, but instead are controlled 
transcriptionally via Gli
A
. 
 
Hh signaling affects epithelial and mesenchymal cells in the GI tract 
Intestinal epithelium 
While neither Shh nor Ihh is required per se for the formation of intestinal villi, a 
transgenic model of strong, intestine-specific Hh inhibition [expression of a soluble form 
of Hedgehog-interacting protein (Hhip), a pan-Hh inhibitor, in intestinal epithelium; 
12.4KVillin-Hhip] shows significant epithelial defects, including loss of villi in animals 
in which Hhip is expressed at high levels [8, 56]. These mice exhibit neonatal wasting 
due to perturbations in enterocyte differentiation and poor intestinal absorption [56]. In 
mice expressing lower levels of the Hhip transgene, the crypt/villus axis pattern is 
perturbed: ectopic pre-crypt pockets are found on the upper villus, where they contribute 
to bizzarely branched villi. Both villus smooth muscle patterning and myofibroblast 
localization is perturbed as well. 
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Stomach epithelium 
Loss of Shh leads to a dramatic overgrowth of glandular epithelium in the posterior 
stomach [8]. While Gli3 null mutants show similar glandular overgrowth, Gli2 null 
mutants have apparently normal stomachs [57]. This suggests that, in contrast to its 
predominant role as a repressor in other tissues (i.e., the neural tube), Gli3 may function 
primarily as an activator in the stomach. 
 
Muscularis externa 
Hh signaling from the endoderm is also required for the development and proper 
positioning of smooth muscle in the intestine. High levels of epithelial Hh signaling are 
thought to inhibit smooth muscle differentiation via activation of Bmp4, and exclusion of 
smooth muscle from the area immediately surrounding the gut tube may be required for 
the correct positioning of the muscularis externa [58]. Alternatively Hh may act directly 
on smooth muscle of the muscularis externa, as loss of either Shh or Ihh shows a reduced 
muscularis externa [8]. A similar smooth muscle phenotype is observed in the 
12.4KVillin-Hhip model of decreased intestinal Hh signaling, as well as Foxf2 null and 
Foxf1/Foxf2 compound heterozygote mice [11, 56]. Foxf1 and Foxf2 may also be targets 
of Hh signaling in the intestine [11]. 
 
Villus smooth muscle 
Unpublished data from our laboratory indicates that Hh signals control differentiation of 
the smooth muscle of the villus core, which is a distinct muscle population from the 
muscularis externa. Villus smooth muscle is dramatically expanded in postnatal 
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transgenic mice that overexpress Ihh in the intestine (Villin-Ihh). Conversely, villus 
smooth muscle differentiation is significantly reduced by inhibition of intestinal Hh 
signaling in postnatal bitransgenic mice (VFHhip; Villin-Cre x Villin-loxP-LacZ-loxP-
Hhip). Exogenous application of Hh ligand or forced expression of constitutively active 
Gli2 in cultured smooth muscle precursor cells stimulates smooth muscle differentiation 
and upregulates the smooth muscle master regulator myocardin (Myocd). 
 
Immune cells 
Finally, recent evidence implicates Hh signaling in the homeostatic control of immune 
cells in the adult intestine [53, 59]. In three separate European sample populations, a non-
synonymous SNP in the coding region of GLI family zinc finger 1 (GLI1) (the human 
ortholog of Gli1) is associated with inflammatory bowel disease, in particular ulcerative 
colitis [53]. This mutation decreases GLI1 transactivation in transfected cells, and Gli1 
heterozygous mice exhibit increased susceptibility to an inflammatory stimulus. In 
addition reduced intestinal Hh signaling in VFHhip transgenic mice is associated with 
spontaneous inflammation [59]. Taken together these data suggest that reductions in Hh 
pathway activity may be pro-inflammatory. 
 
I.5. Hh regulation of gene expression 
 
The diversity of cellular responses to a single source of Hh signal in the GI tract suggests 
a complex regulation of Hh target gene activation in gut mesenchyme. Secreted Hh 
ligands can act as morphogens and elicit distinct transcriptional responses at discrete 
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distances from the source of the signal [60]. Examples of Hh morphogen activity are 
found throughout eukaryotic evolution, including the larval imaginal wing disc in D. 
melanogaster and the neural tube in mice [61, 62]. Cell type-specific transcriptional 
response of Hh target genes is tightly controlled by a number of mechanisms, including 
sequence-specific binding of the repressor (Ci
R
/Gli
R
) and activator (Ci
A
/Gli
A
) forms to 
cis-regulatory elements (i.e., enhancers) in genomic DNA [55]. Here I will introduce 
known Hh-regulated enhancers in D. melanogaster and outline in silico methods to 
identify novel enhancers from analysis of genomic sequence. 
 
The structure of Hh-regulated enhancers in D. melanogaster 
In D. melanogaster Hh signaling is essential for establishing segment polarity in the early 
embryo and A-P patterning in the larval imaginal discs [55]. During segmentation hh is 
expressed in repeating stripes of epidermal cells at the parasegmental borders [63]. 
Secreted Hh diffuses anteriorly and posteriorly to activate target gene expression. Thus 
many early embryo Hh targets are expressed in repeating stripes, including the Wnt 
ortholog wingless (wg). In the larval imaginal wing and leg discs, Hh is expressed in the 
posterior compartment and signals to the anterior compartment [55]. Hh activates 
expression of wing and leg disc target genes, including the Bmp ortholog 
decapentaplegic (dpp), in a stripe of cells along the A-P boundary. Hh-regulated 
enhancers have been characterized for ptc, wg, dpp and the Notch-regulated Hes1 
ortholog hairy [64-67]. Despite their shared responsiveness to Hh signals, these 
enhancers exhibit substantial structural variation. 
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ptc canonical enhancer 
ptc is the canonical Hh target in D. melanogaster and one of few known orthologous 
targets (Ptch1) in the mouse [68, 69]. In Hh-responsive tissues activation of the Hh 
inhibitor Ptc serves as an important negative feedback mechanism that controls the range 
and duration of Hh signaling [70]. In larval imaginal wing discs of transgenic flies the ptc 
canonical enhancer activates reporter gene expression in a thin stripe of cells along the A-
P compartmental boundary adjacent to Hh-expressing cells [64]. The ptc canonical 
enhancer is about one kilobase (kb) upstream of the ptc transcriptional start site and 
contains three closely-spaced, optimal consensus Ci binding sites (GACCACCCA). 
Deletion of these sites completely eliminates A-P compartmental boundary expression in 
vivo. 
 
h leg disc enhancer 
In leg imaginal discs the basic helix-loop-helix (bHLH) transcription factor hairy is 
expressed in a dorsal stripe along the A-P compartmental boundary, where it represses the 
formation of microchaete sensory bristles [71]. Hh is secreted by cells in the posterior 
compartment and signals to cells in the anterior compartment, and Hh pathway activity 
activates hairy expression in a narrow domain, just a few cells anterior to the A-P 
compartmental boundary. This pattern is regulated by the hairy leg disc enhancer, which 
is located between 30-35 kb downstream of the hairy transcriptional start site [67]. This 
enhancer contains two putative, non-optimal Ci binding sites: GACCTCCCA and 
GACCACCAT (nucleotide deviations from the optimal consensus are underlined). 
Directed mutagenesis of these sites reduced competitive binding to Ci protein in vitro, 
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and the presence of either mutant site (or both) eliminated reporter gene expression along 
the A-P compartmental boundary in vivo. 
 
wg embryo enhancer 
In the early embryo Wg regulates denticle formation, which leads to alternating bands of 
naked and denticular cuticle [54]. During segmentation, Hh is secreted from cells 
immediately posterior to the parasegmental borders, and Hh signaling in adjacent anterior 
cells activates wg expression via the wg embryo enhancer [65, 72]. This enhancer is 
located approximately five kb upstream of the wg transcriptional start site and contains 
four putative, non-optimal Ci binding sites: GAGCAGCCA, GTCCACGCT, 
GTTCACGCA, and GACCTCCCA (nucleotide deviations from the optimal consensus 
are underlined) [65]. Cumulative, directed mutagenesis of these sites reduces response to 
Hh signaling in vitro and specifically eliminates the segmental stripe pattern of reporter 
gene expression in the early embryo in vivo. 
 
dpp wing disc enhancer 
dpp is essential for proper A-P patterning of the wing imaginal disc and like ptc is 
expressed in a stripe along the A-P compartmental boundary [73, 74]. Unlike ptc, 
however, dpp is excluded from cells just anterior to the A-P compartmental boundary, 
likely via transcriptional repression by the homeodomain protein engrailed (en) [75]. Hh 
pathway activity in anterior compartment cells directs dpp expression via the dpp wing 
disc enhancer, which is located more than 20 kb downstream of the dpp locus and 
contains three putative, non-optimal Ci binding sites: GGCCACCTA, GACCGCCCG, 
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and TACCTCCCC (nucleotide deviations from the optimal consensus are underlined) 
[66]. In the wing disc, Hh signaling establishes opposing A-P gradients of Ci
R
 and Ci
A
; 
Ci
R
 levels are highest furthest from the A-P compartmental boundary and vice versa for 
Ci
A
. Deletion or directed mutagenesis of the putative Ci sites in the dpp wing disc 
enhancer expands (and shifts) reporter gene expression anteriorly in vivo. This suggests 
that in addition to Hh-independent local activators, input from both Ci
R
 and Ci
A
 are 
required for proper transcription control by the dpp wing disc enhancer. Ci
R
 defines the 
anterior dpp expression boundary by limiting the effect of local activators to the region 
transducing Hh signals, while Ci
A
 is necessary for activation close to the A-P 
compartmental boundary. 
 
Summary: general properties of Hh-regulated enhancers? 
It is clear from the varied location and structure of these enhancers that there is 
tremendous mechanistic diversity of Hh-regulated gene expression. At the same time, 
however, several important commonalities begin to emerge including the type and 
distribution of Ci binding sites. Despite being essential for proper reporter gene 
expression in vivo, most of the putative sites in these enhancers do not correspond to the 
optimal consensus. In fact of the enhancers described above, optimal consensus Ci 
binding sites are only found in the ptc canonical enhancer, which has three such sites 
clustered tightly together [64]. ptc is unique in that it is a universal Hh-responder (i.e., it 
responds to Hh signals in all cellular and tissue contexts). All other characterized Hh 
enhancers are context specific and may thus require non-optimal sites. Indeed, 
unpublished work from Dr. Scott Barolo’s laboratory (Department of Cell and 
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Developmental Biology, University of Michigan) shows that substitution of optimal 
consensus Ci sites for non-optimal Ci sites in the wg embryo enhancer and dpp wing disc 
enhancer disrupts reporter gene expression. These results indicate that non-optimal Ci 
sites are required for proper activation of some Hh-regulated enhancers. 
  
Another characteristic of these enhancers is the presence of multiple putative Ci binding 
sites. While the requirement for individual sites has not been rigorously examined in all 
of the enhancers, analysis of the hairy leg disc enhancer revealed that mutagenesis of 
either Ci site significantly altered reporter gene expression [67]. Similarly mutagenesis of 
the dpp wing disc enhancer demonstrated the individual requirement for two of its three 
putative Ci sites [66]. Taken together these data suggest that clustering of non-optimal Ci 
binding sites may be a general property of many cell type-specific Hh-regulated 
enhancers. Indeed, functional clustering of transcription factor binding sites has been 
noted in several other contexts [76-78]. 
 
Genome-wide methods of enhancer identification 
Experimental approaches 
The identification of enhancers is integral to the establishment of transcriptional 
relationships in gene regulatory networks, and until recently this was a laborious 
experimental task analogous to the mapping and cloning of genes [79]. For example in D. 
melanogaster large-scale, genome-wide “enhancer trapping” screens were carried out by 
random insertional transgenesis [80]. Reporter gene expression patterns of interest (e.g., 
larval imagine wing disc) were selected for further analysis, and once the genomic 
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position of the transgenic insertion was mapped, surrounding genomic regions could be 
analyzed for their ability to direct transgene expression in the expected pattern [81]. 
 
The emergence of chromatin immunoprecipitation (ChIP) techniques to characterize 
protein-DNA interactions in cells and tissues has changed the way enhancers are studied 
[82]. In particular, ChIP experiments that are combined with new technologies for 
genome-wide nucleotide profiling (i.e., ChIP-on-chip and ChIP-seq) have greatly 
increased the identification of cell- and tissue-specific DNA binding events for a given 
transcription factor [83]. However the degree of correlation between transcription factor 
binding events and enhancer activity for a given ChIP experiment is unpredictable and 
likely depends on both intrinsic biological properties and extrinsic experimental 
variables. Technical issues arising from the ChIP experiment itself (i.e., sensitivity and 
specificity of the immunoprecipitation step) can affect the reliability of the results, and 
the interpretation of ChIP data is subject to the spatiotemporal limitations of the analyzed 
cells or tissues. Recent Gli1 and Gli3 ChIP experiments in neuralized mouse embryoid 
bodies (EBs) and the developing mouse limb, respectively, have identified many novel 
Gli binding regions in the genome [84, 85]. While a surprising number of these regions 
are bound by Gli protein in both neuralized EBs and the limb, their Gli protein-binding 
status in intestinal mesenchyme, for example, is unclear. 
 
In silico approaches: general considerations 
The availability of high quality sequence data in the post-genome era, concomitant with 
the elucidation of DNA binding preferences for specific transcription factors, has 
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facilitated the development of genome-wide in silico methods to identify potential 
enhancers. A fundamental aspect of many of these approaches is finding the location of 
putative transcription factor binding sites in genomic sequence, which can be 
accomplished in a variety of ways. For example a set of consensus binding sites for a 
given transcription factor can be represented by an IUPAC nucleotide string, and matches 
to that string can be identified quickly in genomic sequence [86]. While simple and 
convenient, information about the binding preferences for that transcription factor is lost, 
including position-specific tolerance (or intolerance) to nucleotide substitution. 
 
An alternative to IUPAC string representation is the construction of a mono-nucleotide 
distribution matrix, which contains the complete frequency distribution of nucleotides for 
a set of transcription factor binding sites [87]. In such matrices there are four rows, each 
pertaining to a specific nucleotide (A, C, G or T) and n columns (where n is the number 
of positions in the binding site). Each element in the matrix corresponds to the relative 
frequency (or weight) of a given nucleotide at a particular position. Hence mono-
nucleotide distribution matrices are commonly referred to as position-weight matrices 
(PWMs). Matrix representation facilitates the analysis of putative binding sites and, in 
particular, non-optimal sites, including those that were not present in the initial set or are 
difficult to detect because of nucleotide substitutions at multiple positions. PWMs are 
also suitable for representing data from in vitro DNA binding assays [88]. 
 
There are at least two methods for evaluating binding sites with PWMs. The log-odds 
score compares the probability of a putative site given the distribution of nucleotides in a 
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PWM to the probability in “background” sequence. Large, positive values indicate a high 
degree of similarity to the PWM and potential binding [89]. A weakness of the log-odds 
score is its reliance on the estimation of background probability. Alternatively the 
MatInspector method gauges the similarity of a putative site to the optimal consensus site 
(“% matrix similarity”); a high % matrix similarity score indicates potential binding [90]. 
This method weights specific positions in a PWM by the “conservation” (i.e., relative 
distribution) of nucleotides. Positions with invariant nucleotides are maximally weighted, 
while those with evenly-distributed nucleotide frequencies are unweighted. Thus 
nucleotide substitutions at unweighted positions have little effect on the overall % matrix 
similarity, while those at maximally weighted positions significantly reduce % matrix 
similarity. In either case a minimum score threshold must be set in order to establish a set 
of potential binding sites. Changing the threshold alters the balance between sensitivity 
and specificity of binding site selection (i.e., raising the threshold increases specificity at 
the expense of sensitivity). 
 
Once putative transcription factor binding sites have been identified in genomic 
sequence, their distribution can be analyzed for patterns correlated with known 
enhancers. For example because enhancers are often associated with regions of high 
interspecies sequence conservation, many in silico approaches utilize pairwise or multiple 
species sequence alignments. 
 
In silico approaches: signaling-regulated enhancers 
Two methods have been described for the identification of Hh-regulated enhancers in 
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vertebrates: Enhancer Element Locator (EEL) and Module Cluster Analysis (MCA) [84, 
91]. EEL locates conserved binding sites in pairwise orthologous sequence alignments 
and uses PWMs and log-odds scores to estimate the energy of transcription factor binding 
(i.e., “primary interaction”) [91]. It then assesses the potential energy from physical 
interaction between transcription factors (i.e., “secondary interaction”) by measuring the 
predicted distance and angle between consecutive conserved sites in DNA. Finally EEL 
calculates a score to estimate the relative contributions of primary and secondary 
interactions to the total energy of an enhancer element, and this score can be used to rank 
potential enhancers. Using genome-wide, mouse-human pairwise sequence alignments 
and PWMs for Gli proteins, EEL identified a set of predicated Hh-regulated enhancers. In 
transgenic mice three of four tested enhancers showed reporter gene patterns consistent 
with Hh target gene activation. 
 
In contrast to EEL, MCA analyzes orthologous sequence alignments of multiple, 
evolutionarily-distant vertebrate species (i.e., mouse, rat, human, dog, and zebrafish), and 
identifies highly conserved, non-coding sequence in the mouse genome [84]. It then uses 
PWMs and log-odds scores to locate transcription factor binding sites in the conserved 
sequence. The occurrence of sites in these sequences is modeled as a Poisson process, 
and MCA calculates a score to measure the enrichment of binding sites and rank potential 
enhancers. Using a PWM for Gli1 derived from ChIP-on-chip experiments in neuralized 
embryoid bodies (EBs), a genome-wide screen with MCA identified a set of predicted 
Hh-regulated enhancers, and a small subset (7 of 16) of these enhancers was associated 
with novel Gli1 ChIP peaks in neuralized EBs. 
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Another in silico approach, Site Clustering Over Random Expectation (SCORE), has 
successfully identified enhancers in D. melanogaster, and in contrast to EEL and MCA it 
does not consider sequence conservation [77]. Instead SCORE assesses the genome-wide 
distribution of binding sites and discriminates between statistically non-significant and 
significant clustering. SCORE tallied the length of each unique cluster of n sites in the D. 
melanogaster genome. It then compared the observed frequency of a particular length for 
a given cluster size n to the average expected frequency from repeated, independent 
Monte Carlo simulations to calculate a “purity” score [purity = (observed – average 
expected) / observed]. Monte Carlo simulations were performed by randomizing binding 
site positions within the entire genomic space and repeating the tallying process used for 
the D. melanogaster genome. A particular length for a given cluster size n was classified 
as statistically significant if the expected frequency was greater than the observed 
frequency in fewer than five out of 1,000 Monte Carlo simulations. The purity score of 
statistically significant clusters gives an estimation of the false positive rate (i.e., high 
purity scores have high specificity). Using a set of consensus sites for the Notch pathway 
transcriptional effector Suppressor of Hairless [Su(H)], SCORE identified a set of 
predicted Su(H)-regulated enhancers in D. melanogaster. These enhancers are correlated 
with known Su(H) transcriptional targets, and at least one enhancer directs reporter gene 
expression in a Su(H)-dependent manner. 
 
Despite its success in detecting Notch-regulated enhancers in D. melanogaster, the 
SCORE method has a number of potential weaknesses. First, it relies on IUPAC string 
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representation to define the set of input binding site sequences, and consequently misses 
many non-optimal sites. Second, its clustering parameters are set manually prior to the 
analysis, instead of being derived from the sequence data itself. Third, the contribution of 
multiple overlapping statistically significant clusters to a single binding site is not 
assessed. Fourth, the Monte Carlo method of background estimation does not aptly 
account for the effect of %G-C content on the expected binding site distribution. Finally, 
SCORE analysis is not integrated with an assessment of evolutionary conservation, either 
sequence or functional. Taken together these factors reduce the sensitivity and specificity 
of SCORE, and indicate the need for computational methods that improve enhancer 
detection in silico. Such an approach is detailed in Chapter IV and should be an important 
tool in the identification of Hh-regulated enhancers. 
 
I.6. Summary and thesis outline 
 
Despite early embryonic patterning of posterior foregut endoderm by signaling molecules 
and the FoxA, Cdx, Sox2, and Pdx1 transcription factors, mature intestinal and stomach 
epithelial cell identities (i.e., expression of terminal differentiation genes) do not emerge 
until late embryogenesis. This suggests that a separate late patterning event may be 
required to establish epithelial cellular identity at the pylorus, and we hypothesized that 
such an event takes place between E14.5 and E16.5, concomitant with the restriction of 
villin expression to intestinal epithelial cells. In Chapter II, I describe transcriptomic 
changes surrounding the pylorus between E14.5 and E16.5 and report a unique domain of 
gene expression at the pylorus itself. 
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From the data presented in Chapter II, Gata3 was identified as a novel pylorus-specific 
gene at E14.5 and E16.5. A role for Gata3 in gut development has never been described, 
but we hypothesized that Gata3 may be required for morphogenesis of the pylorus. In 
Chapter III, I describe the effect of loss of Gata3 on the development of the pylorus and 
its smooth muscle sphincter. 
 
Despite the paucity of confirmed Hh target genes in intestinal mesenchyme, Hh-
dependent, cell-specific gene expression is essential for gut development and adult 
intestinal homeostasis. We hypothesized that Hh-regulated enhancers could be 
prospectively identified in silico. In Chapter IV, I outline a method to analyze the 
genome-wide distribution of Ci binding sites in D. melanogaster and describe the 
precision of subsequent enhancer predictions.  Finally, in Chapter V, I will discuss the 
application of this thesis to future research.
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CHAPTER II 
 
DYNAMIC PATTERNING AT THE PYLORUS: FORMATION OF AN 
EPITHELIAL INTESTINE-STOMACH BOUNDARY IN LATE FETAL LIFE 
 
In the adult mouse, distinct morphological and transcriptional differences separate 
stomach from intestinal epithelium. Remarkably, the epithelial boundary between these 
two organs is literally one cell thick. This discrete junction is established suddenly and 
precisely at E16.5, by sharpening a previously diffuse intermediate zone. In the present 
study, we define the dynamic transcriptome of stomach, pylorus and intestinal tissues 
between E14.5 and E16.5. We show that establishment of this boundary is concomitant 
with the induction of over a thousand genes in intestinal epithelium, and these gene 
products provide intestinal character. Hence, we call this process intestinalization. We 
identify specific transcription factors [i.e., hepatocyte nuclear factor 4, gamma (Hnf4 , 
cAMP responsive element binding protein 3-like 3 (Creb3l3), and transcription factor EC 
(Tcfec)] and examine signaling pathways [i.e., Hh and Wnt] that may play a role in this 
process. Finally, we define a unique expression domain at the pylorus itself and detect 
novel pylorus-specific patterns for the transcription factor Gata3 and the secreted protein 
nephrocan (Nepn). 
 
II.1. Introduction 
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The vertebrate GI tract consists of a series of connected organs (i.e., esophagus, stomach, 
small intestine, large intestine), each with a highly specialized epithelial surface that 
enables it to perform a distinct function during digestion. In adults, the epithelial 
boundaries between some of these adjacent organs are remarkably sharp. At the pylorus, 
for example, gastric and intestinal cells lie directly next to one another, without a 
transitional cell type (i.e., the epithelial pyloric border) [1]. 
 
Such discrete organ boundaries have fetal origins. In the embryo, the gut tube is molded 
from endoderm, along with its associated splanchnic mesoderm [2]. Anteroposterior 
patterning of the GI tract begins even before tube formation is complete; by E10 the 
developing gut tube has a clear Hox code that marks out the major organ domains and 
future sphincter locations [3]. Expression patterns of other gut transcription factors are 
also established early, including: the HMG-box protein Sox2 in early endoderm of the 
stomach domain [4], the caudal-related parahox factor Cdx2 in presumptive intestinal 
endoderm [5], and the homeodomain protein Nkx2-5 in a thin band of mesenchymal cells 
at the site of the future pylorus [6]. Despite this pattern, the epithelial surface exhibits few 
obvious morphological differences from stomach to intestine, even as late as E14.5. 
 
While examining the expression pattern of villin, an intestine-specific actin bundling 
protein, we previously found that, at E14.5, it is expressed in a diminishing gradient 
(posterior to anterior) at the pyloric border. Two days later however, at E16.5, a sharp 
anterior expression boundary resolves: villin is detected at high levels in intestinal cells, 
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while neighboring gastric cells exhibit little or no expression [1]. We speculated that the 
formation of this boundary may reflect an important epithelial compartmentalization 
event in the GI tract. If so, it is remarkable for its late timing, more than five days after 
the initial establishment of the broad territorial domains that specify the location of 
stomach and intestine. 
 
In the present study, we sought to determine whether compartmentalization of villin 
expression is accompanied by the formation of similar dramatic expression boundaries 
for other genes. Microdissection and microarray analysis was used to examine gene 
expression patterns at and around the pylorus at E14.5 and E16.5. Our data reveal that at 
E14.5, the transcriptomes of stomach, pylorus and intestine are only subtly different. At 
E16.5, however, hundreds of genes are coordinately upregulated in intestine. 
Remarkably, this transcriptional burst is seen in the intestinal epithelium but not the 
mesenchyme, and the batteries of activated genes are involved in the prototypical 
intestinal functions of absorption and metabolism. Interestingly, a similar large scale 
burst of gene induction does not occur in the stomach; the transcriptome of this organ 
changes little between E14.5 and E16.5. We identify several upregulated transcription 
factors (i.e., Hnf4 , Tcfec, and Creb3l3), which, similar to villin, exhibit dramatic pyloric 
expression boundaries at E16.5. We also investigate signaling pathways (i.e., Hh and 
Wnt) that may be modulated during this compartmentalization event. Finally, we uncover 
novel genes with expression patterns that are restricted to the pyloric region itself and 
could participate in this patterning event. These include genes that encode the zinc finger 
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transcription factor Gata3 and the secreted transforming growth factor, beta (TGF-  
modulator nephrocan. 
 
II.2. Materials and methods 
 
Tissue collection 
Embryos from C57BL/6J mice were collected from timed pregnant females, with the day 
of vaginal plug detection considered day 0.5. Intestine and stomach were removed and 
three contiguous segments were collected from antrum (stomach), pylorus, and 
duodenum (Figure II.1). For the microarray experiment, a total of 174 E14.5 embryos and 
95 E16.5 embryos were dissected, and for each time/tissue group (e.g., E14.5 duodenum; 
six groups total), collected tissue was randomly pooled into one of three samples for 
replicate analysis. Total RNA was isolated with TRIzol and purified using the RNeasy 
kit, per the manufacturers’ instructions. Separate collections were performed for RT-PCR 
and qPCR validation of microarray results. 
 
Microarray processing 
RNA samples were hybridized to MOE 430.2 microarrays (eighteen total chips: six 
time/tissue groups, three replicate chips for each group) by the University of Michigan 
Cancer Center Microarray
 
Core Facility. Microarrays were scanned and processed using 
GCOS software (Affymetrix) and the resulting .CEL files were analyzed using RMA 
(Robust Multiarray Average; affy package in BioConductor; www.bioconductor.org), 
which does background adjustment, normalization and conversion of probeset intensity 
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data to log2 expression values [7, 8]. Probeset expression values were imported into MeV 
(Multi-experiment Viewer; www.tm4.org) for evaluation of statistical significance using 
the Student’s t-test [9]. Replicate probeset expression values were averaged and log fold 
change (LFC) was determined by calculating the difference between any two groups 
[e.g., LFC = log2(E14.5 duodenum)avg - log2(E14.5 stomach)avg], which was then 
converted to numerical fold change (FC) [if LFC > 0, FC = 2
(LFC)
; else, FC = -(2
(-LFC)
)]. 
Probesets with a p-value less than 0.05 and |FC| greater than 2 were selected for further 
analysis. To provide independent validation for the array results, we evaluated gene 
expression by RT-PCR. These results, shown in Figure II.2, reveal concordance with the 
array findings. Functional Annotation Clustering in DAVID, using the default options 
and “Medium” Classification Stringency, was performed with the following sets of Gene 
Ontology terms: GOTERM_BP_ALL, GOTERM_MF_ALL, PANTHER_BP_ALL and 
PANTHER_MF_ALL. 
 
In situ hybridization 
Staged E14.5 and E16.5 C57BL/6J embryos were dissected in DEPC-treated 1X PBS. 
Isolated gastrointestinal tracts were fixed overnight at 4°C in 4% PFA, embedded in 
paraffin, and cut into 5 m sections. In situ hybridization was performed as described 
previously [10]. Specific probes used for in situ hybridization included: Gata3 
(NM_008091.3; 1028-1591 bp), nephrocan (NM_025684.2; 758-1450 bp), Sfrp5 
(NM_018780.2; 203-985 bp), Creb3l3 (NM_145365.3; 683-1361 bp), Tcfec 
(NM_031198.2; 258-789), Grem1 (NM_011824.4; 487-1281), and Axin2 
(NM_015732.4; 2227-3358). 
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Antibodies and immunostaining 
Staged E14.5 and E16.5 C57BL/6J embryos were dissected in 1X PBS. Excised 
gastrointestinal tracts were fixed for overnight at 4°C in 4% PFA, embedded in paraffin, 
and cut into 5 m sections. Vectastain ABC was used for Hnf4γ immunohistochemistry, 
per the manufacturer’s instructions. Sox2 immunofluorescence was performed as 
described previously [11]. Briefly, sections were deparaffinized in xylene, rehydrated 
through increasing alcohol concentrations, and boiled for 10 minutes either in Antigen 
Unmasking Solution (Vector Laboratories, CA) (Sox2) or 10 mM sodium citrate, pH 6.0 
(Hnf4γ). Slides were allowed to slowly cool down and then washed with 1X PBS. The 
sections were blocked with 10% donkey serum/0.01% Triton X-100 in 1X PBS for 1 
hour at room temperature. Antibodies used were: rabbit polyclonal anti-Sox2 antibody 
(1:500, Chemicon, MA); goat polyclonal anti-Hnf4γ (1:500, Santa Cruz Biotechnology, 
CA); biotinylated horse anti-goat IgG (1:200, Vector); and, Alexa Fluor 488 donkey anti-
rabbit IgG (1:1000, Invitrogen, OR). Primary antibodies were diluted in blocking solution 
and incubated on slides overnight at 4°C. Slides were washed in 1X PBS prior to 
incubation with appropriate secondary antibodies and DAPI (1:100) (Sox2) for 30 to 60 
minutes at room temperature. After 1X PBS wash, coverslips were mounted with 
ProLong Gold Antifade Reagent (Sox2), or sections were lightly counterstained with 
hematoxylin, dehydrated with serial alcohol/xylene washes and coverslips were mounted 
with Permount. Imaging was done on a Nikon E800 microscope digital imaging system. 
 
X-gal staining 
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Staged E14.5 or E16.5 embryos from genetic crosses of villin
lacZ/+
 or Gli1
lacZ/+
 males with 
C57BL/6J females were dissected on ice in 1X PBS [1, 12]. The gastrointestinal tract was 
excised, fixed with 4% PFA for 10 minutes at 4°C, and washed three times in 1X PBS. 
Tissues were saturated overnight with 30% sucrose (in 1X PBS), embedded and frozen in 
Optimal Cutting Temperature (OCT) compound, and cut into 5 m sections. X-gal 
staining solution was prepared fresh, as follows: 1X PBS (pH 7.5), 2 mM magnesium 
chloride, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 1 mg X-gal 
(from 20 mg/ml stock in DMF). Sectioned tissue was incubated in staining solution at 
37°C and monitored periodically to control staining intensity. Sections were then washed 
three times in 1X PBS, counterstained lightly with eosin and dehydrated with serial 
alcohol/xylene washes, and coverslips were mounted with Permount. Slides were imaged 
on an E800 microscope imaging system.
 
Real-time quantitative RT-PCR (qPCR) 
Staged E14.5 and E16.5 C57BL/6J embryos were dissected in 1X PBS. Samples from the 
duodenum and antrum of individual embryos were collected and RNA was harvested by 
brief vortexing in MELT (Multi-Enzymatic Liquefaction of Tissue) digestion buffer 
(Applied Biosystems/Ambion, TX) and purified using the RNeasy kit. A total of eight 
E14.5 and nine E16.5 samples were obtained (for each tissue). cDNA was prepared with 
the iScript cDNA Synthesis Kit. qPCR reactions were set up using 2X iQ Supermix 
buffer and iQ iCycler 96-well plates and carried out in an iCycler real-time PCR 
detection system. Data were processed using the iCycler program and imported into 
Excel for normalization and statistical analysis. Gli1 Ct values were normalized to Hprt 
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( Ct) and then compared to the average Ct for E14.5 intestine ( Ct). Average Ct 
values were calculated to determine relative fold difference to E14.5 tissue [2^(- Ct)]. 
95% confidence intervals were determined using Excel (CONFIDENCE function). PCR 
conditions were optimized previously in the lab (i.e.- temperature, DMSO, etc; see Table 
II.1). 
 
Reverse transcriptase PCR (RT-PCR) 
Staged E14.5 and E16.5 C57BL/6J embryos were dissected in 1X PBS. Samples from 
four independent collections were separated by tissue type and time point (e.g. - E14.5 
border, E16.5 duodenum, etc.) and then pooled randomly into two groups for replicate 
analysis. Additionally, fragments of contiguous tissue spanning the antrum, border and 
proximal duodenum were collected from E14.5 and E16.5 embryos as an input control. 
Tissue from each group was homogenized in 1 mL of TRIzol by drawing it through a 30-
gauge needle. Total RNA was prepared according to the manufacturer’s instructions, 
purified by consecutive phenol-chloroform (2X) and chloroform (2X) extractions, and 
quantitated by UV spectrophotometry using a NanoDrop. For each RNA sample, two 
independent cDNA preparations were performed using the iScript cDNA Synthesis Kit 
and pooled for subsequent analysis. Negative “No RT” controls for genomic 
contamination were prepared from whole E14.5 and E16.5 RNA in a similar manner. 
PCR was performed on cDNA samples using qRT-PCR-quality primers created by 
Beacon Designer. Individual primer conditions were optimized (i.e.- temperature, number 
of cycles, magnesium chloride, DMSO, etc; see Table II.1) prior to PCR. Products from 
PCR reactions were resolved under UV light with ethidium bromide-loaded, 2% TBE-
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agarose gels. The band intensity of experimental genes was compared to the 
housekeeping gene Hprt. 
 
II.3. Results 
 
Diffuse pyloric expression boundaries at E14.5 
Expression of Cdx2 (an intestinal marker) and Sox2 (a stomach marker) in early foregut 
endoderm was previously examined using whole mount confocal immunofluorescence 
[4]. By E9.5, the staining domains of these two proteins at the pylorus appear to be 
essentially distinct, prompting the authors of the study to propose that Cdx2 repression of 
Sox2 establishes this boundary. Indeed, loss of Cdx2 in the intestinal domain leads to 
increased Sox2 expression and conversion of the epithelium to an esophageal 
morphology [13].  If Cdx2 suppression of Sox2 is responsible for formation of the pyloric 
border and if the expression of these two proteins is compartmentalized across that border 
by E9.5, as suggested by Sherwood et al., then the compartmentalization of villin 
expression, which occurs seven days later at E16.5 (Braunstein et al, 2002), likely 
requires additional cues. 
 
To investigate this more carefully, we examined pyloric Cdx2 and Sox2 expression at 
E14.5 in sectioned material, and compared these patterns to that of villin. As shown in 
Figures II.3A-C, the boundaries of the expression domains of Cdx2 and Sox2 are, like 
that of villin, diffuse at the pyloric region. Thus, it appears that while a regional pattern of 
endoderm identity (Sox2 in stomach and Cdx2 in intestine) is established by E14.5, the 
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precise boundaries of this pattern at the pylorus are not yet mature at the cellular level. 
The discrepancy between these results and those of Sherwood et al. may be explained by 
the use of sectioned material and the much higher magnification used here. 
 
Gastric and duodenal transcriptomes are similar at E14.5 but distinct at E16.5 
To learn more about the process of epithelial pyloric border formation, we analyzed 
global gene expression patterns at and around the developing pylorus. Using C57BL/6J 
mice, small (1-2mm) tissue fragments were microdissected from the pyloric region itself 
(easily recognized grossly by the muscular constriction) and from adjacent stomach and 
duodenum both before (E14.5) and after (E16.5) border formation (Figure II.1). 
Triplicate samples of extracted RNA were processed for microarray. 
 
To assess the similarities and differences among the various tissue samples, and to 
determine the reproducibility of the replicate microarray chips, Principal Component 
Analysis (PCA) was applied, as described in the legend to Figure II.4. The clustering of 
replicate chip samples seen in Figure II.4A demonstrates that the collection process was 
reproducible. Importantly, the three E14.5 tissue samples (stomach, pylorus and 
duodenum) are tightly grouped, indicating that the transcriptomes of these tissues are 
quite similar to one another. In contrast, the three E16.5 groups are clearly different from 
one another and different from the E14.5 groups. Of the three E16.5 groups, the 
duodenum shows the most change from E14.5 to E16.5, as measured by the degree of 
separation between the points along the axis of Principal Component 1 (PC1). PC1, by 
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definition, contains the majority of the variation in the data [14]. In contrast, the stomach 
samples exhibit much less change along the PC1 coordinate. 
 
A dramatic change in the duodenal transcriptome at E16.5 
To identify gene expression changes underlying the emergence of distinct gastric and 
duodenal transcriptomes at E16.5, we assembled a list of all significant pairwise probeset 
enrichments, including comparisons of: a) each tissue at E14.5 to the same tissue at E16.5 
(time axis; three comparisons); and, b) stomach, pylorus and duodenum to one another at 
either E14.5 or E16.5 (tissue axis; six comparisons). A total of 10,499 unique 
differentially expressed probesets were identified for all comparisons. (Due to space 
limitations, we do not present these data here; please see [15]). Of these, 9,137 showed 
significant changes in the time comparisons, 5,909 in the tissue comparisons, and 4,547 
in both. We selected the group of probesets that are dynamic in both time and tissue 
dimensions for further analysis. 
 
Although some genes were unique to the pyloric region (addressed below), the results of 
the PCA analysis (Figure II.4A) shows that the pyloric area generally (with some 
exceptions) exhibits probeset intensity values that are essentially the average of stomach 
and intestine values. Thus, for initial analysis, we compared temporally dynamic 
probesets in stomach and intestine to catch patterning differences that were emerging 
between these two tissues at E16.5. Of the 4,547 time and tissue dynamic probesets, 86% 
(3,917) showed enrichment in either stomach or duodenum at E16.5.  Plotting these 
results in a Venn diagram (Figure II.4B) reveals that from E14.5 to E16.5, probesets 
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exhibiting transcriptional change in the duodenum far outnumber the probesets changing 
in stomach. In the stomach, 1,127 probesets show temporal change, but only 40% of 
these (452) are specific to the stomach. (675 probesets were changed in both stomach and 
duodenum.) In contrast, the robust temporal transcriptional change in the duodenum 
encompasses differences in 3,420 probesets, 80% of which (2,745) change only in the 
duodenum. These temporally dynamic duodenal probesets could be further annotated as 
enriched at E16.5 (i.e., depleted at E14.5) or depleted at E16.5 (i.e., enriched at E14.5). 
Tallying these groups, labeled D16 enriched or D16 depleted, respectively, reveals that 
D16 enriched probesets accounts for 61% (1,664 probesets) of the duodenum-specific 
temporal change. (Due to space limitations, we do not present these data here; please see 
[15]). 
 
Upregulated genes in E16.5 duodenum are primarily epithelial, while 
downregulated genes are mesenchymal 
We were next interested to determine whether the dramatic transcriptional change seen in 
duodenum at E16.5 was primarily due to changes in genes that are expressed in 
epithelium or mesenchyme. In an earlier study, we separated intestinal tissue using non-
enzymatic methods and profiled gene expression in freshly isolated epithelium and 
mesenchyme to create a catalog of epithelial and mesenchymal genes [10]. Though the 
earlier study was done using E18.5 intestine, we reasoned that the 
epithelial/mesenchymal compartmentalization of genes would be largely similar at E16.5 
and E18.5. Thus, using the earlier data, we tagged all D16 enriched and D16 depleted 
probesets as epithelial or mesenchymal. Some probesets could not be classified this way 
due to low expression or expression in both compartments. For classified D16 enriched 
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probesets, the vast majority (98.3%) were epithelial. These striking results predict that the 
formation of the distinct epithelial boundary between stomach and intestine is 
concomitant with a massive transcriptional inductive event in duodenal epithelium. 
Interestingly, and in contrast, 99.6% of compartment classified probesets that were 
depleted at E16.5 were mesenchymal (Figure II.4C). 
 
Dramatic tissue rearrangement accompanies the emergence of intestinal villi between 
E14.5 and E16.5. Thus, we were concerned that the transcriptional changes observed 
might merely reflect an alteration in the ratio of epithelium to mesenchyme. We therefore 
examined the distribution of fold changes seen among D16 epithelial upregulated 
probesets or among D16 depleted mesenchymal probesets (Figure II.4D). This analysis 
revealed that 42% of the probesets in the D16 epithelial group are upregulated at levels 
greater than five-fold; in fact, 20% were upregulated over ten-fold. (Maximum 
upregulation of over 100-fold was seen in the case of four probesets.) However, only 8% 
of the D16 mesenchymal probesets are downregulated by five-fold or more and none are 
downregulated over ten-fold. In fact, nearly 75% of all D16 mesenchymal probesets show 
less than a four-fold change. Thus, we conclude that tissue rearrangement may account 
for some of the low level transcriptional change seen among the downregulated (and 
primarily mesenchymal) probesets. However, the dramatic inductive change observed in 
the epithelial compartment cannot be accounted for by this mechanism. 
 
Duodenal gene expression changes at E16.5 correlate with functional differentiation 
of the small intestine 
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We used functional annotation clustering methods (DAVID; david.abcc.ncifcrf.gov) to 
classify D16 probesets [16]. Since there were only four probesets downregulated in 
epithelium [i.e., Foxa1, glucagon (Gcg), melanoregulin (Mreg), and serine (or cysteine) 
peptidase inhibitor, clade A, member 1C (Serpina1c)] we could not use DAVID analysis 
for this group. However, for the eighteen probesets upregulated in mesenchyme, the most 
enriched annotation terms were apoptosis, immune response and guanosine triphosphate 
(GTP) binding. Conversely, among the 73 mesenchymal probesets that are 
downregulated more than five-fold, we found that cell differentiation, neuronal 
development and cell migration are the most frequent terms represented (data not shown). 
Importantly, for the group of 431 epithelial upregulated probesets, genes involved in 
metabolic processes and cell transport are statistically overrepresented (Table II.2). This 
finding suggests that, between E14.5 and E16.5, there is a compartmentalized, functional 
switch in duodenal gene expression. The mesenchyme downregulates genes involved in 
development and morphogenesis, while the large burst of gene expression in the 
epithelium appears to prepare the intestine for its major role in absorption and 
metabolism. Thus, we can think of this significant epithelial change as a process of 
intestinalization. 
 
Upregulated duodenal transcription factors display a sharp epithelial boundary at 
the pylorus 
It is of interest to identify which transcription factors show significant change during  of 
the epithelium. Table II.3 lists the most enriched transcription factors in the D16 
epithelial group. Among these genes, Tcfec, Creb3l3, nuclear receptor subfamily 2, 
group E, member 3 (Nr2e3), v-maf musculoaponeurotic fibrosarcoma oncogene family, 
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protein B (avian) (Mafb) and Hnf4  exhibit expression levels that are over ten-fold 
enriched in duodenum relative to stomach. Hnf4  is the lesser studied paralog of Hnf4 , 
a protein critical for epithelial function in pancreas, liver and colon [17-19]. Hnf4  is also 
highly expressed in intestinal epithelium, but is only two- to three-fold enriched in 
intestine relative to stomach at both E14.5 and E16.5 (data not shown). The basic leucine 
zipper (bZip) factor Mafb is mutated in kreisler mice, which exhibit morphogenic defects 
in hindbrain and inner ear [20, 21]. Interestingly, a recent genome-wide screen links Mafb 
to polygenic dyslipidemia [22]. Nr2e3 (also known as PNR or photoreceptor-specific 
nuclear receptor) was initially implicated in eye development [23], but a recent study 
demonstrated that it is highly induced in intestinal epithelium during midgestation [24]. 
Neither Tcfec nor Creb3l3 has previously been associated with intestinal gene regulation. 
 
We looked carefully at the expression of three of these highly enriched D16 transcription 
factors to determine whether, similar to villin, they display a sharp, cell-specific anterior 
boundary at E16.5. Immunohistochemical staining for Hnf4  shows both nuclear and 
cytoplasmic staining in the epithelium. At E16.5, cytoplasmic staining extends into the 
stomach, but strong nuclear staining is sharply demarcated at the pylorus (Figure II.5A). 
In situ hybridization reveals a sharp anterior expression boundary for Creb3l3 (Figure 
II.5C) and Tcfec (Figure II.5E) at E16.5. Additionally, for both Creb3l3 (Figure II.5D) 
and Tcfec (Figure II.5F), expression is primarily localized to the differentiated cells of the 
villus tips. Hnf4  nuclear staining also appears to display a diminishing villus-crypt 
expression gradient (Figure II.5B). Thus, activation of these three transcription factors 
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(and likely others in Table II.3) in E16.5 duodenal epithelium appears to be concomitant 
with the maturation of the crypt/villus axis. 
 
Modulation of developmental signaling pathways accompanies formation of the 
epithelial pyloric border 
Soluble signaling factors play major roles in gut patterning, and previous data suggest 
that, in particular, Hh [25] and Wnt [26-28] signaling are critical in the context of 
intestinal differentiation. Thus, we examined the array results for expression of key 
elements of these pathways. We also directly tested, using transcriptional reporter 
readouts, whether there is differential activation of either of these two pathways across 
the pylorus at E14.5 or E16.5. The results are summarized below and presented in Table 
II.4 (Hh) and Table II.5 (Wnt). 
 
Hh pathway 
At E14.5, the Hedgehog ligands Shh and Ihh were expressed similarly in stomach and 
duodenum. However, by E16.5, Shh, which is expressed in the epithelium and signals in 
a paracrine manner to the mesenchyme [29, 30], was specifically downregulated in the 
duodenum (6.7 fold relative to stomach). In accordance with the drop in Shh, all three Gli 
factors (i.e., Gli1, Gli2, and Gli3) were reduced in the duodenum, as were the co-
receptors Ptch1 and Smo and the mouse Fused homolog serine/threonine kinase 36 (fused 
homolog, Drosophila) (Stk36). A number of recently identified pathway modulators [i.e., 
growth arrest specific 1 (Gas1), biregional cell adhesion molecule-related/down-
regulated by oncogenes (Cdon) binding protein (Boc), cell adhesion molecule-
related/down-regulated by oncogenes (Cdon), and RAB23, member RAS oncogene family 
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(Rab23)] were also reduced in duodenum [31-33]. Only megalin (Lrp2), an endocytic 
receptor for Hedgehog ligands [34], is upregulated in epithelium of E16.5 duodenum. 
However, megalin is not dedicated to the transport of Hedgehog ligands and is known to 
transport cholesterol and vitamins among the over 50 molecules that it can bind [35]. 
 
We examined Hedgehog signaling across the pylorus at E14.5 and E16.5 using Gli1
lacZ/+
 
reporter mice as a direct readout of pathway activity [12]. Figure II.6A shows that, at 
E14.5, Gli1
lacZ/+
 staining is similar in stomach and intestine. However, at E16.5, Gli1 
activity is apparently reduced on the duodenal side of the pylorus, but maintained in the 
stomach (Figure II.6B), in agreement with the array results and with another recent study 
[30]. To validate this observation in a more quantitative manner, we assayed Gli1 mRNA 
expression using real-time quantitative RT-PCR (qPCR). When normalized to the 
housekeeping gene Hprt and compared to levels in E14.5 intestine, Gli1 expression was 
significantly decreased in E16.5 intestine (95% confidence interval: 0.8 to 0.3 fold 
change; Student’s t-test: p<0.05; Figure II.6D). In contrast, Gli1 expression in stomach 
did not vary significantly between E14.5 and E16.5 (Figure II.6C). 
 
Wnt pathway 
The expression of several Wnt ligands is modulated during pyloric border formation. At 
E16.5, Wnt4, Wnt5a and Wnt11 show significant enrichment in stomach relative to 
duodenum. The Wnt receptors frizzled homolog 1 (Drosophila) (Fzd1), Fzd2, and Fzd6 
also show significant enrichment in stomach at this time, as do a number of Wnt pathway 
modulators (i.e., secreted frizzled-related protein 1 (Sfrp1), Sfrp2, Sfrp4, dickkopf 
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homolog 2 (Xenopus laevis) (Dkk2), and Dkk3). However, the most robust tissue-specific 
expression pattern of all Wnt pathway components is that of the secreted modulator 
Sfrp5, which is highly duodenum-specific at both E14.5 (32 fold relative to stomach) and 
E16.5 (10.7 fold relative to stomach). Taken together, these findings predict that Wnt 
signaling activity, like that of Hh, is decreased in intestine at E16.5. To investigate this 
further, we explored some of these expression patterns by in situ hybridization.  
 
We first examined Sfrp5 expression. By E14.5, Sfrp5 is robustly expressed in duodenal 
epithelium, with a soft anterior boundary of expression that extends a short distance into 
the stomach (Figure II.7A). By E16.5, when villus formation has begun, this expression 
domain resolves dramatically; Sfrp5 expression is excluded from the villus tips and 
present only in cells of the proliferative intervillus region (Figure II.7B). The localized 
expression of this Wnt modulator (thought to be a Wnt inhibitor) in intervillus cells is 
consistent with the recent study of Kim et al., which concludes that, between E16.5 and 
birth, canonical Wnt signaling is excluded from intervillus regions and restricted to villus 
epithelium [26]. 
 
To clearly define the domain of active canonical Wnt signaling and establish whether a 
gradient of Wnt signaling indeed exists across the pylorus at either E14.5 or E16.5, we 
examined the expression of Axin2, a Wnt target gene and a commonly accepted read-out 
of canonical signaling activity [36]. Previous studies using an Axin2 -galactosidase ( -
gal) reporter mouse suggested that Axin2 is expressed mainly on villus tip cells and 
excluded from intervillus cells [26]. Because the detection of -gal reporter activity in 
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intestinal epithelium can be complicated by the presence of an endogenous -gal activity 
in this compartment (indeed, the endogenous -galactosidase gene Glb1 is more than six-
fold upregulated, specifically in the duodenum at E16.5), we used in situ hybridization 
with an antisense Axin2 riboprobe to directly examine this question. We found that at 
E14.5, Axin2 expression is very low in both stomach and duodenum, indicating that the 
level of canonical Wnt pathway activity is low at this time (Figure II.7C). At E16.5, 
Axin2 expression and therefore, canonical Wnt pathway activity increases considerably, 
but no visible gradient of canonical signaling activity can be detected across the pyloric 
region (Figure II.7D). Interestingly, in the duodenum, Axin2 staining is exclusively seen 
in the intervillus region of E16.5 intestine (Figure II.7E); no signaling activity is 
detectable in villus tip epithelium. 
 
A specific domain of gene expression at the pylorus 
Using the group of tissue enriched probesets described earlier, we selected probesets that 
showed a pyloric expression pattern that was significantly different from both the 
stomach and duodenum at either E14.5 or E16.5. Of these probesets with pylorus-specific 
expression patterns, fifteen were detected at E14.5 and 79 were detected at E16.5. Known 
transcription factors and signaling pathway components among these pylorus-specific 
probesets are shown in Table II.6 and the remaining pyloric probesets are listed in Table 
II.7. 
 
Pylorus-specific genes detectable at both E14.5 and E16.5 include the transcription factor 
Nkx2-5 and the secreted BMP antagonist gremlin, both of which were previously shown 
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to exhibit pyloric expression in chick [37, 38]. However, the most pylorus-enriched gene 
detected at E14.5 was Gata3, which encodes a transcription factor not previously 
associated with pylorus patterning or function. Furthermore, at E16.5, the most enriched 
gene at the pylorus was nephrocan, a secreted regulator of TGF-  pathway activity [39]. 
We confirmed these novel findings by in situ hybridization. 
 
Nephrocan and gremlin 
Gremlin and nephrocan are both secreted modulators of TGF-  superfamily signaling and 
thus it was of interest to compare their expression patterns. At E14.5 and E16.5, gremlin 
is mesenchymal and expressed in a broad band at the pylorus (Figures 6A-B). 
Interestingly, nephrocan is expressed in E14.5 pyloric epithelium (Figure II.8C); its 
expression is slightly asymmetric with respect to the pylorus, with a broader expression 
domain on the stomach side. At E16.5, nephrocan becomes restricted to cells to the 
intervillus base of the intestine and cells at the base of developing antral glands. 
Interestingly, despite its epithelial localization, there is no clear boundary of expression 
across the pylorus for nephrocan at E16.5 (Figure II.8D). 
 
Gata3 
Gata3 expression is detectable in a narrow band at the pylorus at E14.5 (Figure II.8E). 
Staining is restricted to the mesenchyme and appears confined to cells outside of the thick 
inner circular smooth muscle of the distal stomach (Figure II.7F-G). Previous studies of 
Nkx2-5 showed a similar well-demarcated mesenchymal pattern at the pylorus [40]. It 
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will be interesting to further compare the extent of possible overlap in both expression 
and function between these two transcription factors. 
 
II.4. Discussion 
 
In this study, we have investigated dynamic gene expression patterns at and around the 
developing pylorus. Although clear regional patterning of the stomach and intestine 
occurs prior to E14.5 (e.g., for Sox2, Cdx2, among other genes), this pattern does not play 
itself out in terms of the global transcriptomes of E14.5 stomach, duodenum, and pylorus 
tissues, all of which are surprisingly similar. In contrast, at E16.5, a dramatic burst of 
transcriptional induction occurs in duodenal epithelium and this event generates a distinct 
compartmentalization of gene expression on the duodenal side of the pyloric border. This 
genetic induction event coordinately activates hundreds of genes involved in absorption 
and metabolism. As a result, for the first time, epithelial cells of the intestine express 
genes that unambiguously distinguish their function during digestion from that of the 
stomach. We call this compartmentalized patterning step intestinalization and note that it 
occurs strikingly late in fetal development. 
 
Though the vast majority of genes activated in the intestine are epithelial, a few 
mesenchymal genes are also upregulated at E16.5, several of which are involved in 
immune response function.  This is interesting in light of recent parallel evidence from 
our laboratory showing that, in adult intestine, decreased Hh signal transduction increases 
inflammatory signaling [41]. Whether there is a direct connection between the 
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downregulation of the Hh pathway that we observe in duodenal mesenchyme at E16.5 
(see Figures 4B,D) and activation of these mesenchymal inflammatory genes requires 
further investigation. 
 
An unexpected finding from our array results is that only four genes (i.e., Foxa1, Gcg, 
Mreg, and Serpina1c) are specifically downregulated in intestinal epithelium at E16.5 
(data not shown). Interestingly, Foxa1 has been shown to be required for Shh expression 
in the developing lung, another foregut endoderm-derived organ [42]. Because of its 
concomitant downregulation with Shh in intestinal epithelium, it is tempting to postulate 
that the attenuation of Foxa1 expression is responsible for reduced Shh expression during 
intestinalization.  If so, it will be important to understand the transcriptional regulation of 
Foxa1 expression and determine whether downregulation of this gene is required for 
intestinalization. 
 
Given the ample published evidence of a role for Wnt signaling during foregut 
specification [26-28], we were surprised to find that the Axin2 expression pattern 
suggests little or no difference in canonical Wnt signaling across the pylorus, either 
before or after pyloric border formation. In fact, at E14.5, very little canonical Wnt 
activity is detectable at all in either distal stomach or intestine. The lack of canonical Wnt 
signal in E14.5 duodenum is concordant with the phenotype of transcription factor 7-like 
2, T-cell specific, HMG-box (Tcf7l2/Tcf4) null mice, which exhibit no apparent defect in 
E14.5 intestine [43]. At E16.5, we see that intestinal Axin2 expression is confined to 
intervillus regions (see Figure II.7E). This is in accordance with the finding that these 
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proliferative cells are dependent upon canonical Wnt signals, as shown by the loss of this 
proliferative population in the face of either Tcf4 deficiency [43] or Dkk1 overexpression 
[44, 45]. Together, these findings and the results of our analysis do not support the idea 
[26] that a canonical Wnt signaling compartment exists on villus tips at E16.5. 
 
In this regard, the expression pattern of Sfrp5 at E16.5 is interesting. Recent work 
indicates that Sfrp5 can modulate either canonical or non-canonical Wnt signals in the 
Xenopus foregut [46]. In that system, Sfrp5 was able to bind the ortholog of the non-
canonical protein Wnt5a. Intriguingly, both overexpression of Sfrp5 (in Xenopus) and 
deficiency of Wnt5a (in mouse) result in shortened hindgut [46, 47]. Data presented 
above show that, at E16.5, Sfrp5 expression is restricted to the intervillus region (see 
Figure II.7B), the same area that is positive for Axin2 staining (and, hence, canonical 
pathway activity). Thus, it will be of interest to test whether Sfrp5 functions in the 
intervillus zone to modulate canonical signals, non-canonical signals, or both. 
 
Several epithelial transcription factors are dramatically upregulated during 
intestinalization and may participate directly in large-scale induction of absorptive and 
metabolic activity in the intestine. The Hnf4  paralog Hnf4  has been previously 
implicated in a similarly late developmental maturation event in the liver. In that system, 
Hnf4  upregulates a large number of structural genes and is thought to be important for 
the re-epithelialization of hepatic cells following their migration out of the gut tube 
proper and into the septum transversum [48]. It is tempting to speculate that 
intestinalization is a similar event. Even though intestinal epithelial cells never leave the 
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confines of the epithelial sheet, as developing hepatoblasts do, the epithelium itself is 
drastically reorganized during the process of villus formation. Perhaps Hnf4  and Hnf4  
are critical in the final stabilization of this remodeled state. Certainly, binding sites for 
these factors are highly enriched in the promoters of intestine-specific and epithelial-
specific genes [10]. 
 
Two previously unstudied factors were among the most upregulated D16 epithelial 
transcription factors. Creb3l3 (also known as Creb-H), a member of the bZip family of 
transcription factors, is involved in the endoplasmic reticulum (ER) stress response [49], 
and interestingly, its expression in the developing liver is dependent upon Hnf4  [50]. 
Since intestinalization involves transcriptional activation of hundreds of genes, several of 
which are expressed at tremendously high levels, the ER of intestinal epithelial cells may 
abruptly require a much higher degree of organization and efficiency to deal with the 
translational onslaught that follows. Indeed, we show that Creb3l3 is expressed in 
epithelial cells of the villi, exactly the population in which differentiated gene expression 
is induced. The idea that ER stress might accompany cell differentiation and might 
activate mediators of the response pathway in order to coordinate protein biosynthesis 
remains functionally untested here, but has been well documented for a number of 
secretory cell types [51]. 
 
Another transcription factor that is highly induced in E16.5 intestinal epithelium is Tcfec. 
This bHLH-Zip factor is a member of the MiT family (with Mitf, Tcfeb, and Tcfe3), 
several of which are expressed in a highly tissue- and cell-specific manner. Often these 
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proteins are responsible for the expression of signature proteins that are critical to organ 
or tissue development and function. For example, MiT family members regulate tartrate-
resistant alkaline phosphatase in osteoclasts [52], melanin in pigment cells [53] and 
proteases in mast cells [54]. The MiT proteins form both homo- and hetero-dimers, a fact 
that may explain why mouse knockout models of several family members show no 
phenotypes, despite the apparent transcriptional importance of these genes [55]. 
According to our microarray data, the related family member Tcfeb is also expressed in 
the intestine and is upregulated during intestinalization, though not as dramatically as 
Tcfec. 
 
Intestinalization occurs concomitantly with formation of a sharp boundary of epithelial 
gene expression at the pylorus. For genes like villin, Cdx2, and Sox2, a broad domain of 
expression with a diffuse boundary is detectable early and reflects the regional divisions 
of organ territory in the developing gut tube. But at E16.5, the boundary of expression 
sharpens exquisitely to allow differentiated intestinal cells to lie directly next to future 
stomach cells. An interesting question for further analysis is whether boundary formation 
and intestinalization actually constitute separate events. The process of intestinalization 
might reflect maturation of the vertical axis of the villus; differentiating cells exiting the 
proliferative compartment of the last villus next to the stomach may travel only a set 
distance from that crypt, coming to rest immediately next to a less differentiated neighbor 
derived from the stomach progenitor compartment. Alternatively, the pyloric border 
region itself could propagate a signal that promotes intestinalization, similar to the 
function of a classical organizer [56]. 
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Our data confirm and extend earlier studies [6] that reveal a characteristic domain of gene 
expression at the pylorus. We show that this domain is present both prior to and after 
intestinalization. We report here the novel finding that, similar to Nkx2-5, Gata3 is 
expressed in a narrow band at the pylorus (see Figure II.7E). Given that Nkx and Gata 
family members are known to interact in other developmental systems, these factors may 
collaboratively regulate pyloric patterning and organogenesis [57-59]. In addition, we 
describe the pyloric expression patterns of gremlin (mesenchyme; see Figures 6A-B) and 
nephrocan (epithelium; see Figures 6C-D), two secreted modulators of TGF-  
superfamily signaling. To our knowledge, nephrocan is the first secreted signaling protein 
to be identified in pyloric epithelium. In this regard, pyloric border patterning might be 
similar to the boundary patterning events observed at the midbrain-hindbrain border in 
the developing brainstem and the atrioventricular boundary of the heart. These events 
involve formation of straight, sharp expression boundaries [60-62], and in both cases, the 
border region itself has signaling activity that influences neighboring tissues [61, 63]. 
  
The intestinalization event that we document occurs without a similar maturation process 
in the stomach, where only limited transcriptional change occurs. The fact that the 
intestine, a more posterior tissue, matures prior to the stomach is somewhat surprising, 
given the tendency of embryonic development to progress in an anterior to posterior 
direction. Indeed, it is possible that this finding has evolutionary roots, as the stomach is 
believed to be an added character that first appeared in primitive fish [38]. It is possible 
then, that the stomach epithelium at E16.5 is governed by a program designed to 
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represses the emerging intestinal state in order to preserve the primitive stomach 
epithelium for the later reception of instructive signals to differentiate as stomach. 
Though this notion is entirely speculative, it has interesting implications for intestinal 
metaplasia, a pathological lesion in which patches of epithelium with intestinal character 
emerge in the stomach. The possibility that active repression of intestinal differentiation 
in stomach exists during pyloric border formation (and persists throughout adult life) will 
become amenable to further investigation now that the transcriptomes of stomach and 
intestine are available during this important developmental event. 
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Figure II.1. Diagram of microdissection for microarray experiment. A photomicrograph 
showing E14.5 foregut. The pylorus was identified grossly by its muscular constriction (arrows). 
Small, contiguous pieces of tissue were dissected from the pylorus and surrounding stomach and 
duodenum. St = stomach, Py = pylorus and D = duodenum. Photograph by Dr. Tracy (Xiaotan) 
Qiao.
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Figure II.2. Independent validation of microarray data by RT-PCR. Semi-quantitative RT-
PCR was carried out as described in Supplemental Methods. Hprt is used as a control; it does not 
vary with time and tissue. Tissue specific regulation of Cdx1, Cdx2, Isx, Barx1, Sox2, and Sfrp5 is 
set by E14.5 and does not vary with time. Mafb and Hnf4γ are preferentially, but not specifically, 
expressed in the intestine. Tcfec and Creb3l3 are greatly induced in E16.5 duodenum. RT-PCR by 
Dr. Neil Richards.
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Figure II.3. The epithelial pyloric boundary is diffuse at E14.5. A) X-gal staining for -gal 
expression in villin
lacZ/+ 
mice [1]. B) In situ hybridization for Cdx2. C) Immunofluorescence 
(green) staining for Sox2. Staining was performed on sectioned E14.5 material. The presumptive 
pyloric border is indicated by the arrow. D = duodenum and S = stomach. X-gal staining and 
immunostaining by Dr. Tracy (Xiaotan) Qiao.
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Figure II.4. Dramatic upregulation of gene expression in E16.5 duodenal epithelium. A) 
Principal components analysis of individual microarray chips. The first two principal components 
(PC1 and PC2), which together represent the majority of the sample variance, are plotted. Note 
grouping of E14.5 tissues. B) Venn diagram of temporal changes (e.g., D16-14, S16-S14) for 
tissue-enriched probesets at E16.5. Overlap between these groups indicates probesets that change 
in both tissues from E14.5 to E16.5. C) Epithelial (Epi) or mesenchymal (Mes) 
compartmentalization of enriched (D16) or depleted (D14) probesets in E16.5 duodenum. 
Probesets with low expression or expression in both compartments are considered unclassified 
(Unc). D) Histogram of duodenal (D16-D14) fold changes for E16.5 upregulated epithelial 
probesets (D16 epi) and downregulated mesenchymal probesets (D16 mes). The height of the bar 
is proportional to the absolute number of probesets. Percentages indicate the relative proportion 
of D16 epi or D16 mes probesets represented by each bar for each fold change category. Principal 
components analysis by Dr. Xing Li.
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Figure II.5. The duodenal epithelial transcription factors Hnf4 , Creb3l3, and Tcfec have 
sharp anterior expression boundaries at E16.5. A) Immunohistochemical staining for Hnf4  
reveals strong nuclear staining in the intestine, but only weak nuclear staining in the stomach. B) 
A gradient of nuclear Hnf4  staining from intervillus (weak) to villus tip (strong) epithelium is 
present. C) In situ hybridization for Creb3l3 shows a dramatic boundary at the stomach-intestine 
border at E16.5. Creb3l3 is not expressed at E14.5 (data not shown). D) Creb3l3 is restricted to 
villus epithelium at E16.5. E) In situ hybridization for Tcfec reveals a discrete boundary of 
expression at E16.5. F) Tcfec is expressed predominately in differentiated duodenal villus 
epithelium and not intervillus epithelium. Arrows denote stomach-intestine expression boundary. 
Arrowheads indicate intervillus (IV) epithelium. D = duodenum and S = stomach. 
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Figure II.6. Downregulation of Hedgehog signaling in duodenum at E16.5. A) X-gal staining 
for -gal expression in Gli1
lacZ/+  
mice at E14.5 reveals similar levels of Hh signaling activity 
across the pyloric border. B) At E16.5, X-gal staining shows an apparent difference in stomach 
and intestinal Hh signaling. C-D) Histogram of fold change values for normalized Gli1 qPCR 
data. Compared to the same tissue at E14.5, Gli1 expression was significantly decreased in E16.5 
intestine but not in stomach. NS = not statistically significant. D, duodenum; S, stomach. X-gal 
staining by Dr. Åsa Kolterud.
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Figure II.7. Canonical Wnt signaling is active across the pylorus at E16.5 and restricted to 
intervillus epithelium in the duodenum. A) In situ hybridization for Sfrp5 at E14.5. Note 
diffuse boundary at pyloric border (arrow). B) Sfrp5 expression in the E16.5 intestine reveals that 
expression is strong in intervillus but not villus tip epithelium. C) In situ hybridization for Axin2 
at E14.5; little or no signal is seen. D) Axin2 expression at 16.5 shows faint staining in both the 
stomach and duodenal epithelium, with little difference between these tissues. The presumptive 
pyloric border is indicated by the arrow. E) Higher magnification of Axin2 intestinal staining at 
E16.5 reveals that staining is confined to the intervillus epithelium. Arrowheads indicate 
intervillus (IV) epithelium. D = duodenum and S = stomach. 
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Figure II.8. Pylorus-specific expression of Gata3, gremlin, and nephrocan. A) In situ 
hybridization for gremlin (Grem1) at E14.5. Mesenchymal expression is strong at the pylorus and 
continues in the inner circular muscle of the intestine and more weakly in the inner circular 
muscle of the stomach. B) Gremlin expression is also mesenchymal at E16.5, as seen in a cross-
section through the pylorus. Arrow shows the pyloric lumen. C) In situ hybridization for 
nephrocan (Nepn) at E14.5 reveals epithelial expression at the pylorus. Expression is more robust 
towards the stomach, and is primarily localized to epithelial cells closer to the basement 
membrane. D) Nephrocan expression at E16.5 is restricted to the base of the developing epithelial 
glands in stomach and developing villi in intestine. E) In situ hybridization for Gata3 at E14.5 
reveals expression in a tight band of cells at the pylorus. F-G) Higher magnification of Gata3 
pyloric staining reveals expression in mesenchyme but not epithelium. Epithelium (epi) is 
demarcated by the solid line, while the inner circular (ic) smooth muscle is outlined by the dashed 
line. D = duodenum and S = stomach. In situ hybridization by Dr. Chunbo Hu.
 Table II.1. Summary of RT-PCR primer sequence and optimized conditions. 
 
Gene 
Symbol 
Forward primer Reverse primer 
Amplicon 
length (bp) 
Temp 
(deg C) 
Cycles 
MgCl2 
(mM) 
DMSO
1,3 
Barx1 GGAGTCGCACCGTATTCACTGAGC CCGCCACCTTGCAGCACTATTTTC 187 58 30 2.5 NO 
Cdx1 CGGACGCCCTACGAATGGATG CTGCTGCTGCTGCTGTTTCTTC 276 61 30 1.5 YES 
Cdx2 GAAACCTGTGCGAGTGGATGC TTGTTGCTGCTGCTGCTGTTG 284 58 30 1.5 YES 
Creb3l3 CAGTGGCATCTCTGAGGATCTACC CAGTGAGGTTGAAGCGGGAGG 266 61 30 1.5 YES 
Foxa1 GGCATGAGAGCAACGACTGG TAGGTGTTCATGGAGTTCATAGAGC 115 57 30 2.5 NO 
Gli1 CGCCAAGCACCAGAATCGG CCGAGACACAAGGTCCTTCATCC 419 61 40 6
2
 YES 
Hnf4a GATGCTTCTCGGAGGGTCTGC TTGGTGGTGATGGCTGTGGAG 200  60 30 1.5 NO 
Hnf4g CGCAGCATTCGGAAGAGTCATG CCGCTTGTGCCAGAGTGTTTATG 220 60 30 1.5 NO 
Hprt AGTCCCAGCGTCGTGATTAGC ATAGCCCCCCTTGAGCACACAG 204 61 30 2 YES 
Isx ACTTCACCCATTACCCTGACATCC TCTTCTCCTGCTTCCTCCACTTG 123 55 30 1.5 YES 
Maf CAACGGCTTCCGAGAAAACG CCCACGGAGCATTTAACAAGG 111 56 30 2.5 YES 
Mafb GCAACAGCTACCCACTAGCC AGCTGGTCATCAGAGAAGCG 108 60 30 2.5 YES 
Sfrp5 CCCTGGACAACGACCTCTGC CACAAAGTCACTGGAGCACATCTG 143 59 30 2.5 YES 
Sox2 CTCGCAGACCTACATGAACG AGTGGGAGGAAGAGGTAACC 146 59 28 3 NO 
Tcfec ATGAACCCATGAGCCCAGACAG AGCATCCGTGAGACCAGCATTAG 173 56 30 2 YES 
 
1
To be used at a 2% final concentration. 
2
iQ Supermix contains 6 mM MgCl2 (qPCR only). 
3
To be used at a 4% final concentration (qPCR only). 
8
2
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Table II.2. DAVID analysis of D16 enriched epithelial genes. 
 
 
 
Annotation Cluster 1 Enrichment Score: 5.05 Count P-value Fold Enrichment FDR 
cellular lipid metabolic process 29 2.0E-7 3.1 0 
Annotation Cluster 2 Enrichment Score: 4.64 Count P-value Fold Enrichment FDR 
transporter 40 2.4E-15 4.7 0 
Annotation Cluster 3 Enrichment Score: 4.1 Count P-value Fold Enrichment FDR 
hydrolase activity, acting on glycosyl bonds 13 1.2E-6 6.2 0 
Annotation Cluster 4 Enrichment Score: 3.95 Count P-value Fold Enrichment FDR 
carbohydrate metabolism 30 2.2E-10 4.2 0 
Annotation Cluster 5 Enrichment Score: 3.44 Count P-value Fold Enrichment FDR 
acyltransferase activity 12 1.7E-4 4.1 0.3 
Annotation Cluster 6 Enrichment Score: 3.18 Count P-value Fold Enrichment FDR 
organic acid metabolic process 22 9.3E-5 2.6 0.2 
 Table II.3. Summary of transcription factor gene expression changes in E16.5 duodenal epithelium. For each comparison, the label (e.g., 
D14, D16, S16, Epi, Mes) refers to the time and/or tissue of maximum expression and the number in parentheses is the fold change. 
 
Probeset ID Symbol Description D16-S16 D16-D14 Epi-Mes 
1419537_at Tcfec transcription factor EC D16 (41.65) D16 (5.45) Epi (18.27) 
1424688_at Creb3l3 cAMP responsive element binding protein 3-like 3 D16 (18.95) D16 (25.92) Epi (11.26) 
1423631_at Nr2e3 nuclear receptor subfamily 2, group E, member 3 D16 (18.68) D16 (23.80) Epi (4.60) 
1451716_at Mafb v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) D16 (14.49) D16 (14.49) Epi (2.93) 
1460127_at Hnf4g hepatocyte nuclear factor 4, gamma D16 (13.19) D16 (3.66) Epi (49.82) 
1449051_at Ppara peroxisome proliferator activated receptor alpha D16 (9.09) D16 (5.04) Epi (6.58) 
1425392_a_at Nr1i3 nuclear receptor subfamily 1, group I, member 3 D16 (8.46) D16 (8.22) Epi (6.08) 
1419185_a_at Mlxipl MLX interacting protein-like D16 (7.87) D16 (2.93) Epi (2.40) 
1437473_at Maf avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene homolog D16 (6.89) D16 (5.38) Epi (2.41) 
1417244_a_at Irf7 interferon regulatory factor 7 D16 (6.77) D16 (8.09) Epi (2.18) 
1425528_at Prrx1 paired related homeobox 1 D16 (5.35) D16 (9.57) Epi (2.73) 
1434416_a_at Solh Small optic lobes homolog (Drosophila) D16 (4.34) D16 (2.64) Epi (2.84) 
1417519_at Plagl2 pleiomorphic adenoma gene-like 2 D16 (3.89) D16 (2.38) Epi (7.06) 
1440831_at Bach1 BTB and CNC homology 1 D16 (3.84) D16 (2.32) Epi (2.67) 
1449854_at Nr0b2 nuclear receptor subfamily 0, group B, member 2 D16 (3.31) D16 (5.04) Epi (2.55) 
1420808_at Ncoa4 nuclear receptor coactivator 4 /// predicted gene, EG627557 D16 (2.98) D16 (2.53) Epi (2.72) 
1435991_at Nr3c2 nuclear receptor subfamily 3, group C, member 2 D16 (2.55) D16 (2.57) Epi (2.36) 
1443100_at Thrb Thyroid hormone receptor beta D16 (2.27) D16 (2.20) Epi (3.34) 
1440870_at Prdm16 PR domain containing 16 D16 (2.20) D16 (3.13) Epi (5.24) 
1426690_a_at Srebf1 sterol regulatory element binding factor 1 D16 (2.10) D16 (2.54) Epi (2.63) 
1418437_a_at Mlx MAX-like protein X D16 (2.09) D16 (2.33) Epi (2.05) 
1419052_at Ovol1 OVO homolog-like 1 (Drosophila) D16 (2.04) D16 (2.14) Epi (2.14) 
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 Table II.4. Summary of gene expression changes in Hedgehog signaling pathway components. NC means no significant change (significant 
change is FC≥2 and p<0.05). For each comparison, the label (e.g., D14, D16, S14, S16) refers to the time and/or tissue of maximum expression 
and the number in parentheses is the fold change. 
 
Probeset ID Symbol Description D14-S14 D16-S16 S16-S14 D16-D14 
1426869_at Boc 
biregional cell adhesion molecule-related/down-regulated by 
oncogenes (Cdon) binding protein 
NC (1.05) S16 (4.09) NC (1.25) D14 (4.86) 
1434957_at Cdon cell adhesion molecule-related/down-regulated by oncogenes NC (1.15) S16 (2.18) NC (1.40) D14 (2.64) 
1448494_at Gas1 growth arrest specific 1 NC (1.11) S16 (2.36) NC (1.67) D14 (4.36) 
1449058_at Gli1 GLI-Kruppel family member GLI1 NC (1.04) S16 (3.06) NC (1.14) D14 (3.65) 
1459211_at Gli2 GLI-Kruppel family member GLI2 NC (1.04) S16 (2.12) NC (1.99) D14 (4.40) 
1455154_at Gli3 GLI-Kruppel family member GLI3 NC (1.26) S16 (3.07) S14 (2.70) D14 (6.56) 
1450704_at Ihh Indian hedgehog NC (1.80) S16 (2.19) NC (1.60) NC (1.32) 
1427133_s_at Lrp2 low density lipoprotein receptor-related protein 2 NC (1.45) D16 (7.29) NC (1.24) D16 (4.04) 
1439663_at Ptch1 Patched homolog 1 NC (1.31) NC (1.63) NC (1.89) D14 (2.35) 
1454876_at Rab23 RAB23, member RAS oncogene family NC (1.02) S16 (2.28) NC (1.65) D14 (3.69) 
1436869_at Shh sonic hedgehog NC (1.75) S16 (6.66) NC (1.30) D14 (8.94) 
1427049_s_at Smo smoothened homolog (Drosophila) NC (1.03) S16 (2.21) NC (1.61) D14 (3.65) 
1434733_at Stk36 serine/threonine kinase 36 (fused homolog, Drosophila) NC (1.12) NC (1.35) S14 (2.15) D14 (2.58) 
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 Table II.5. Summary of gene expression changes in Wnt signaling pathway components. NC means no significant change (significant change 
is FC≥2.0 and p<0.05). For each comparison, the label (e.g., P14, P16, D14, D16, S14, S16) refers to the time and/or tissue of maximum 
expression and the number in parentheses is the fold change. 
 
Probeset ID Symbol Description D16-D14 S16-S14 D14-S14 D16-S16 
1437351_at Cxxc4 CXXC finger 4 D14 (5.01) NC (1.93) NC (1.15) S16 (2.25) 
1438884_at D830007B15Rik RIKEN cDNA D830007B15 gene D14 (3.70) NC (1.36) D14 (3.62) NC (1.40) 
1420512_at Dkk2 dickkopf homolog 2 (Xenopus laevis) D14 (6.56) S14 (2.05) NC (1.06) S16 (3.01) 
1417312_at Dkk3 dickkopf homolog 3 (Xenopus laevis) D14 (2.57) NC (1.11) NC (1.24) S16 (2.29) 
1437284_at Fzd1 frizzled homolog 1 (Drosophila) D14 (3.15) NC (1.04) NC (1.42) S16 (2.14) 
1418532_at Fzd2 frizzled homolog 2 (Drosophila) D14 (5.61) S14 (2.00) NC (1.62) S16 (4.55) 
1449730_s_at Fzd3 frizzled homolog 3 (Drosophila) D14 (2.24) NC (1.43) NC (1.12) NC (1.76) 
1417301_at Fzd6 frizzled homolog 6 (Drosophila) NC (1.57) NC (1.14) NC (1.45) S16 (2.59) 
1450044_at Fzd7 frizzled homolog 7 (Drosophila) D14 (4.02) S14 (2.46) NC (1.19) NC (1.95) 
1451022_at Lrp6 low density lipoprotein receptor-related protein 6 NC (1.76) S14 (2.02) NC (1.36) NC (1.19) 
1417278_a_at Nkd1 naked cuticle 1 homolog (Drosophila) D14 (2.14) NC (1.14) NC (1.46) NC (1.67) 
1452249_at Prickle1 prickle like 1 (Drosophila) D14 (2.70) NC (1.51) NC (1.19) NC (1.50) 
1428808_at Prickle2 prickle-like 2 (Drosophila) D14 (3.94) NC (1.50) NC (1.62) NC (1.62) 
1446780_at Ror2 Receptor tyrosine kinase-like orphan receptor 2 NC (1.23) S14 (2.07) NC (1.11) NC (1.52) 
1423986_a_at Scotin scotin gene D16 (3.66) S16 (3.35) NC (1.03) NC (1.06) 
1448395_at Sfrp1 secreted frizzled-related sequence protein 1 D14 (5.45) S14 (3.24) NC (1.29) S16 (2.17) 
1448201_at Sfrp2 secreted frizzled-related protein 2 D14 (7.70) NC (1.55) NC (1.28) S16 (6.37) 
1451031_at Sfrp4 secreted frizzled-related sequence protein 4 NC (1.62) S16 (2.13) NC (1.91) S16 (2.52) 
1436075_at Sfrp5 secreted frizzled-related sequence protein 5 D14 (4.71) NC (1.58) D14 (31.69) D16 (10.66) 
1450117_at Tcf3 transcription factor 3 D14 (6.03) NC (1.63) NC (1.45) S16 (5.35) 
1441756_at Tcf7l2 Transcription factor 7-like 2, T-cell specific, HMG-box NC (1.87) S14 (2.45) NC (1.87) NC (1.43) 
1423852_at Tmem46 transmembrane protein 46 D14 (5.03) NC (1.02) D14 (2.79) NC (1.84) 
1438426_at Tmem58 transmembrane protein 58 D14 (3.61) NC (1.64) NC (1.03) S16 (2.25) 
1436118_at Vangl2 vang-like 2 (van gogh, Drosophila) D14 (4.56) NC (1.81) NC (1.10) S16 (2.78) 
1450772_at Wnt11 wingless-related MMTV integration site 11 NC (1.29) NC (1.93) NC (1.48) S16 (2.21) 
1450782_at Wnt4 wingless-related MMTV integration site 4 NC (1.97) S16 (6.34) NC (1.35) S16 (4.35) 
1436791_at Wnt5a wingless-related MMTV integration site 5A D14 (2.99) NC (1.59) S14 (2.34) S16 (4.38) 
1436978_at Wnt9a wingless-type MMTV integration site 9A D14 (2.17) NC (1.20) NC (1.22) NC (1.47) 
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 Table II.6. Summary of pyloric transcription factors and signaling molecules. NC means no significant change (significant change is FC≥2 
and p<0.05). For each comparison, the label (e.g., P14, P16, D14, D16, S14, S16) refers to the time and/or tissue of maximum expression and the 
number in parentheses is the fold change. 
 
Probeset ID Symbol Description P14-S14 P14-D14 P16-S16 P16-D16 
A. Transcription factors 
1447500_at Cutl2 cut-like 2 (Drosophila) NC (1.67) NC (-1.23) P16 (2.09) P16 (2.44) 
1448886_at Gata3 GATA binding protein 3 P14 (6.75) P14 (10.35) P16 (2.55) P16 (3.39) 
1449566_at Nkx2-5 
NK2 transcription factor related, locus 5 
(Drosophila) 
P14 (5.64) P14 (6.58) P16 (2.49) P16 (2.76) 
1431899_at Nkx6-3 
NK6 transcription factor related, locus 3 
(Drosophila) 
NC (1.51) P14 (4.56) P16 (2.00) P16 (2.08) 
1451569_at Nr2c2 nuclear receptor subfamily 2, group C, member 2 NC (1.48) NC (1.79) P16 (2.02) P16 (2.25) 
 
B. Signaling molecules 
1451991_at Epha7 Eph receptor A7 NC (1.16) NC (1.01) P16 (2.14) P16 (2.10) 
1424007_at Gdf10 growth differentiation factor 10 NC (1.54) NC (1.23) P16 (2.74) P16 (8.62) 
1425357_a_at Grem1 gremlin 1 P14 (7.13) P14 (2.26) P16 (4.90) P16 (2.69) 
1419065_at Nepn Nephrocan NC (1.10) P14 (6.31) P16 (17.06) P16 (16.73) 
1426561_a_at Npnt Nephronectin NC (1.33) NC (1.13) S16 (2.85) D16 (2.05) 
1422553_at Pten phosphatase and tensin homolog NC (1.98) NC (1.94) P16 (3.36) P16 (2.02) 
1442067_at Ror1 Receptor tyrosine kinase-like orphan receptor 1 NC (1.20) NC (1.27) P16 (2.29) P16 (3.33) 
1436892_at Spred2 sprouty-related, EVH1 domain containing 2 NC (1.54) NC (1.79) P16 (2.87) P16 (3.22) 
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Table II.7. Summary of pyloric genes. NC means no significant change (significant change is FC≥2 and p<0.05). For each comparison, the label 
(e.g., P14, P16, D14, D16, S14, S16) refers to the time and/or tissue of maximum expression and the number in parentheses is the fold change. 
 
 
Probeset ID Symbol Description P14-S14 P14-D14 P16-S16 P16-D16 
1459266_at --- --- P14 (2.05) P14 (2.08) NC (1.53) NC (1.47) 
1429286_at 1190003M12Rik RIKEN cDNA 1190003M12 gene NC (1.12) NC (1.64) P16 (2.48) P16 (12.56) 
1424439_at 1810065E05Rik RIKEN cDNA 1810065E05 gene NC (1.76) NC (1.67) P16 (4.51) P16 (6.56) 
1425233_at 2210407C18Rik RIKEN cDNA 2210407C18 gene P14 (5.01) P14 (2.87) NC (1.00) P16 (17.46) 
1427437_at 2610203C20Rik RIKEN cDNA 2610203C20 gene NC (1.54) P14 (2.87) P16 (2.40) P16 (2.20) 
1432556_a_at 3100002J23Rik RIKEN cDNA 3100002J23 gene P14 (6.30) NC (1.46) P16 (2.65) P16 (2.19) 
1438798_at 4931406P16Rik RIKEN cDNA 4931406P16 gene NC (1.62) NC (1.75) P16 (2.92) P16 (2.18) 
1435163_at 9030612M13Rik RIKEN cDNA 9030612M13 gene P14 (2.19) P14 (2.45) P16 (3.37) NC (1.75) 
1438531_at A730054J21Rik RIKEN cDNA A730054J21 gene NC (1.69) P14 (2.65) P16 (2.47) P16 (3.95) 
1415927_at Actc1 actin, alpha, cardiac NC (1.91) NC (1.24) P16 (2.04) P16 (2.58) 
1451675_a_at Alas2 aminolevulinic acid synthase 2, erythroid P14 (3.26) P14 (2.03) P16 (2.89) P16 (3.41) 
1416649_at Ambp alpha 1 microglobulin/bikunin P14 (2.20) NC (1.33) P16 (8.72) P16 (2.39) 
1459253_at Arrdc3 Arrestin domain containing 3 P14 (2.57) P14 (2.84) NC (1.27) NC (1.08) 
1443801_at AW822216 Expressed sequence AW822216 NC (1.55) NC (1.84) P16 (3.37) P16 (2.10) 
1438663_at Bat2d BAT2 domain containing 1 NC (1.32) n/1 (1.87) P16 (2.34) P16 (2.28) 
1440990_at BC056349 cDNA sequence BC056349 NC (1.83) P14 (2.34) P16 (2.25) P16 (3.26) 
1457458_at BC057627 cDNA sequence BC057627 NC (1.50) NC (1.77) P16 (2.14) P16 (2.10) 
1450624_at Bhmt betaine-homocysteine methyltransferase NC (1.96) NC (1.64) P16 (2.56) P16 (2.89) 
1439040_at Cenpe centromere protein E NC (1.40) NC (1.55) P16 (2.25) P16 (3.42) 
1427767_a_at Cftr 
cystic fibrosis transmembrane 
conductance regulator homolog 
NC (1.40) NC (1.04) P16 (3.73) P16 (2.33) 
1436343_at Chd4 
chromodomain helicase DNA binding 
protein 4 
NC (1.37) NC (1.63) P16 (2.46) P16 (2.19) 
1439427_at Cldn9 claudin 9 NC (1.32) NC (1.41) P16 (2.53) P16 (2.67) 
1428571_at Col9a1 procollagen, type IX, alpha 1 P14 (2.76) P14 (2.48) P16 (4.63) P16 (10.41) 
1448326_a_at Crabp1 cellular retinoic acid binding protein I NC (1.63) P14 (5.02) P16 (2.14) P16 (5.53) 
1424598_at Ddx6 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 6 
NC (1.49) P14 (2.13) P16 (2.68) P16 (3.54) 
1437403_at E130306M17Rik RIKEN cDNA E130306M17 gene P14 (2.30) P14 (2.23) P16 (2.80) P16 (4.29) 
1456319_at EG665081 predicted gene, EG665081 P14 (2.19) P14 (2.36) NC (1.58) NC (1.72) 
1449077_at Eraf erythroid associated factor P14 (2.46) NC (1.71) P16 (2.88) P16 (3.60) 
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Probeset ID Symbol Description P14-S14 P14-D14 P16-S16 P16-D16 
(Table II.7 continued) 
1456326_at Gm784 gene model 784, (NCBI) NC (1.46) NC (1.04) P16 (2.24) P16 (4.08) 
1423436_at Gsta3 glutathione S-transferase, alpha 3 P14 (4.12) NC (1.01) P16 (2.97) P16 (2.24) 
1423016_a_at Gypa glycophorin A P14 (2.86) NC (1.96) P16 (4.00) P16 (4.59) 
1448716_at Hba-x 
hemoglobin X, alpha-like embryonic 
chain in Hba complex 
P14 (2.14) NC (1.33) P16 (2.17) P16 (2.70) 
1427866_x_at Hbb-b1 hemoglobin, beta adult major chain P14 (2.46) NC (1.92) P16 (2.44) P16 (3.60) 
1418199_at Hemgn hemogen P14 (3.02) P14 (2.07) P16 (3.14) P16 (3.79) 
1426114_at Hnrpab 
heterogeneous nuclear ribonucleoprotein 
A/B 
NC (1.39) NC (1.29) P16 (2.67) P16 (2.00) 
1458492_x_at Hnt neurotrimin NC (1.26) P14 (2.59) P16 (2.32) P16 (3.77) 
1423276_at Ildr1 
immunoglobulin-like domain containing 
receptor 1 
NC (1.41) NC (1.41) P16 (2.85) P16 (2.07) 
1442368_at Kctd12b 
potassium channel tetramerisation domain 
containing 12b 
NC (1.72) NC (1.80) P16 (2.49) P16 (3.28) 
1460258_at Lect1 leukocyte cell derived chemotaxin 1 P14 (4.27) P14 (4.45) NC (1.06) NC (1.52) 
1422071_at Lgals6 lectin, galactose binding, soluble 6 P14 (7.12) P14 (4.57) P16 (2.79) P16 (2.29) 
1421278_s_at LOC630963 similar to spectrin alpha 1 P14 (4.19) NC (1.50) P16 (5.80) P16 (5.54) 
1418188_a_at Malat1 
Metastasis associated lung 
adenocarcinoma transcript 1 (non-coding 
RNA) 
NC (1.27) P14 (2.21) P16 (3.23) P16 (4.01) 
1451989_a_at Mapre2 
microtubule-associated protein, RP/EB 
family, member 2 
NC (1.31) NC (1.01) P16 (2.13) P16 (2.14) 
1422643_at Moxd1 monooxygenase, DBH-like 1 P14 (2.12) NC (1.07) P16 (2.30) P16 (3.95) 
1437250_at Mreg melanoregulin S14 (3.33) D14 (3.12) S16 (-4.30) NC (1.01) 
1435521_at Msi2 Musashi homolog 2 (Drosophila) NC (1.51) P14 (2.03) P16 (2.25) P16 (3.03) 
1436309_at Neto2 neuropilin (NRP) and tolloid (TLL)-like 2 P14 (2.36) NC (1.00) P16 (2.24) P16 (2.98) 
1448290_at Pap pancreatitis-associated protein P14 (2.67) D14 (2.09) P16 (63.15) P16 (2.80) 
1428952_at Pdia2 protein disulfide isomerase associated 2 NC (1.41) NC (1.07) S16 (5.69) D16 (2.88) 
1460332_at Pln phospholamban NC (1.91) NC (1.60) P16 (2.00) P16 (3.63) 
1448186_at Pnliprp2 pancreatic lipase-related protein 2 P14 (2.49) NC (1.50) P16 (23.05) P16 (2.39) 
1449876_at Prkg1 protein kinase, cGMP-dependent, type I NC (1.82) NC (1.19) P16 (2.33) P16 (2.97) 
1460633_at Prpf19 
PRP19/PSO4 pre-mRNA processing 
factor 19 homolog (S. cerevisiae) 
NC (1.81) NC (1.66) P16 (2.02) P16 (2.12) 
1454791_a_at Rbbp4 retinoblastoma binding protein 4 NC (1.94) P14 (2.11) P16 (2.56) P16 (2.44) 
1438069_a_at Rbm5 RNA binding motif protein 5 NC (1.75) P14 (2.16) P16 (3.15) P16 (2.88) 
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Probeset ID Symbol Description P14-S14 P14-D14 P16-S16 P16-D16 
(Table II.7 continued) 
1442263_at Rgs13 regulator of G-protein signaling 13 NC (1.03) NC (1.01) P16 (3.50) P16 (2.90) 
1419014_at Rhag 
Rhesus blood group-associated A 
glycoprotein 
P14 (2.84) P14 (2.01) P16 (2.12) P16 (2.33) 
1422552_at Rprm 
reprimo, TP53 dependent G2 arrest 
mediator candidate 
NC (1.76) P14 (5.06) P16 (2.14) P16 (3.67) 
1460623_at Skap2 src family associated phosphoprotein 2 P14 (2.56) P14 (2.06) NC (1.19) NC (1.04) 
1447517_at Skiv2l2 
superkiller viralicidic activity 2-like 2 (S. 
cerevisiae) 
P14 (3.88) P14 (3.84) NC (1.31) NC (1.51) 
1420334_at Slc12a8 
solute carrier family 12 
(potassium/chloride transporters), 
member 8 
NC (1.22) NC (1.22) P16 (2.77) P16 (2.04) 
1434502_x_at Slc4a1 
solute carrier family 4 (anion exchanger), 
member 1 
P14 (2.69) NC (1.71) P16 (4.11) P16 (5.28) 
1436853_a_at Snca synuclein, alpha NC (1.90) NC (1.72) P16 (2.40) P16 (3.87) 
1421277_at Spna1 spectrin alpha 1 P14 (2.96) NC (1.22) P16 (2.73) P16 (2.09) 
1441858_at Uck2 Uridine-cytidine kinase 2 NC (1.23) P14 (2.03) P!6 (2.19) P16 (2.42) 
1439174_at Unc5c Unc-5 homolog C (C. elegans) NC (1.77) NC (1.09) P16 (2.48) P16 (2.28) 
1426305_at Upk1a uroplakin 1A P14 (2.73) NC (1.27) P16 (4.91) P16 (4.09) 
1446886_at Usp3 Ubiquitin specific peptidase 3 P14 (2.23) P14 (2.86) P16 (2.56) NC (1.20) 
1419195_at Wfdc15 WAP four-disulfide core domain 15 P14 (2.50) NC (1.20) P16 (2.90) P16 (2.34) 
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CHAPTER III 
 
GATA3 IS ESSENTIAL FOR SMOOTH MUSCLE STRUCTURES AT THE 
PYLORUS 
 
The smooth muscle pyloric sphincter is a critical regulator of gastroduodenal flux during 
digestion. Recent analysis of the pyloric transcriptome has identified a number of novel 
pyloric genes including Gata3, which encodes a zinc finger transcription factor. In the 
present study we report that Gata3 is required for normal pyloric morphogenesis. We 
show that Gata3 and Nkx2-5 are expressed in specific smooth muscle cell populations at 
the pylorus, including pylorus smooth muscle proper as well as two previously 
undescribed, superficial muscular cords that form on the lesser curvature of the stomach. 
Loss of Gata3 results in the loss of these specific muscle populations and loss of the 
pyloric constriction. Finally we use a reporter-marked Gata3 allele to show that in the 
absence of Gata3, cells that co-express the reporter-marked Gata3 locus and Nkx2-5 
persist. This indicates that Gata3 is not epistatic to Nkx2-5 at the pylorus. 
 
III.1. Introduction 
 
The pylorus is the anatomical junction between the stomach and the small intestine, and 
its muscular sphincter helps to regulate the passage of food between these organs during 
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digestion. Similar to other organs of the gastrointestinal tract, the pylorus has a distinctive 
histology. The pyloric lumen is lined by endoderm-derived mucosal epithelium, and it is 
here that a tight, one-cell-thick boundary between intestinal and gastric epithelial cells 
(i.e., the epithelial pyloric border) is established during late embryogenesis [1]. The 
mucosal epithelium is surrounded by several layers of mesoderm-derived tissue. The 
loose sub-mucosal layer directly supports the overlying epithelium and contains nervous 
tissue as well as a number of mesenchymal cell types (i.e., myofibroblasts, endothelial 
cells, lymphatic cells, etc). Concentric inner circular and outer longitudinal layers of 
smooth muscle cells ensheathe the sub-mucosa, providing the main structural support for 
the pylorus. 
 
The orientation of smooth muscle cells in the outer longitudinal layer is parallel to the 
long axis of the lumen, while the cells of the inner circular layer are oriented 
circumferentially. Throughout most of the gastrointestinal tract, these muscle layers are 
mostly (if not entirely) distinct.  At the pylorus, however, the inner circular and outer 
longitudinal layers coalesce to form the pyloric sphincter, a complex muscle structure 
that controls the lumenal size of the gastric outlet by integrating numerous nervous 
innervations and local hormonal feedback [2-5]. In the common human congenital 
pathology infantile hypertrophic pyloric stenosis (IHPS), both the structure and function 
of the pyloric sphincter are abnormal [5].  Yet despite the significant incidence of IHPS 
(approximately three per 1,000 live births), the pathology of the disease is not completely 
understood. A better understanding of the events involved in the development of the 
pyloric region could shed light on the molecular etiology involved.  
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The pylorus forms at a precise point between the stomach and the duodenum. 
Anteroposterior patterning events are directed by extracellular signaling molecules in 
combination with the “gastrointestinal Hox code”. Together these integrated molecular 
programs establish broad organ domains, each of which display unique endodermal and 
mesodermal gene expression patterns [6, 7]. For example by embryonic day (E) 10.5 
three members of the Nkx family of homeodomain proteins (Nkx2-3, Nkx2-5, and Nkx3-
2/Bapx1) subdivide the mesoderm of the distal foregut. Nkx2-3 and Bapx1 mark the 
proximal small intestine and distal stomach, respectively, while Nkx2-5 is expressed in a 
narrow domain at the pylorus [8, 9]. 
 
Experiments in the chick embryo have established a basic genetic network for pylorus 
development [10-14]. Hh signaling from the intestinal endoderm activates Bmp4 
expression in the underlying mesenchyme. Secreted Bmp4 then independently activates 
Nkx2-5 and Sox9 in pyloric mesenchyme. Subsequently Sox9, but not Nkx2-5, 
upregulates the Bmp signaling modulator gremlin, which patterns the overlying pyloric 
endoderm. Germline loss of Bapx1 or Six2 is each associated with significant pyloric 
sphincter defects in the mouse [15, 16]. 
 
Recent transcriptional profiling of E14.5 and E16.5 pyloric tissues confirmed a number of 
these pylorus-specific genes in mouse, including Nkx2-5 and gremlin, and identified 
several novel pyloric genes, such as Gata3 [1]. Gata3 is of particular interest because it 
encodes a zinc finger transcription factor and is expressed in a narrow domain at the 
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pylorus, similar to Nkx2-5. In the present study we compare the spatiotemporal and cell 
type-specific expression of Gata3 and Nkx2-5 at the pylorus and show that both mark 
subdomains of smooth muscle. Both factors are expressed in superficial, cord-like 
structures on the ventral stomach surface. We also demonstrate that the loss of Gata3 
perturbs pyloric morphogenesis and results in the loss of specific smooth muscle 
structures, including portions of the outer longitudinal layer and the ventral pyloric cords. 
 
III.2. Materials and methods 
 
Mice 
The generation of Gata3
lacZ/+ 
and Nkx2-5
lacZ/+ 
mice have been described previously [17-
19]. Gata3
lacZ/+ 
intercrosses result in wild type (Gata3
+/+
), Gata3 heterozygous 
(Gata3
lacZ/+
), and Gata3 null (Gata3
lacZ/lacZ
) genotypes. Gata3 null embryos die at E11 of 
sympathoadrenal insufficiency, but can be rescued by administration of a 
pharmacological cocktail containing - and -adrenergic agonists to the pregnant dam, as 
previously described [20, 21]. Rescue solution was prepared fresh: 15 mg each of 
isoproterenol (Sigma I-5627) and phenylephrine (Sigma P-6126) was added to 50 mL of 
ddH20 and supplemented with 100 mg of ascorbic acid and 2 g of sucrose. This solution 
(which supplanted normal drinking water) was administered once daily to timed pregnant 
dams, beginning at E7.5. Rescued embryos survived until birth, but died shortly 
thereafter, likely due to palatal defects and failure to suckle. Although Gata3 null 
embryos can be identified phenotypically, all genotypes were confirmed by RT-PCR. 
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Antibodies 
Primary antibodies used were: Cy3-conjugated mouse monoclonal to SMA (1:500, 
Sigma C6198), rabbit polyclonal to desmin (1:500 Abcam ab8952), goat polyclonal to 
Nkx2-5 (1:100, Santa Cruz sc-8697), mouse monoclonal to Gata3 (1:100, Santa Cruz sc-
268), and chicken polyclonal to -gal (1:1000, Abcam ab9361). Secondary antibodies 
used were: biotinylated horse anti-universal (mouse/rabbit/goat) IgG (Vector BA-1400), 
biotinylated rabbit anti-chicken IgY (1:200, Abcam ab6752-1500), and Alexa Fluor 488 
donkey anti-rabbit IgG (1:500 Invitrogen A-21206). Tertiary antibodies used were: 
Cy3/Cy5-conjugated mouse monoclonal anti-biotin (1:100, Jackson Immunoresearch 
200-162-211/200-172-211). 
 
Whole mount X-gal staining 
X-gal staining was performed as described previously [22]. Staged embryos from 
intercrosses of Gata3
lacZ/+
 mice, Gata3
lacZ/+
 and wild type (C57BL/6J), or Nkx2-5
lacZ/+
 
and wild type mice were dissected in 1X PBS. The gastrointestinal tract was fixed with 
4% PFA for 10 minutes at 4°C, and washed in 1X PBS. X-gal staining solution was 
prepared fresh: 1X PBS (pH 7.5), 2 mM magnesium chloride, 5 mM potassium 
ferrocyanide, 5 mM potassium ferricyanide, and 1 mg/mL X-gal (from 20 mg/ml stock in 
DMF) were combined. Fixed tissue was incubated in staining solution at 37°C and 
monitored periodically to control staining intensity. Stained tissue was washed in 1X PBS 
and then post-fixed overnight at 4°C in 4% PFA. Tissue was cleared with increasing 
concentrations of glycerol in 1X PBS. 
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Whole mount immunofluorescence 
Dissected foreguts from adult mice were fixed overnight in 4% PFA. Samples were cut in 
half with microsurgical scissors and embedded in 2% low melt agarose. While still in 
agarose, tissues were washed and stained in a 1X PBS blocking solution containing 0.1% 
Triton-X and 10% BSA. The first primary antibody staining (rabbit polyclonal to desmin) 
was done overnight at 4°C. Tissues were washed with blocking solution and stained with 
the secondary antibody (Alexa Fluor 488 donkey anti-rabbit IgG) at room temperature 
(RT) for 2 hours. Tissues were washed with blocking solution and stained with the 
second primary antibody (Cy3-conjugated mouse monoclonal to SMA) at RT for 2 
hours. Tissues were washed in 1XPBS prior to microscopy. 
 
Histology 
Staged embryos were dissected in 1X PBS. Gastrointestinal tracts were fixed overnight at 
4°C in 4% PFA, embedded in paraffin, cut into 5-10 m sections and adhered to 
Superfrost Plus glass slides (Fisher 22-034-979). 
 
Hematoxylin and eosin staining 
For hematoxylin and eosin (H&E) staining standard laboratory methods were used. 
Sections were deparaffinized in xylene, rehydrated through decreasing alcohol 
concentrations, stained with hematoxylin, incubated in bluing solution, counterstained in 
eosin, dehydrated through increasing alcohol concentrations, and equilibrated with 
xylene. Glass coverslips were mounted with Permount (Fisher SP15-100). 
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Immunofluorescence 
Sections were deparaffinized in xylene, rehydrated through decreasing alcohol 
concentrations, and boiled for 10 minutes in 10 mM sodium citrate, pH 6.0. Slides were 
allowed to slowly cool down and then washed with 1X PBS. Sections were pre-blocked 
sequentially using the Avidin/Biotin Blocking Kit (Vector SP-2001) and the MOM Kit 
(Vector FMK-2201). The sections were then blocked in 10% animal serum/0.03% Triton 
X-100 in 1X PBS for 1 hour at RT. Primary antibodies were diluted in blocking solution 
prior to incubation on slides. Slides were washed in 1X PBS prior to incubation with 
appropriate secondary antibodies and DAPI (1:100). After 1X PBS washes, glass 
coverslips were mounted with ProLong Gold Antifade Reagent. See Table 1 for details of 
specific immunostaining experiments. 
 
Microscopy 
Whole mount tissue was photographed in 1X PBS or 80% glycerol (in 1X PBS) on a 
Leica dissecting microscope with a Leica CCD camera. Slides were photographed on a 
Nikon E800 microscope with a Nikon CCD camera. 
 
III.3. Results 
 
Gata3 expression in the developing foregut 
Previously we reported a novel pyloric expression domain for Gata3 at E14.5 using in 
situ hybridization [1]. To better characterize the spatiotemporal pattern of pyloric Gata3 
during embryogenesis, we analyzed Gata3
lacZ/+
 embryos by whole mount X-gal staining. 
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At E10.5 there is robust Gata3 expression in several tissues but no discrete staining in the 
foregut, while at E11.5 weak Gata3 expression is occasionally seen in the foregut region 
(Figures III.1A-B). By E12.5 an obvious band of Gata3-expressing cells appears in the 
distal stomach near the gastroduodenal junction (Figure III.1C). This band forms a nearly 
circumferential ring around the gut with a small gap on the lesser curvature (ventral side) 
of the stomach. A day later at E13.5 the Gata3 expression domain is wider, and two 
small, cellular prominences are discernible on the ventral side of the band at either end of 
the gap (Figure III.1D). These clusters of Gata3-expressing cells lie along the lesser 
curvature of the stomach and extend slightly anteriorly towards the esophagus. Pyloric 
Gata3 expression continues to expand at E14.5, particularly on the greater curvature 
(dorsal side) of the stomach, where a small, distinct nodule of Gata3-expressing cells 
protrudes from the band (Figure III.1E). On the ventral aspect, the cellular prominences 
first observed a day earlier have coalesced into thin, bilateral cellular cords that extend 
anteriorly from the pylorus to the esophagus along the lesser curvature of the stomach. At 
E14.5, if viewed anteriorly from the duodenum, the pyloric Gata3 expression domain 
resembles a horseshoe (Figure III.1E). Between E15.5 and E18.5 there are relatively few 
significant changes in this pattern. The dorsal nodule disappears by E16.5 (data not 
shown), and the ventral cords lengthen, such that by E18.5 they extend to the level of the 
gastroesophageal junction (Figure III.1F). 
 
To confirm and extend these observations, we analyzed Gata3 protein expression in 
sectioned wild type tissue by immunostaining. At E14.5 and E18.5 nuclear Gata3 signal 
is detected in a narrow domain of mesenchymal cells at the gastroduodenal junction 
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(Figure III.2). Gata3-expressing cells are positioned within the outer mesenchymal layer 
of the gut but not the loose layer of sub-mucosal mesenchyme. Consistent with our whole 
mount X-gal staining results, at E14.5 Gata3-positive cells were found in the dorsal 
nodule as well as the ventral cords, while at E18.5 the dorsal nodule was absent and 
Gata3 was only expressed in the pyloric mesoderm and ventral cords. No epithelial 
staining was observed at either time point. 
 
Nkx2-5 is expressed in a similar domain to Gata3 in the foregut 
Nkx2-5 is a known pyloric gene in a number of vertebrate species, including the mouse 
[9]. The expression pattern of Nkx2-5 in early foregut mesenchyme and spleen 
morphogenesis was recently described, but the embryonic expression of Nkx2-5 at the 
pylorus has not been fully explored [23]. To examine the spatiotemporal pattern of 
pyloric Nkx2-5 expression, we analyzed Nkx2-5
lacZ/+
 embryos by whole mount X-gal 
staining [17]. Nkx2-5 is expressed in a discrete domain in the foregut at E10.5 and E11.5, 
48 hours earlier than Gata3 expression is detected (Figures III.3A-B). Between E12.5 and 
E13.5 Nkx2-5-positive, splenic precursor cells (SPCs) migrate anteriorly from the pyloric 
mesenchyme and through the mesogastrium along the greater curvature of the stomach to 
populate the developing spleen [23]. Gata3 is not expressed in this migrating splenic 
population. By E14.5 the migration of SPCs ceases and Nkx2-5 is expressed in a band at 
the pylorus (Figure III.3C). Like Gata3, Nkx2-5 is expressed in the dorsal nodule and 
ventral cords at E14.5, and between E15.5 and E18.5 there are few changes in the Nkx2-5 
pyloric expression pattern (Figure III.3D). At all time points, however, the Nkx2-5 
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domain is apparently broader than the corresponding Gata3 domain, and in contrast to 
Gata3, the Nkx2-5 band forms a complete circumferential ring around the gut. 
 
Nkx2-5 protein expression was next examined in sectioned wild type tissue by 
immunostaining. At E14.5 and E18.5, nuclear Nkx2-5 is detected in a narrow domain of 
mesenchymal cells at the gastroduodenal junction (Figure III.4). This domain is broader 
than the corresponding Gata3 domain. Nkx2-5-expressing cells are positioned within the 
inner and outer smooth muscle layers of the gut, but unlike Gata3, Nkx2-5-positive cells 
are also present in the loose layer of sub-mucosal mesenchyme. Consistent with our 
whole mount X-gal staining results, Nkx2-5-positive cells were found at E14.5 in the 
dorsal nodule, as well as the ventral cords, while at E18.5 the dorsal nodule was absent 
and Nkx2-5 was only expressed in the ventral cords. [At E14.5 some residual migrating 
SPCs were also detected in the mesogastrium attached to the pylorus (Figure III.4A).]  
No epithelial staining was observed at either time point. 
 
Gata3 and Nkx2-5 are expressed in smooth muscle cell populations at the pylorus 
We analyzed Nkx2-5 co-expression with two molecular markers of smooth muscle [i.e., 
actin, alpha 2, smooth muscle, aorta (Acta2/ SMA) and desmin (Des)] by 
immunostaining. Co-staining with these markers identifies four possible cell populations: 
non-smooth muscle ( SMA
neg
/desmin
neg
), myofibroblast ( SMA
+
/desmin
neg
), smooth 
muscle precursor ( SMA
neg
/desmin
+
), and differentiated smooth muscle cells 
( SMA
+
/desmin
+
). At E18.5 the majority of Nkx2-5-positive cells are SMA
+
/desmin
+
, 
while a subset are SMA
+
/desmin
neg
 (Figures III.5A-B). 
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The Gata3 expression domain also appeared to correspond to the location of smooth 
muscle cell populations at the pylorus. To confirm this we analyzed Gata3 co-expression 
with desmin, a molecular marker of differentiated smooth muscle cells as well as smooth 
muscle precursors. At E16.5 the vast majority of Gata3-positive cells throughout the 
pylorus are also desmin-positive (Figures III.5C-D). Thus both Nkx2-5 and Gata3 are 
expressed in a subset of smooth muscle cells at the pylorus. 
 
The ventral pyloric cords are a novel smooth muscle structure 
To our knowledge the bilateral, Gata3- and Nkx2-5-positive ventral cords described 
above are novel structures. We examined these cords in whole mount and sectioned wild 
type tissue using markers for smooth muscle populations ( SMA and desmin). At E18.5, 
the majority of cells in the cords are SMA
+
/desmin
+
, indicating that they are composed 
of differentiated smooth muscle (Figures III.6A-B). At the anterior tip of the cord near 
the esophagus there is a diffuse meshwork of SMA
neg
/desmin
+
 smooth muscle precursor 
cells. The fact that the cords apparently lengthen in a posteroanterior direction, from the 
pylorus towards the esophagus, suggests that this SMA
neg
/desmin
+
 cell population may 
be a source of precursors for the developing smooth muscle cells within the cord. In 
whole mount specimens stained at postnatal day (P) 30, the ventral cords are readily 
observable, indicating that they persist after birth (Figure III.6C). Similar to E18.5 cells 
within the cords are SMA
+
/desmin
+
, but at the anterior tip a subset of cells near the 
esophagus are SMA
neg
/desmin
+
. Filamentous structures originating from 
SMA
+
/desmin
+ 
cells extend from the cords into this population of SMA
neg
/desmin
+
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cells. At the posterior (pyloric) end the differentiated smooth muscle cells of the cords 
integrate into the outer smooth muscle layer of the gut (data not shown). These ventral 
cords are a novel smooth muscle structure of the pylorus, although whether they 
contribute to the physiological regulation of pyloric function is not yet clear. 
 
Gata3 is required for pylorus morphogenesis 
To determine the requirement for Gata3 during pylorus development we intercrossed 
Gata3
lacZ/+
 mice. We compared the structure of the pylorus in wild type, Gata3 
heterozygous, and Gata3 null embryos in whole mount and H&E-stained, sectioned 
material. In whole mount E18.5 Gata3 null embryos, the gastroduodenal angle is altered, 
and the pyloric constriction is lost (Figures III.7A-B). These characteristics are confirmed 
in H&E-stained, sectioned samples. The gastroduodenal angle of Gata3 null embryos is 
more acute than wild type littermates, and the diameter of the inner ring of the pyloric 
sphincter, measured as the distance between inner smooth muscle layers on opposite 
sides of the gut, is wider in Gata3 null embryos (Figures III.7C-D). In addition, the outer 
longitudinal smooth muscle at the pylorus appears perturbed (Figures III.7E-F). These 
results indicate that Gata3 is required for proper morphogenesis of the pylorus and 
suggest that Gata3 may directly or indirectly effect pyloric mesenchymal cell 
populations, including smooth muscle. 
 
Loss of Gata3 is associated with the absence of specific smooth muscle structures at 
the pylorus 
To correlate the pyloric phenotype of Gata3 null embryos with the spatiotemporal pattern 
of Gata3 expression, we analyzed intercross matings of Gata3
lacZ/+
 mice by whole mount 
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X-gal staining. Compared to Gata3 heterozygous littermates at E16.5, Gata3 null mice 
displayed obvious differences in the pattern of X-gal staining (Figures III.8A-B). In 
Gata3 null mice, the band of X-gal staining around the pylorus is more diffuse and 
extends into associated pancreatic tissue on the dorsal side of the stomach. The ventral 
cords are perturbed but still present. At day later at E17.5, however, there is complete 
absence of the ventral cords (Figures III.8C-D). Instead the ventral side of the stomach 
contains a small prominence of X-gal positive cells. This indicates that Gata3 is required 
for the maintenance of the ventral pyloric cords. 
 
To investigate the function of Gata3 in smooth muscle cell populations at the pylorus, we 
analyzed wild type and Gata3 null embryos by immunostaining of sectioned tissue for 
SMA and desmin. Compared to wild type littermates at E18.5, the morphology of the 
inner circular smooth muscle and loose sub-mucosal layers in Gata3 null embryos are 
similar, despite the obvious difference in constriction of the pyloric smooth muscle 
sphincter (Figure III.9). In wild type and Gata3 null tissue, aSMA
+
/desmin
+
 differentiated 
smooth muscle cells populate the inner smooth muscle layer and aSMA
+
/desmin
neg
 
myofibroblasts are present in the sub-mucosal layer. Even so, there are subtle differences 
in the shape of the inner smooth muscle layer, with loss of the knob-like shape of this 
muscle at the pylorus. Additional changes are apparent in the outer smooth muscle layer 
on the dorsal side of the stomach. Whereas wild type tissue has a distinct outer smooth 
muscle layer at the pylorus, Gata3 null tissue does not (Figures III.9B and D). In contrast, 
the thin outer layer of longitudinal smooth muscle persists in both the duodenum and the 
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stomach of Gata3 null mice. Thus, Gata3 is required for the persistence of smooth muscle 
cells in the outer longitudinal layer of the pyloric sphincter. 
 
Gata3 and Nkx2-5 are co-expressed but Gata3 is not epistatic to Nkx2-5 at the 
pylorus 
Our immunostaining experiments indicate that Gata3 and Nkx2-5 are both expressed in a 
subset of smooth muscle cells at the pylorus (see Figure III.5). To test whether Gata3 is 
required for Nkx2-5 expression, we intercrossed Gata3
lacZ/+
 mice and analyzed Gata3 
heterozygous (Gata3
lacZ/+
) and Gata3 (Gata3
lacZ/lacZ
) null progeny by immunostaining 
sectioned tissue for Nkx2-5 and -gal (the protein encoded by lacZ). In Gata3 
heterozygotes, cells that express -gal also express Nkx2-5 (Figures III.10A and C). This 
is strong indirect evidence for co-expression of Gata3 and Nkx2-5 at the pylorus. Cells 
expressing -gal were reduced in number but were still present in Gata3 null embryos, 
indicating that at least a subset of the cells that express Gata3 transcripts do not require 
Gata3 protein for survival (Figures III.10B and D). Additionally, the vast majority of 
these -gal-expressing, Gata3 null cells also express Nkx2-5, demonstrating that at least 
in this surviving cell population, Gata3 is not required for Nkx2-5 expression at the 
pylorus. 
 
III.4. Discussion 
 
In this study, we examined the role of Gata3 during the development of the mouse 
pylorus. We report that germline loss of Gata3 leads to pyloric dysmorphogenesis: Gata3 
null embryos have an altered gastroduodenal angle and reduced pyloric constriction. This 
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phenotype suggests a defect in the development of the pyloric sphincter, and we show 
that loss of Gata3 is correlated with the absence of specific smooth muscle structures at 
the pylorus. At E18.5 Gata3-positive cells are found in the inner circular and outer 
longitudinal smooth muscle layers, and many of these cells co-express the smooth muscle 
marker desmin. In addition Gata3-positive cells form bilateral cords that originate at the 
pylorus and lie along the lesser curvature of the stomach; these ventral pyloric cords co-
express markers of differentiated smooth muscle. In Gata3 null embryos the ventral 
pyloric cords and the outer longitudinal smooth muscle layer of the pylorus are absent. 
Thus we propose that the loss of these specific smooth muscle structures results in the 
pyloric phenotype of Gata3 null embryos. 
 
Interestingly, despite the fact that Gata3 is apparently expressed in both inner circular and 
outer longitudinal smooth muscle layers of the pylorus, only the outer longitudinal layer 
is lost in Gata3 null embryos. Careful analysis shows that while the pyloric muscle 
proper appears to be an extension of the inner circular muscle, the bulk of the muscle at 
the pylorus is actually contributed by the outer longitudinal muscle. In both the proximal 
small intestine and distal stomach, the outer longitudinal layer is quite thin, especially 
when compared to the inner circular layer. At the pylorus, however, within the narrow 
domain of Gata3 and Nkx2-5 expression, the outer smooth muscle layer is almost as thick 
as the inner circular layer. In addition, many of the cells in this hyperplastic region are no 
longer oriented parallel to the long axis of the gut, but rather are oblique or even 
perpendicular (data not shown). These observations are supported by anatomical findings 
from guinea pigs and cadaveric human pylori, which reveal hyperplasia of the outer 
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longitudinal layer and fascicular connections to the inner circular layer [2, 4]. Whether 
Gata3 and/or Nkx2-5 direct this hyperplasia of the outer longitudinal muscle at the 
pylorus remains to be tested. Certainly the absence of this thickened muscle in Gata3 
animals demonstrates that Gata3 is critical for the survival of its component smooth 
muscle cell population. The deterioration of the ventral pyloric cords in Gata3 null 
embryos is further evidence that Gata3 is required for the survival of these smooth 
muscle populations. A survival role for Gata3 is not without precedent as Gata3 is also 
required for the survival of adrenal chromaffin cells [24].   
 
The pattern of pyloric expression of Nkx2-5 is very similar to that of Gata3. However, 
Nkx2-5 expression begins earlier and its domain is broader, which suggests that Nkx2-5 
may be epistatic to Gata3 at the pylorus. Germline Nkx2-5 null embryos are embryonic 
lethal by E10, which precludes further analysis of its role in pylorus development or a 
complete assessment of epistasis between Nkx2-5 and Gata3 [25]. We show here that 
Nkx2-5 is present in cells that express transcripts from the Gata3 locus; thus it is possible 
that Nkx2-5 regulates Gata3. It is clear that Gata3 is not epistatic to Nkx2-5. Nkx and 
Gata family factors interact in a number of other tissues including cardiac muscle, where 
they directly regulate each other’s transcription and/or cooperatively activate gene 
expression [26-36]. For example, a translocation in human T-cell acute lymphoblastic 
leukemia (T-ALL) results in co-expression of Nkx2-5 and Gata3. In these leukemic cells, 
Nkx2-5 and Gata3 physically interact and may cooperatively regulate gene expression 
[37]. Thus at least in some cellular contexts Nkx2-5 and Gata3 may interact to control 
gene transcription. 
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Gata3 null animals lose the pyloric constriction, likely due to smooth muscle changes. 
Similar pyloric phenotypes are reported for germline loss of either Bapx1 or Six2. These 
genes encode posterior stomach transcription factors that regulate Bmp4 expression. 
Misexpression of Bapx1 in the anterior glandular stomach (proventriculus) of chicken 
embryos inhibits Bmp4, while germline loss of Six2 de-represses Bmp4 in the posterior 
glandular stomach [8, 15]. The expression pattern of Gata3 (i.e., in the Bmp-responsive 
domain of pyloric mesenchyme) suggests that, similar to Nkx2-5, it could potentially be a 
target of Bmp signaling. Alternatively, as discussed above Nkx2-5 may regulate Gata3. 
In such a scenario the pyloric phenotype of Bapx1 and Six2 null embryos could 
potentially be due to changes in Gata3 expression, downstream of Bmp4. Pyloric Nkx2-5 
expression is altered but not extinguished in either Bapx1 or Six2 null embryos [15, 16]. 
In follow-up studies it will be important to explore the potential relationship between 
Gata3 and Bmp signaling, Six2, and Bapx1, so that Gata3 can be properly placed within 
the genetic network of pylorus development. 
 
To our knowledge, this study is the first to report the existence of the ventral pyloric 
cords. While it is unclear whether these cords are present in humans, they appear 
analogous in structure and development, although not position, to the Ligament of Treitz. 
Also known as the suspensory muscle of the duodenum, the Ligament of Treitz contains 
a thin smooth muscle that connects the duodenum at the duodenojejunal flexure to the 
abdominal aorta between the celiac and superior mesenteric arteries [38]. At the 
duodenojejunal flexure the muscle of the Ligament of Treitz integrates into both the outer 
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longitudinal and inner circular smooth muscle layers; at the other end it connects to the 
aorta via dense fibers of connective tissue. Contraction of the muscle of the Ligament of 
Treitz alters the angle of the duodenojejunal flexure, facilitating passage of food from the 
duodenum to jejunum [39]. The nascent Ligament of Treitz first appears in early fetal 
development as a band of loose connective tissue (i.e., superior retention band). Later, 
smooth muscle cells populate the band and form the muscle of the Ligament of Treitz 
[38, 40]. The similarities between the ventral pyloric cords and the Ligament of Treitz are 
striking and suggest that the function of the cords may be to regulate the tone of the 
pyloric sphincter. Follow-up studies will be necessary to more specifically examine this 
possibility in vivo. 
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Figure III.1. Embryonic expression of Gata3 in the posterior foregut. Whole mount X-gal 
staining of Gata3
lacZ/+
 embryos or foreguts between E10.5 and E18.5: A) E10.5, B) E11.5, C) 
E12.5, D) E13.5, E) E14.5, and F) E18.5. Blue X-gal staining represents Gata3 expression. The 
white boxes in A) and B) roughly correspond to the area of high magnification in the inset. Notice 
that the circumferential band of X-gal staining is incomplete in D) and E). In C) and E) the 
stomach is on the left and right, respectively. D) is a ventral view of the lesser curvature of the 
stomach. E) is an anterior view of the pyloric lumen from the position of the duodenum. Note 
than in F) the cords of X-gal staining extend anteriorly to the esophagus (black arrowhead). X-gal 
staining in F) by Mr. Ajay Prakash.
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Figure III.2. Gata3 is expressed in the outer mesenchymal layer at the pylorus. 
Immunofluorescence for Gata3 in sectioned wild type foregut at E14.5 and E18.5: A) E14.5 
(10X), B) E18.5 (10X), C) E14.5 (20X), and D) E18.5 (20X). Gata3 staining is in green, while 
nuclei are counterstained blue with DAPI. Nuclear Gata3 staining is cerulean. Non-nuclear green 
staining in the epithelium and mesenchyme is background. The white boxes in A) and B) roughly 
correspond to the area of higher magnification in C) and D), respectively. In all panels, stomach 
is on the right and intestine is on the left. Notice that there is no Gata3 staining in epithelium (e) 
or the loose sub-mucosal mesenchyme. The bulge of Gata3-positive cells in C) is the dorsal 
nodule (white arrowhead). Immunostaining by Mr. Ajay Prakash.
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Figure III.3. Embryonic expression of Nkx2-5 in the posterior foregut. Whole mount X-gal 
staining of Nkx2-5
lacZ/+
 embryos or foreguts between E10.5 and E18.5: A) E10.5, B) E11.5, C) 
E14.5, and D) E18.5. Blue X-gal staining represents Nkx2-5 expression. Notice the discrete 
domain of X-gal staining in A) (white arrowhead) and B). Also note the complete circumferential 
band of X-gal staining in C) and D) and the X-gal stained spleen (s) in C). Note that the X-gal 
stained ventral cords extend towards the esophagus in C) and D). In those panels the stomach is 
on the right and the intestine is on the left. X-gal staining in D) by Mr. Ajay Prakash.
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Figure III.4. Nkx2-5 is expressed broadly in the mesenchyme at the pylorus. 
Immunofluorescence for Nkx2-5 in sectioned wild type foregut at E14.5 and E18.5: A) E14.5 
(10X), B) E18.5 (10X), C) E14.5 (20X), and D) E18.5 (20X). Nkx2-5 staining is in green, while 
nuclei are counterstained blue with DAPI. Nuclear Nkx2-5 staining is cerulean. Non-nuclear 
green staining in the epithelium and mesenchyme is background. The white boxes in A) and B) 
roughly correspond to the area of higher magnification in C) and D), respectively. Notice that 
there is no Nkx2-5 staining in epithelium (e). The mesogastrium is denoted by the white asterisks 
in A) and C). In all panels, stomach is on the right and intestine is on the left. Immunostaining by 
Mr. Ajay Prakash.
121 
 
Figure III.5. Nkx2-5 and Gata3 are expressed in smooth muscle cell populations at the 
pylorus. Immunofluorescence for Nkx2-5, desmin, and SMA or Gata3 and desmin in sectioned 
wild type foregut at E18.5 and E16.5, respectively: A) Nkx2-5, desmin, and SMA at E18.5 
(10X), B) Gata3 and desmin at E16.5 (10X), C) Nkx2-5, desmin, and SMA at E18.5 (20X), and 
D) Gata3 and desmin at E16.5 (20X). In A) and C) red is Nkx2-5, blue is SMA, and green is 
desmin. Blue staining is myofibroblasts, green staining is smooth muscle precursor cells, and 
cerulean staining is differentiated smooth muscle. Green staining in the epithelium (e) is 
background. Notice in C) that red nuclei co-localize with cerulean staining in the smooth muscle 
layers and red staining in the loose sub-mucosal mesenchyme. In B) and D), red is Gata3, green is 
desmin, and the nuclei are counterstained blue with DAPI. Magenta staining is nuclear Gata3 and 
green staining is smooth muscle precursors and differentiated smooth muscle. Notice that 
magenta nuclei co-localize with green staining in the smooth muscle layers at the pylorus. The 
white boxes in A) and B) roughly correspond to the area of higher magnification in C) and D), 
respectively. In all panels, stomach is on the right and intestine is on the left. The ventral cord is 
apparent is B) and D) (white arrowhead). Immunostaining by Mr. Ajay Prakash.
  
Figure III.6. The ventral pyloric cords are smooth muscle structures. Immunofluorescence for desmin and SMA in sectioned and whole 
mount wild type tissue at E18.5 and P30, respectively: A) E18.5 (10X), B) E18.5 (20X), and C) P30. In A) and B) green is desmin, red is SMA, 
and nuclei are counterstained in blue with DAPI. In C) green is desmin and red is SMA. Red staining is myofibroblasts, green staining is smooth 
muscle precursor cells, and yellow staining is differentiated smooth muscle. Notice that nuclei in the ventral pyloric cord co-localize with yellow 
staining. The anterior tip of the cord is denoted by an asterisk in all panels. Notice that nuclei in loose tissue just outside of the tip co-localizes with 
green staining in B) and C) (white arrowheads). The white box in A) roughly corresponds to the area of higher magnification in B). 
Immunostaining by Mr. Ajay Prakash.
1
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Figure III.7. Gata3 is required for pylorus morphogenesis. Whole mount photomicroscopy 
and H&E staining of sectioned wild type and Gata3 null (G3KO) foreguts at E18.5: A) WT 
whole mount at E18.5, B) G3KO whole mount at E18.5, C) WT H&E at E18.5 (10X), D) G3KO 
H&E at E18.5 (20X), E) WT H&E at E18.5 (20X), and F) G3KO H&E at E18.5 (20X). Notice 
the attenuation of the pyloic constriction in D) and apparent loss of smooth muscle in F) (black 
arrowheads). The white boxes in C) and D) roughly correspond to the area of higher 
magnification in E) and F), respectively.
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Figure III.8. Gata3 is required for the maintenance of the ventral pyloric cords. Whole 
mount X-gal staining of Gata3 heterozygote (G3het) and Gata3 null (G3KO) foreguts at E16.5 
and E17.5: A) G3het at E16.5, B) G3KO at E17.5, C) G3het at E17.5, and D) G3KO at E17.5. In 
A) and C) blue X-gal staining represents Gata3 expression, while in B) and D) it represents 
transcription from the endogenous Gata3 locus. Notice the presence of blue staining in the ventral 
pyloric cords in B) but the absence of that staining in D) (white arrowheads). Also note the 
expansion of X-gal stain into pancreatic tissue in B) and D) (white arrowheads).
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Figure III.9. Loss of Gata3 disrupts the outer longitudinal smooth muscle layer at the 
pylorus. Immunofluorescence for desmin and SMA in sectioned wild type and Gata3 null 
(G3KO) foregut at E18.5: A) WT at E18.5 (10X), B) G3KO at E18.5 (10X), C) WT at E18.5 
(20X), and D) G3KO at E18.5 (20X). Green is desmin, red is SMA, and nuclei are 
counterstained in blue with DAPI. Red staining is myofibroblasts, green staining is smooth 
muscle precursor cells, and yellow staining is differentiated smooth muscle. Notice the absence of 
yellow staining in the OL region in B) and D) (white arrowheads). The white boxes in A) and B) 
roughly correspond to the area of higher magnification in C) and D), respectively. OL = outer 
longitudinal smooth muscle layer. Note again the apparent attenuation of pyloric constriction and 
the difference in shape of the inner circular smooth muscle layer. Immunostaining by Mr. Ajay 
Prakash. 
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Figure III.10. Gata3 is not epistatic to Nkx2-5. Immunofluorescence for Nkx2-5 and -gal in 
sectioned Gata3 heterozygous (G3het) and Gata3 null (G3KO) foregut: A) G3het at E18.5 (10X), 
B) G3KO at E18.5 (10X), C) G3het at E18.5 (40X), and D) G3KO at E18.5 (40X). Nkx2-5 is red, 
-gal is green, and nuclei have been counterstained blue with DAPI. In A) and C) red staining is 
Nkx2-5 expression, green staining is Gata3 expression, and yellow staining is co-expression of 
Gata3 and Nkx2-5. In B) and D) red staining is Nkx2-5 expression, green staining is transcription 
from the endogenous Gata3 locus, and yellow is co-expression of Nkx2-5 and the endogenous 
Gata3 locus. Notice the presence of yellow nuclei in C) and D) (white arrowheads). The white 
boxes in A) and B) roughly correspond to the area of higher magnification in C) and D), 
respectively. Immunostaining by Mr. Ajay Prakash.
 Table III.1. Protocols for immunostaining experiments. 
Experiment Protocol 
Gata3 only (Figure III.2) 
1. Mouse anti-Gata3 O/N at 4°C (1:100) 
2. Biotinylated horse anti-mouse/rabbit/goat (universal) IgG for 30 min at RT (1:200) 
3. Cy3-conjugated mouse anti-biotin for 30 min at RT (1:100) 
Nkx2-5 only (Figure III.4) 
1. Goat anti-Nkx2-5 O/N at 4°C (1:100) 
2. Biotinylated horse anti-mouse/rabbit/goat (universal) IgG for 30 min at RT (1:200) 
3. Cy3-conjugated mouse anti-biotin for 30 min at RT (1:100) 
Nkx2-5, SMA, and desmin (Figures III5.A,C) 
1. Goat anti-Nkx2-5 O/N at 4°C (1:100) 
2. Biotinylated horse anti-mouse/rabbit/goat (universal) IgG for 30 min at RT (1:200) 
3. Cy5-conjugated mouse anti-biotin for 30 min at RT (1:100) 
4. Rabbit anti-desmin O/N at  4°C (1:500) 
5. Alexa Fluor 488 donkey anti-rabbit IgG for 30 min at RT (1:500) 
6. Cy3-conjugated, mouse anti-aSMA for 30 min at RT (1:500) 
Gata3 and desmin (Figures III5B,D) 
1. Mouse anti-Gata3 O/N at 4°C (1:100) 
2. Biotinylated horse anti-mouse/rabbit/goat (universal) IgG for 30 min at RT (1:200) 
3. Cy3-conjugated mouse anti-biotin for 30 min at RT (1:100) 
4. Rabbit anti-desmin O/N at  4°C (1:500) 
5. Alexa Fluor 488 donkey anti-rabbit IgG for 30 min at RT (1:500) 
SMA and desmin (Figures III.6,9) 
1. Rabbit anti-desmin O/N at  4°C (1:500) 
2. Alexa Fluor 488 donkey anti-rabbit IgG for 30 min at RT (1:500) 
3. Cy3-conjugated, mouse anti-aSMA for 30 min at RT (1:500) 
Nkx2-5 and -gal (Figure III.10) 
1. Goat anti-Nkx2-5 O/N at 4°C (1:100) 
2. Biotinylated horse anti-universal IgG for 30 min at RT (1:200) 
3. Cy5-conjugated mouse anti-biotin for 30 min at RT (1:100) 
4. Chicken anti- -gal O/N at 4°C (1:1000)1 
5. Biotinylated rabbit anti-chicken IgY for 30 min at RT (1:200) 
6. Cy3-conjugated mouse anti-biotin for 30 min at RT (1:100) 
1Sections were pre-blocked again with the Avidin/Biotin Blocking Kit prior to incubation with the chicken anti- -gal primary antibody
1
2
7
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III.5. Attribution 
The first draft of this chapter was written by Aaron Udager. The text was subsequently 
revised with suggestions from Dr. Deborah Gumucio, Dr. Linda Samuelson, Dr. Scott 
Barolo, and Mr. Ajay Prakash. 
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III.6. Publication 
We anticipate that text from this chapter will be revised to form a manuscript for 
publication. 
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CHAPTER IV 
 
GENOME-WIDE CLUSTERING ANALYSIS OF GLI/CI BINDING SITES 
ACROSS DIVERGENT DROSOPHILA SPECIES REVEALS HEDGEHOG-
REGULATED ENHANCERS 
 
Hh pathway activity regulates gene expression via interaction of Gli/Ci transcription 
factors with specific sequences, Gli/Ci binding sites, in genomic DNA. In Drosophila 
many previously characterized Hh-regulated enhancers contain clusters of Gli/Ci binding 
sites, and the relative clustering of these sites is preserved in divergent Drosophila 
species. In a genome-wide analysis we detected significant clustering of Gli/Ci sites in D. 
melanogaster and D. pseudoobscura, while a closely related set of Gli/Ci sites containing 
an in silico “mutation” that is predicted to prevent binding of Ci protein in vitro showed 
little clustering. We therefore determined the clustering topography surrounding every 
Gli/Ci site in the genome by calculating a clustering coefficient (CC) that reflected the 
degree of clustering for each site. To determine the significance of observed clustering, 
we used Monte Carlo modeling of randomly generated genomes with preserved guanine-
cytosine (GC) topography. This analysis revealed a large number of predicted Hh-
regulated enhancers. Comparison of clustering topography in multiple Drosophila species 
revealed conserved clusters, several of which were functionally tested. We show that 
novel intronic enhancers within the genes inv and rdx are active in Hh-responsive cells of 
the larval imaginal wing disc. 
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IV.1. Introduction 
The core components of the Hh signaling pathway are highly conserved across evolution, 
as are the mechanisms of pathway activation and signal transduction [1]. In Drosophila 
extracellular ligand Hh binds to the transmembrane receptor Ptc, which allows another 
transmembrane protein, Smo, to act on intracellular components. Following a complex 
series of phosphorylation and proteolysis events, the Hh signal is finally transduced by 
the downstream transcription factor Ci. [The Gli family of transcription factors (i.e., Gli1, 
Gli2, and Gli3) transduce Hh signals in the mouse.] Nuclear translocation and binding of 
Gli/Ci proteins to specific DNA sequences, Gli/Ci binding sites, regulates Hh target gene 
expression. 
 
In Drosophila, Hh signaling is essential for early embryonic segmentation and larval 
imaginal disc patterning [1]. In these tissues Hh acts as a morphogen: it elicits distinct 
transcriptional responses at discrete distances from the source of signal. For example, in 
the developing wing disc, Hh is secreted by cells in the posterior compartment and 
activates target gene expression in anterior compartment cells close to the A-P 
compartment boundary. The larval wing disc Hh target genes ptc and decapentaplegic 
(dpp) are expressed in distinct but overlapping domains. ptc is activated in a stripe of 
cells along the A-P compartment boundary [2]. dpp is expressed in a wider domain 
anteriorly but is excluded from cells that abut the A-P compartment boundary [3]. A few 
Hh target genes have been identified in other tissues including wingless (wg) in the early 
embryo and hairy (h) in the larval leg disc [4, 5]. However, the paucity of known direct 
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Hh targets (and by extension Hh-regulated enhancer sequences) is an impediment to a 
more complete understanding of the roles for Hh in development and homeostasis. 
 
The identification of enhancers is central to distinguishing direct from indirect 
transcriptional targets of signaling pathways such as that directed by Hh [6]. A number of 
in vivo experimental techniques are available for this purpose [i.e., enhancer traps, 
chromatin immunoprecipitation (ChIP), etc.] [7, 8]. However, the abundance of high-
quality sequence data and annotation resources has spurred the development of in silico 
methods to find enhancers. Many of these approaches analyze the relative spacing (i.e., 
clustering) of transcription factor binding sites [9-11]. Other methods consider 
evolutionary conservation as well, including two for identifying Hh-regulated enhancers 
in mice [12, 13]. In these latter two approaches, evolutionary conservation of sequence 
and/or transcription factor binding site arrangement is used to limit the amount of 
sequence that will be searched for binding sites. Much of the genome is therefore ignored 
from the start. However, it is clear that enhancers evolve, and this evolution appears to 
depend on selection for function (phenotypic character) rather than for sequence, order or 
spacing of component binding sites [14]. 
 
Rebeiz et al. described a genome-wide approach to identify enhancers regulated by the 
Notch signaling pathway in Drosophila [9]. This method, known as SCORE (Site 
Clustering Over Random Expectation), detects statistically significant clustering of 
binding sites for the Notch-regulated transcription factor Suppressor of Hairless [Su(H)]. 
SCORE, however, focuses primarily on predicted high affinity binding sites that are most 
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similar to the consensus binding sequence, and information regarding potentially 
functional low affinity sites is lost. As illustrated by the enhancers for dpp and wg in 
Drosophila, clustering of non-optimal Gli/ci sites is a property of some Hh-regulated 
enhancers [3, 5]. Thus, a narrow focus on high-affinity sites is likely to net only a subset 
of functional enhancer elements. An additional limitation of SCORE is that its method of 
background clustering estimation does not account for the effect of local variation in 
genomic GC-content on the probability of clustering, an important consideration for GC-
rich binding sites, such as that of Gli/Ci. 
 
In the present study we describe a novel approach that analyzes optimal consensus as 
well as non-optimal sites, models background clustering to account for genomic 
topography in GC-content, and uses conservation as a final filter rather than an initial 
selector. Using this tool, Topo-TX, we show that in the genomes of two distantly related 
Drosophlia species (D. melanogaster and D. pseudoobscura) there is statistically 
significant local clustering of Gli/Ci sites. These clusters of Gli/Ci sites occur at 
frequencies well above the level of clustering predicted in random genomes. In contrast, 
when the search parameters are slightly modified to include a single nucleotide in silico 
“mutation” in the Gli/Ci binding matrix, which abrogates ci binding in vitro, the 
clustering profile resembles that of the random genome set [12]. We therefore identify 
potential Hh-regulated enhancers genome-wide by assessing the topography of clustered 
Gli/Ci sites in D. melanogaster and D. pseudoobscura. Topo-TX predictions were 
assessed by examining the ability of putative enhancer sequences to activate reporter 
gene expression in transgenic flies. We describe novel enhancers within the genes 
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roadkill (rdx) and invected (inv) that are co-expressed in Hh-responsive cells in the larval 
imaginal wing disc. 
 
IV.2. Materials and methods 
 
Identification of predicted Gli/Ci binding sites in genomic sequence 
A nucleotide distribution matrix derived from in vitro DNA binding assays with 
recombinant Ci protein was obtained from the Genomatix database (www.genomatix.de) 
[12]. The consensus index vector for a matrix reflects the degree of nucleotide preference 
at each position [15]. The first 9 bp of the Ci matrix had the highest consensus index 
vector values; therefore we focused on those positions in our analysis. Custom Perl 
scripts were designed to analyze the matrix and define a set of 9-mers that passed 
minimum thresholds for core region (75%) and matrix (81%) similarity to an optimal 
consensus Gli/ci site [15]. A closely-related set of 9-mers (“mutant” Gli/ci sites) that do 
not bind Ci protein in vitro was defined by changing the invariant cytosine at position 6 
of the nucleotide distribution matrix to a guanine (C6G) [12]. 
 
Repeat-masked, whole genome FASTA files for D. melanogaster (dm3) and D. 
pseudoobscura (dp3) were downloaded from the UCSC Genome Bioinformatics website 
(genome.ucsc.edu). Custom Perl scripts were designed to catalog the coordinates of 
Gli/Ci binding sites in both genomes. This list of site positions was annotated using 
custom Perl scripts and a refFlat transcript annotation file (available from UCSC) to mask 
potential sites in coding exons. 
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Generation of scrambled genomic sequence and random genomic distributions of 
binding sites 
One hundred artificial genomes were generated by scrambling bases but maintaining GC-
content topography (e.g., A becomes A or T, C becomes C or G, etc) at each position in 
dm3 or dp3. In this manner the genome-wide topography of GC-content is preserved 
between real and scrambled genomes. Potential Gli/Ci binding sites were then annotated 
in these scrambled genomes. Using the total population of positions from these artificial 
genomes 1,000 independent, random genomic distributions of Gli/Ci binding site 
positions were generated using a Monte Carlo simulation approach: site positions were 
pooled and then selected randomly without replacement. These distributions preserve the 
overall characteristics of sites dm3 or dp3 (i.e., number, affinity, and orientation). This 
method of random genome generation and modeling ensures that GC topography, the 
total number of Gli/Ci sites, and the distribution of relative affinities of Gli/Ci sites are 
similar in random genomes and dm3 or dp3. 
 
Statistical analysis 
For the analysis of number and relative distribution of Gli/Ci binding sites in real and 
scrambled genomic sequences we used the Microsoft Excel function NORMDIST. For 
Topo-TX, we numerically ordered inter-site distances (cluster sizes) for clusters of n 
adjacent sites in either dm3 or dp3 and calculated the cumulative frequency of each size 
(“observed value”). These data were plotted as an empirical distribution function. We 
then compared observed values to the average cumulative frequency (“expected value”) 
in random binding site distributions generated by the Monte Carlo simulation. We 
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calculated 95% confidence intervals associated with the expected value and determined 
whether the observed value was within this range [16]. For observed values that were not 
within the 95% confidence intervals, we calculated the clustering coefficient: observed 
frequency divided by expected frequency. 
 
Mapping orthologous regions of Gli/Ci clustering 
We compared lists of highly clustered Gli/Ci binding sites in either dm3 or dp3 using 
nearest gene annotation. If an orthologous gene was associated with highly clustered sites 
in both genomes, we retrieved the genomic coordinates of clustered sites and looked for 
areas of overlap: batches of genomic coordinates from dm3 were converted to the 
coordinates of the orthologous region in dp3 by the liftOver tool from the UCSC Genome 
Bioinformatics website, and custom Perl scripts identified overlapping coordinate 
domains. 
 
Generation of transgenic reporter flies 
Putative enhancers were PCR amplified from wild type D. melanogaster genomic DNA 
and cloned into an eGFP reporter vector (pGanesh-G2) [17]. Plasmid DNA was 
microinjected into embryos and adults were screened for transgene integration. Larval 
wing discs were dissected for imaging with whole mount confocal microscopy. Embryos 
were analyzed by in situ hybridization for eGFP and imaged with light microscopy. 
Results are representative of multiple (>3) independent lines. 
 
IV.3. Results 
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Identification of putative Gli/Ci binding sites from in vitro binding data 
The relative affinity of recombinant Ci protein for specific DNA sequences has been 
assayed in vitro via measurement of independent, competitive DNA binding reactions 
between a labeled optimal consensus Gli/Ci binding site (GACCACCCA) and unlabeled, 
non-optimal binding sites that carry a single nucleotide substitution [12, 18]. Ci-DNA 
binding data from these experiments can be conveniently represented as a 
mononucleotide distribution [or position weight (PW)] matrix with four rows, one for 
each of the potential nucleotides (A, C, G or T), and n columns (where n is equal to the 
number of positions in the binding site). To evaluate potential Gli/Ci binding sites with 
this matrix, we utilized the MatInspector method, which calculates the weighted 
similarity to the optimal consensus site (“% matrix similarity”) [15]. With reference to 
the in vitro binding data, % matrix similarity can be used as an estimate of relative 
affinity [15, 18]. 
 
The MatInspector-defined optimized threshold, which was designed to minimize false 
positive Gli/Ci binding sites but likely also misses some low affinity sites, is 81% matrix 
similarity. Forty-one 9-mer binding sites (of distinct sequence) meet or exceed this 
threshold (Table IV.1). Changing the minimum threshold alters the balance between 
sensitivity and specificity of binding site selection: 236 and six unique sites pass a 
minimum threshold of 70% or 90% matrix similarity, respectively (Figure IV.1). The 
scores for non-optimal Gli/Ci binding sites in the wg, dpp, and hairy Hh-regulated 
enhancers range from 68.7% to 91.5% matrix similarity (Table IV.2). Thus an 81% 
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matrix similarity threshold establishes a comprehensive set of Gli/Ci binding sites for 
computational analysis, though some potentially functional Gli/Ci binding sites are 
missed. 
 
Non-coding regions of the D. melanogaster genome are significantly enriched in 
Gli/Ci binding sites 
Using an 81% matrix similarity threshold, we identified a total of 35,707 putative Gli/Ci 
binding sites in the D. melanogaster genome. Of those, 9,542 (26.7%) are found in 
coding exons of annotated genes, 2,879 (8.1%) are in located in repeat sequence, and 
23,509 (65.8%) are in non-repeat, non-coding DNA (i.e., promoters, untranslated regions, 
introns, intergenic regions). We then generated a cohort of 100 scrambled D. 
melanogaster genomes that have preserved GC-content topography. Using the same 
matrix similarly threshold, we identified Gli/Ci binding sites in these scrambled D. 
melanogaster genomes. Compared to the scrambled genomes the real D. melanogaster 
genome has more total sites, 35,707, as opposed to an average of 26,330 in the scrambled 
genomes (Figure IV.2A). This represents a 1.36-fold increase (p < 0.01) in total sites, and 
the number of sites in non-repeat, non-coding sequence, repeat sequence, and exonic 
sequence is 1.45-, 1.58-, and 1.12-fold enriched (p < 0.01), respectively (Figures IV.2B-
D). 
 
Beyond the total number of sites, the relative distribution of sites in the various sequence 
types (i.e., non-repeat, non-coding, repeat, and exonic) is significantly different. 
Compared to the scrambled genomes the percentage of sites in non-repeat, non-coding 
and repeat sequence in the real D. melanogaster genome is 1.06- and 1.16-fold greater (p 
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< 0.01), respectively (Figures IV.2.E-F). In contrast, the occurrence of sites in exons is 
1.20-fold less (p < 0.01) than in the scrambled genomes (Figure IV.2.G). 
 
Significant genome-wide clustering of Gli/Ci binding sites in divergent Drosophila 
species 
The ptc, dpp, wg, and hairy enhancers all contain multiple Gli/Ci binding sites, which 
suggests that tight clustering of Gli/Ci binding sites may be a property of many Hh-
regulated enhancers [2-5]. To identify other regions in the genome that contain clusters of 
Gli/Ci binding sites, we determined the clustering profile of all Gli/Ci sites genome-wide. 
Using a modification of the method described previously by Rebeiz et al., we recorded 
the distances between all possible clusters of n consecutive sites in the real D. 
melanogaster genome ([9]; see Chapter IV.2). Using these values we determined the 
observed frequency distribution of inter-site distances (i.e., cluster interval sizes) for 
clusters of n sites, for n = 2-10. We then used a Monte Carlo method to model the 
expected frequency distribution of cluster interval sizes for clusters of n sites (see 
Materials and Methods). Finally we compared the observed and expected frequencies for 
each of these cluster interval sizes and, on a site by site basis, calculated a clustering 
coefficient (CC) that describes the probability that each identified binding site is part of a 
cluster of Gli/Ci sites [CC = (observed frequency of clustering at a given interval size) / 
(expected frequency of clustering at the same interval size)]. A CC greater than 1 
indicates that the observed frequency of a cluster interval size is greater than expected. 
 
After excluding Gli/Ci sites in coding exons and/or repeat sequences, we performed 
independent analyses on clusters of varying number of n sites, for n = 2-10. Significant 
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clustering is observed for all n examined, and the maximum CC of cluster interval sizes 
ranges from 4.929 (for n = 2 sites) to 74 (for n = 3 sites) (Figure IV.3A). Genome-wide 
28% (6,295) and 3% (653) of sites had a maximum CC of greater than two or ten, 
respectively. Similar results were observed when this analysis was applied to Gli/Ci 
binding sites in the genome of the distantly related species D. pseudoobscura. The range 
of maximum CC, however, was lower for all n examined (Figure IV.3B). 
 
Clustered Gli/Ci binding sites are associated with known Hh-regulated enhancers 
To provide initial validation that our method can identify Hh-regulated enhancers in 
silico, we examined the clustering coefficient for each of the Gli/Ci binding sites in the 
ptc, dpp, wg, and hairy enhancers. The three optimal consensus sites in the ptc enhancer 
are part of a larger cluster of four sites in 502 bp, each having a maximum CC of 14.2. At 
the selected % matrix similarity threshold (81%) of our analysis, only one of the three 
known non-optimal sites in the dpp enhancer is identified (GGCCACCTA), but it is part 
of a large cluster of nine sites in 8,060 bp, each having a maximum CC of 3.739. These 
sites span a large cis-regulatory region that directs dpp expression in Hh-responsive 
patterns in larval imaginal discs and the early embryo [19]. Similarly, in the wg enhancer, 
only a single previously identified site (GACCTCCCA) is detected in our analysis, but it 
is part of a larger cluster of seven sites in 7,799 bp, each having a maximum CC of 2.007. 
In the hairy enhancer there are two previously identified Gli/Ci binding sites, one of 
which (GACCTCCCA) is detected by our method. This site is part of a larger cluster of 
ten sites in 9,293 bp, each having a maximum CC of 4.027. In addition, two previously 
unrecognized predicted sites in the hairy enhancer are identified by our analysis 
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(GACCGCCAA and GACCCCACA): these sites are 8 bp apart and each has a maximum 
CC of 4.196. Thus Topo-TX detects all four of these previously identified enhancers 
because they are each associated with a statistically significant cluster of Gli/ci sites. 
 
A set of mutant Gli/ci binding sites shows little clustering in D. melanogaster 
To assess whether the significant clustering observed for Gli/Ci binding sites was a 
specific property of functional Gli/Ci sites, we repeated the analysis in D. melanogaster 
using a set of mutant Gli/Ci sites. The analysis was done using the same binding matrix 
characteristics and threshold as was used for functional Gli/Ci sites, except that the 
sequence of the binding matrix contained a single nucleotide substitution [cytosine to 
guanine at position 6 (mut6CG)], which is predicted from in vitro DNA binding data to 
prevent Ci protein binding while preserving GC-content topography. For cluster sizes n = 
2-10 the distribution of CC for mutC6G sites was dramatically different than wild type 
(Figure IV.4; data not shown). Whereas CC for wild type sites increased significantly at 
smaller interval sizes, mutC6G CC did not. Furthermore there was no significant 
association between clustered mutC6G sites and the ptc, dpp, wg, or hairy enhancers 
(data not shown). This suggests that the high clustering coefficients observed for wild 
type Gli/Ci sites in D. melanogaster are a functionally relevant property. 
 
Conservation of Gli/ci binding site clustering between divergent Drosophila species 
identifies known and potential hh-regulated enhancers 
From the Topo-TX analysis, we identified many significant clusters of Gli/ci sites, which 
we classified as potential Hh-regulated enhancers. One approach to further enrich for 
functional vs. non-functional enhancers is to examine the conservation of binding site 
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clustering in two distantly related Drosophila species, D. melanogaster and D. 
pseudoobscura [20]. Table IV.3 lists 25 such regions that exhibit significant Gli/Ci 
clustering in both genomes. The ptc and hairy enhancers are identified by this analysis. In 
contrast, neither the dpp nor wg enhancers are detected. However, a part of the large dpp 
cis-regulatory element just flanking the dpp enhancer is found [19]. 
 
Though some functional enhancers are overlooked by the application of the conservation 
filter, this may be an appropriate way to decrease the false discovery rate. Among the 
regions identified by this analysis are potential intronic enhancers within the genes inv 
and rdx (Table IV.3). Both of these genes are expressed in the larval imaginal wing disc 
[21, 22]. The predicted inv enhancer has nine Gli/ci sites in 2,549 bp and these sites have 
maximum clustering coefficients that vary between 21 and 27 (Table IV.4); this is one of 
the most Gli/Ci site-enriched areas of the genome. The inv enhancer contains two optimal 
consensus Gli/ci sites and the other seven sites differ from the optimal consensus by a 
single nucleotide. The predicted rdx enhancer has very different properties. In 1,567 bp it 
contains three sub-optimal Gli/Ci sites, each of which has a maximum CC of 2.7 (Table 
IV.4).  
 
Predicted Hh-regulated enhancers are active in Hh-responsive cells of the 
Drosophila wing disc 
To functionally test the putative intronic Hh enhancers identified in inv and rdx, we 
generated transgenic flies carrying reporter constructs driven by these sequences and 
examined their expression in spatial domains known to be regulated by Hh in the 
imaginal wing disc. The inv enhancer drives GFP expression in a narrow stripe, 
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perpendicular to the A-P axis (Figure IV.5A). Similar to the ptc enhancer the inv-GFP 
expression domain is in the center of the wing disc, near the A-P compartmental 
boundary. Its dorsal and ventral boundaries, however, do not extend beyond the wing 
pouch [2]. In contrast, the rdx enhancer drives GFP expression extending along the entire 
D-V axis of the wing disc near the A-P compartmental boundary (Figure IV.5D). 
 
We next examined whether inv-GFP and rdx-GFP are expressed in Hh-responsive cells 
of the wing disc. To accomplish this, we took advantage of a transgene reporter driven by 
a synthetic dpp enhancer [dpp(ci-HiAf)-RFP], which contains optimal consensus Gli/Ci 
sites in place of its three non-optimal sites; this transgene drives RFP expression in Hh-
responsive cells in the wing disc (Scott Barolo, University of Michigan, Department of 
Cell and Developmental Biology, personal communication). The expression domain of 
dpp(ci-HiAf)-RFP is shown in Figures IV.5B and E. Co-expression of dpp(ci-HiAf)-RFP 
and inv-GFP is observed within the wing pouch but not in more dorsal or ventral 
domains of the wing disc (Figure IV.5C). Similarly, there is significant co-expression 
between dpp(ci-HiAf)-RFP and rdx-GFP along the entire D-V axis (Figure IV.5F). 
However, whereas the inv-GFP expression domain is narrower than dpp(ci-HiAf)-RFP, 
rdx-GFP is slightly wider. These differences in expression domain might reflect the 
difference in affinity of Ci protein for the sites within the two enhancers. Indeed, the rdx 
enhancer and the native dpp enhancer share a wide expression domain and predicted low-
affinity, non-optimal Gli/Ci sites, while the inv enhancer, the ptc enhancer and the 
synthetic dpp(ci-HiAf) transgene contain high-affinity Gli/Ci sites and a narrower 
expression domain that abuts the A-P boundary. The association of high-affinity Gli/Ci 
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sites with expression close to the morphogen source has also been noted and extensively 
investigated in Dr. Barolo’s laboratory. 
 
IV.4. Discussion 
 
In this study we examined the genome-wide clustering properties of Gli/Ci sites in 
divergent Drosophila species (D. melanogaster and D. pseudoobscura). We report that 
there is significantly greater clustering of these sites than expected by random chance, 
and clustered Gli/Ci sites are associated with known Hh-regulated enhancers. In contrast, 
a set of highly similar sites that cannot bind Ci protein in vitro shows little overall 
clustering. By comparing orthologous regions of clustered Gli/Ci sites, we identified a 
number of putative Hh-regulated enhancers.  Finally, we show that two of these novel 
intronic enhancers, located within the genes rdx and inv, are active in Hh-responsive cells 
of the larval imaginal wing disc. Thus we propose that Hh-regulated enhancers can be 
identified in silico by comparative evolutionary analysis of genome-wide Gli/Ci site 
clustering. 
 
The two novel enhancers identified and functionally tested here, inv and rdx, are both 
located in intron 1, but they have different properties with respect to their component 
Gli/Ci sites and drive GFP expression in spatially distinct, but overlapping domains. Inv 
contains highly clustered Gli/Ci sites in both D. melanogaster and D. pseudoobscura. inv 
and engrailed (en) are linked genes in extant Drosophila species, and inv is thought to 
have arisen by a duplication of the ancestral en gene [21]. While inv and en share 
149 
significant homology within a 117 amino acid region that includes the homeodomain, the 
inv and en genes are very different. The inv locus spans more than 30 kb, while the en 
locus is only about 4 kb. In particular, intron 1 of inv is much larger than the 
corresponding en intron 1 (27,659 bp vs. 1,133 bp), which contains regulatory elements 
that direct expression in the early embryo [21, 23, 24]. There are only subtle differences 
in inv and en expression patterns in early embryos; these differences are mediated by 
tightly linked regulatory elements [21, 25]. The extent to which the inv enhancer controls 
en versus inv expression is not clear. In the wing disc, inv and en are expressed 
throughout the posterior compartment, where they repress anterior compartment cell fate 
and regulate hh expression [26]. In late larval stages, inv and/or en are activated by Hh in 
a narrow domain of anterior compartment cells within the wing pouch, along the A-P 
compartmental boundary [27-30]. The correlation between this Hh-dependent expression 
pattern and the expression domain of inv-GFP suggests that the inv enhancer directs inv 
and/or en expression specifically in the cells of the anterior compartment. 
 
The rdx enhancer is located in the large intron 1 of the rdx isoforms B/C/D and contains 
clustered Gli/Ci sites in both D. melanogaster and D. pseudoobscura [22]. rdx was 
recently identified as a negative regulator of the Hh signaling pathway [22, 31]. It 
encodes a small adaptor protein involved in ubiquitination and degradation of full-length 
Ci protein. Interestingly, rdx expression is activated by Hh signaling, similar to the 
canonical negative Hh pathway regulator ptc. In the wing disc, rdx is expressed in a 
broad domain of anterior compartment cells near the A-P compartmental boundary along 
the length of D-V axis [22]. This pattern is very similar to rdx-GFP expression, which 
150 
indicates that rdx is a likely a direct target of Hh signaling in the wing disc. In addition to 
ptc (and now rdx) in Drosophila and Ptch1, Gli1 and Hhip1 in mouse, there is recent 
evidence of transcriptional regulation of other Hh pathway components by Hh pathway 
activity [32]. This illustrates the complex cellular mechanisms that are involved in 
establishing discrete domains of transcriptional response to Hh morphogen signaling. For 
example, in the wing disc, the negative Hh pathway regulators ptc and rdx are expressed 
in overlapping domains, but act on different parts of the pathway [22]. Finally SPOP, the 
human ortholog of Rdx, can regulate Gli protein levels, and SPOP has been linked to 
renal cell cancer [31, 33]. 
 
The expression domains of the inv and rdx enhancers reveal an apparent correlation 
between the stripe patterns in the wing disc (i.e., A-P width, D-V length, proximity to the 
A-P compartmental boundary) and the composition of Gli/Ci sites in Hh-regulated 
enhancers. The enhancer that contains optimal consensus Gli/Ci sites (inv) has a narrow 
expression domain. The cells in this region directly abut the A-P compartmental 
boundary, are closest to the source of Hh, and thus, experience the highest levels of Hh 
signaling. In contrast, the enhancer that contains non-optimal Gli/Ci sites (rdx) has a 
broader expression domain. Similar findings are seen for the ptc and dpp enhancers, 
which have high- and low-affinity Gli/Ci sites, respectively. These findings suggest that 
the type of Gli/Ci binding sites (i.e., optimal consensus vs. non-optimal) in a putative Hh-
regulated wing disc enhancer may have predictive value for its expression pattern. In 
addition, these data agree well with a proposed “reverse French flag” model of Hh 
morphogen signaling, wherein opposing A-P gradients of Ci repressor (Ci
R
) and activator 
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(Ci
A
) expression mediate distinct transcriptional responses (unpublished data, Dr. Scott 
Barolo, Department of Cell and Developmental Biology, University of Michigan). In this 
model, optimal consensus sites direct expression in a narrow region close to the Hh 
source: high protein binding affinity for both Ci
A
 and Ci
R
 renders optimal consensus sites 
acutely sensitive the decreasing ratio of Ci
A
 to ci
R
 expression at increasing distances from 
the Hh source. Mutagenesis of Gli/Ci sites in the inv and rdx enhancers will be necessary 
to test this hypothesis.
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Figure IV.1. The number of predicted Gli/Ci binding sites increases exponentially as a 
function of % matrix similarity. An X-Y scatter plot of the total number of Gli/Ci binding sites 
(plotted on the y-axis) for a given % matrix similarity threshold (plotted on the x-axis). The data 
are plotted as “x” marks. The inverse exponential function (y = 700,000,000e-0.209x) is plotted as a 
dashed line. R
2
 is the coefficient of determination. It is an estimator of goodness of fit between 
data and underlying models. For example an R
2
 of 1 indicates that the model is a perfect fit. In 
our case the model is the inverse exponential function and the R
2
 indicates that it fits the data 
reasonably well. 
 
  
Figure IV.2. Non-coding regions in D. melanogaster are significantly enriched in Gli/Ci binding sites. Vertical scatter plot comparing the 
total number or relative percentage of Gli/Ci sites (plotted on the y-axis) for specific sequence types in real and 100 scrambled D. melanogaster 
genomes: A) total number of sites in the genome, B) total number of sites in non-repeat, non-coding regions, C) total number of sites in repeat 
sequence, D) total number of sites in coding exons, E) percentage of all sites in non-coding regions, F) percentage of sites in repeat sequence, and 
G) percentage of sites in coding exons. The population of data from the scrambled genomes was approximately normally distributed. Notice that 
there is significant enrichment of Gli/Ci sites in A), B), C), and D) relative to the scrambled genomes (p<0.01). Also note that while the relative 
percentage of Gli/Ci sites in E) and F) is significantly greater than expected, it is significantly less than expected for Gli/Ci sites in G) (p<0.01). 
Small circles = scrambled genomes; large circle with “x” in the middle = real genome.
1
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Figure IV.3. Gli/Ci binding sites are significantly clustered in two divergent Drosophila species. X-Y scatter plots of the maximum clustering 
coefficient (CC; plotted on the y-axis) for a given number of adjacent Gli/Ci sites in a cluster (plotted on the x-axis): A) D. melanogaster, for n = 
2-10 sites and B) D. pseudoobscura, for n = 2-8 sites. The data are connected by a smoothed line. The scale of the y-axis is log base 2. Notice that 
both A) and B) show large maximum CC, with a peak between three and four sites. Also note that A) has larger values than B) for all number of 
adjacent sites in a cluster. 
 
1
5
4
 
  
Figure IV.4. Significant clustering of likely functional Gli/Ci binding sites and lack of clustering of a closely related set of mutant Gli/Ci 
sites that cannot bind Ci protein. X-Y scatter plots of the clustering coefficient (CC; plotted on the y-axis) for various cluster sizes (in bp; 
plotted on the x-axis) and number n of adjacent sites in a cluster. Top = wild type (WT) Gli/Ci binding sites; Bottom = mutant (MUT) Gli/Ci 
binding sites. Data are connected by a smoothed line. For a given number n of adjacent sites in a cluster the WT and MUT data are paired and 
plotted on the same axes. Notice that for WT sites the CC increases dramatically as cluster size decreases, CC changes little for MUT sites.
1
5
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Figure IV.5. Novel predicted enhancers are active in Hh-responsive cells of the Drosophila 
larval imaginal wing disc. Fluorescent microscopy of inv-GFP or rdx-GFP and dpp(ci-HiAf)-
RFP expression patterns in D. melanogaster larval imaginal wing discs: A) inv-GFP, B) dpp(ci-
HiAf)-RFP, C) inveGFP and dpp(ci-HiAf)-RFP merge, D) rdx-GFP, E) dpp(ci-HiAf)-RFP, and F) 
rdx-GFP and dpp(ci-HiAf)-RFP merge. In A) and C) green is inv-GFP expression, while in D) 
and F) green is rdx-GFP expression. In B), C), D), and E), red is dpp(ci-HiAf)-RFP expression. In 
C) and F) yellow is co-expression between either inv-GFP or rdx-GFP and dpp(ci-HiAf)-RFP. 
The nuclei are gray. In all panels anterior is to the left, ventral is at the top, posterior is to the 
right, and dorsal is at the bottom. dpp(ci-HiAf)-RFP is just along the A-P compartmental 
boundary. Notice the green staining along the A-P compartmental boundary in A) and D). Also, 
note the yellow staining in C) and F). Transgenic fly experiments were performed by Dr. Dave 
Parker in Dr. Scott Barolo’s laboratory (Department of Cell and Developmental Biology, 
University of Michigan). 
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Table IV.1. Predicted Gli/Ci binding sites used in the Topo-TX analysis. 
 
 
Site sequence 
Nucleotide 
substitutions
1 
% core 
similarity 
% matrix 
similarity 
GACCACCCA 0 100 100 
GACCCCCCA 1 78.347 91.841 
GACCTCCCA 1 77.755 91.618 
GGCCACCCA 1 100 91.502 
GCCCACCCA 1 100 91.492 
GACCGCCCA 1 77.06 91.356 
GACCACACA 1 100 90.674 
GACCACCTA 1 100 89.686 
GACCACCAA 1 100 89.663 
GACCACCGA 1 100 89.519 
GACCACCCC 1 100 88.859 
GACCACCCT 1 100 88.859 
GACCACCCG 1 100 88.778 
AACCACCCA 1 100 88.214 
TACCACCCA 1 100 88.202 
CACCACCCA 1 100 88.105 
GGCCCCCCA 2 78.347 83.343 
GCCCCCCCA 2 78.347 83.333 
GGCCTCCCA 2 77.755 83.12 
GCCCTCCCA 2 77.755 83.11 
GGCCGCCCA 2 77.06 82.858 
GCCCGCCCA 2 77.06 82.848 
GACCCCACA 2 78.347 82.515 
GACCTCACA 2 77.755 82.292 
GGCCACACA 2 100 82.177 
GCCCACACA 2 100 82.167 
GACCGCACA 2 77.06 82.03 
GACCCCCTA 2 78.347 81.526 
GACCCCCAA 2 78.347 81.504 
GACCCCCGA 2 78.347 81.36 
GACCTCCTA 2 77.755 81.303 
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Site sequence 
Nucleotide 
substitutions
1 
% core 
similarity 
% matrix 
similarity 
(Table IV.1 continued) 
GACCTCCAA 2 77.755 81.281 
GGCCACCTA 2 100 81.188 
GCCCACCTA 2 100 81.178 
GGCCACCAA 2 100 81.166 
GCCCACCAA 2 100 81.156 
GACCTCCGA 2 77.755 81.137 
GACCGCCTA 2 77.06 81.041 
GGCCACCGA 2 100 81.021 
GACCGCCAA 2 77.06 81.019 
GCCCACCGA 2 100 81.011 
1
From the optimal consensus.
 Table IV.2. Analysis of Gli/Ci binding sites in four known Hh-regulated enhancers. 
 
Site Sequence 
Nucleotide 
substitutions 
% core 
similarity 
% matrix 
similarity 
Annotation 
ptc1 GACCACCCA 0 100 100 Strongest in vitro binding
1 
ptc2 GACCACCCA 0 100 100 Strong in vitro binding
1
 
ptc3 GACCACCCA 0 100 100 Strong in vitro binding
1
 
dpp1 GGCCACCTA 2 100 81.2 Weak in vitro binding
1
 
dpp2 GACCGCCCG 2 81.7 80.1 Moderate in vitro binding
1
 
dpp3 GACCTCCCC 2 82.2 80.5 Little or no in vitro binding
1
 
wg1 GTCCACGCT 3 100 69.7 Little or no in vitro binding
1
 
wg2 GACCTCCCA 1 82.2 91.6 Weak in vitro binding
1
 
wg3 GAGCAGCCA 2 46.3 74.7 Little or no in vitro binding
1 
wg4 GTTCACGCA 3 74.2 68.7 Moderate in vitro binding
1 
hairy1 GACCACCAT 2 100 78.5 Weak in vivo function [4] 
hairy1 GACCTCCCA 1 82.2 91.6 Strong in vivo function [4] 
1
Personal communication, Dr. Scott Barolo, Cell and Developmental Biology, University of Michigan 
1
5
9
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Table IV.3. Orthologous regions of significant Gli/Ci clustering in two divergent Drosophila 
species. Bold regions are previously known Hh-regulated enhancers, while underlined regions are 
novel Hh-regulated enhancers confirmed in this study. 
 
Nearest annotated 
gene 
D. melanogaster 
coordinates (dm3) 
D. pseudoobscura 
coordinates (dp3) 
18w chr2R:15,942,280-15,944,765 chr3:13,041,031-13,045,198 
ac chrX:271,178-273,582 chrXL_group1e:4,244,990-4,248,028 
Actn chrX:1,927,416-1,927,424 chrXL_group1a:2,534,873-2,535,008 
beat-IV chr3R:19,406,564-19,407,130 chr2:2,857,832-2,858,310 
CG17341 chr2L:14,138,121-14,138,129 chr4_group4:5,505,850-5,507,590 
CG5036 chr2R:13,680,860-13,681,982 chr3:16,462,330-16,462,891 
CG8701 chr2R:4,269,955-4,272,576 chr3:2,232,782-2,236,006 
Dot chr2L:3,612,212-3,614,251 chr4_group3:5,111,713-5,113,669 
dpp
1 
chr2L:2,467,642-2,470,099 chr4_group4:1,742,911-1,745,729 
Frq2 chrX:18,086,163-18,086,189 chrXL_group3a:55,279-55,299 
gsb chr3:10,036,940-10,037,990 chr2R:20,952,508-20,953,535 
heph chr3R:27,705,343-27,708,738 chr2:14,965,397-14,968,428 
hth chr3R:6,416,903-6,417,440 chr2:7,012,120-7,013,078 
htl chr3R:13,885,074-13,885,097 chr2:28,877,667-28,877,695 
inv chr2R:7,379,044-7,381,376 chr3:4,545,120-4,547,216 
Mrtf chr3L:2,716,608-2,717,636 chrXR_group5:94,297-95,278 
Or65a chr3L:6,291,390-6,293,089 chrXR_group3a:329,548-331,399 
osp chr2L:14,684,404-14,685,171 chr4_group1:3,152,528-3,154,008 
Pk chr2R:3,055,985-3,061,029 chr3:1,332,897-1,338,014 
ps chr3R:5,268,610-5,270,365 chr2:3,111,760-3,113,925 
ptc chr2R:4,533,170-4,536,527 chr3:13,642,912-13,646,107 
Ptx1 chr3R:26,734,929-26,734,937 chr2:431,845-432,440 
rdx chr3R:9,815,395-9,816,961 chr2:13,535,966-13,537,231 
SrpRbeta
2 
chr3L:8,700,707-8,700,731 chrXR_group8:8,871,522-8,871,546 
tara chr3R:12,070,577-12,074,288 chr2:25,218,494-25,224,094 
1This region near dpp is located in a well-characterized domain of cis-regulatory sequence [19]. 
2This region is the hairy enhancer.
 Table IV.4. Analysis of predicted Gli/Ci binding sites in two novel Hh-regulated enhancers. 
 
Site 
D. melanogaster 
coordinates (dm3) 
Sequence 
Nucleotide 
substitutions 
% core 
similarity 
% matrix 
similarity 
D. melanogaster 
maximum CC 
inv intronic enhancer (chr2R:7,378,778-7,381,476) 
inv1 chr2R:7,378,828-7,378,836 GACCACCCA 0 100 100 27 
inv2 chr2R:7,379,044-7,379,052 GACCACACA 1 100 90.7 27 
inv3 chr2R:7,379,218-7,379,226 GGCCACCCA 1 100 91.5 27 
inv4 chr2R:7,379,440-7,379,448 TACCACCCA 1 100 88.2 27 
inv5 chr2R:7,380,187-7,380,195 GACCACACA 1 100 90.7 27 
inv6 chr2R:7,380,383-7,380,391 GACCACCTA 1 100 89.7 27 
inv7 chr2R:7,380,446-7,380,454 GACCACCCT 1 100 88.9 27 
inv8 chr2R:7,381,338-7,381,346 GACCACCCA 0 100 100 21 
inv9 chr2R:7,381,368-7,381,376 GACCACACA 1 100 90.7 21 
rdx intronic enhancer (chr3R: 9,815,295-9,817,061) 
rdx1 chr3R:9,815,395-9,815,403 GGCCACACA 2 100 82.2 2.7 
rdx2 chr3R:9,816,122-9,816,130 GGCCACCAA 2 100 81.2 2.7 
rdx3 chr3R:9,816,953-9,816,961 AACCACCCA 1 100 88.2 2.7 
1
6
1
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IV.5. Attribution 
The first draft of this chapter was written by Aaron Udager. The text was subsequently 
revised with suggestions from Dr. Deborah Gumucio, Dr. Linda Samuelson, and Dr. 
Scott Barolo.
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IV.6. Publication 
We anticipate that text from this chapter will be revised to form a manuscript for 
publication.
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CHAPTER V 
 
CELL-SPECIFIC GENE EXPRESSION: MECHANISMS AND CONSEQUENCES 
 
In this thesis, I have presented data from my investigations of the mechanisms of pylorus 
morphogenesis and the identification of Hh-regulated enhancers. Here, I will expand on 
the significance of these findings and outline potential future areas of research. 
 
V.1. Evolutionary change and genetic redundancy in the GI tract 
 
In Chapter II, I described the antral, pyloric, and duodenal transcriptomes at two critical 
time periods during pylorus development (E14.5 and E16.5). I showed that, at E14.5, 
global gene expression is largely similar in the antrum and duodenum, while two days 
later, at E16.5, there is a dramatic upregulation of hundreds of genes, specifically in 
duodenal epithelium. We call this event intestinalization because these genes are 
associated with the identity and function of mature intestinal epithelium. It is remarkable 
that this maturation of the tubular gut occurs so late in gut development, well after the 
accessory organs, such as liver and pancreas, are well established. It is also striking that 
this event is limited to the intestine; the stomach does not show an equivalent up-
regulation of factors associated with stomach identity until 24-48 hours later. 
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Concomitant with intestinalization, I identified several duodenal epithelial transcription 
factors (i.e., Tcfec, Creb3l3, and Hnf4) that are upregulated dramatically at E16.5 and 
may be involved in the intestinalization event. I found that levels of Hh but not Wnt 
signaling are significantly altered in intestinal mesenchyme during the intestinalization 
event, suggesting that down-regulation of Hh signaling is important for intestinalization. 
Finally, I described a unique expression domain centered at the pylorus and identified 
several novel pyloric genes, including the zinc finger transcription factor Gata3 and the 
TGF- modulator nephrocan. 
 
The further study of these pyloric-specific genes identified in this study may improve our 
understanding of clinical syndromes such as Infantile Hypertrophic Pyloric Stenosis and 
duodenogastric reflux. Such studies are well underway, beginning with the analysis of 
Gata3 function in Chapter III. Another interesting aspect of our transcriptional analysis, 
however, is its implications for our appreciation of the events involved in the evolution of 
the GI tract. The transcriptome of an organ reflects the transitory culmination of 
evolutionary co-adaptation to changing organismal requirements and environmental 
stimuli, and therefore, it is of interest to consider the ontogeny of an organ within its 
evolutionary history. 
 
The earliest and most primitive “gut” within the Animalia kingdom was formed by the 
invagination of epithelial cells in primitive multicellular sponges, which created a sealed 
pocket for extracellular digestion [1]. The first tubular gut (i.e., a digestive tract with both 
mouth and anus) appeared in the Bilateria subregnum and, thus, predates the split 
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between vertebrates and invertebrates. The accessory organs of the vertebrate GI tract 
were acquired later, and interestingly, the stomach also appears to be a relatively recent 
evolutionary adaptation [2]. Indeed, our studies indicate that the development of stomach 
identity within the gut tube lags behind that of the intestine. In Chapter II, I showed that 
between E14.5 and E16.5, hundreds of genes are simultaneously up-regulated in 
intestinal epithelium, and these genes are associated with the adult function of the 
intestine. In contrast, relatively few expression changes are seen in the stomach during 
this time; the stomach transcriptome remains relatively “primitive” at E16.5. 
 
At some point after E16.5, however, the stomach will also up-regulate genes associated 
with adult stomach function and identity. I speculated in Chapter II that the stomach 
region may have been “carved out” of the intestinal tube with the help of a repressor. 
This repressor may have insulated the stomach region of the GI tube from further 
development at the time of major transcriptional change in the intestine, while allowing it 
to be plastic enough to respond to later changes that make it uniquely a stomach. Of 
course, this evolutionary path seems to require two changes: (1) the expression of a 
repressor in the stomach domain; and (2) the activation of stomach-specific genes in this 
region. As a first step in this evolutionary path, it is much easier to imagine the 
evolutionary advantage of (2) than (1). It will be of interest to carefully examine the 
transcriptomes of the distal foregut in organisms that lack a stomach to determine 
whether, indeed, a rudimentary pattern for stomach-like gene expression is present. If so, 
this may suggest that the later evolution of an intestinal repressor expression domain in 
this territory could help specialize the function of the rudimentary stomach. 
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Another striking finding not discussed in Chapter II is that the intestinal transcriptome 
seems to exhibit a tremendous genetic redundancy. This may reflect the fact that the 
intestine, as the primary site for nutrient absorption and one of the few common organs of 
the GI tract among Bilateria, is essential for the survival of an organism [1]. As such, 
there is likely strong evolutionary pressure to preserve intestinal function, and this may 
explain the genetic redundancy of transcription factors and signaling molecules involved 
in intestinal development. Paralogous genes commonly arise by duplication of a common 
ancestral gene, and therefore, it is not unusual for their expression patterns to be similar 
[3]. However, many paralogs eventually evolve unique cis-regulatory elements and 
distinct tissue- or cell-specific gene expression patterns. The intestine is unusual in this 
manner because many paralogs share similar expression patterns.  Two of the three 
members of the paralogous group of Cdx transcription factors (i.e., Cdx1, Cdx2, and 
Cdx4), for example, have similar, overlapping expression domains in intestinal 
epithelium [4]. Additionally, several other families of transcription factors (i.e., Hox, 
Fox, Gata, and Hnf4) and signaling molecules (i.e., Hh, Bmp, Notch, and Wnt) have 
paralogous members with similar expression patterns in the intestine ([5-12]; unpublished 
data from our laboratory). 
 
Single mutants for many of the intestinal genes in these paralogous groups show little 
obvious effect on intestinal development [13-17]. In contrast, pancreas development is 
completely and specifically perturbed in single mutants for Pdx1 [18]. This is intriguing 
because the pancreas develops precisely within a narrow domain of Pdx1 expression, and 
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Pdx1 does not have any paralogs. Also, the pancreas is a more recently acquired GI tract 
organ than the intestine. Together, these observations suggest that the duplication of 
critical intestinal developmental genes during Bilateria evolution may be a mechanism to 
preserve essential intestinal functions during GI tract development. 
 
V.2. The establishment and maintenance of differentiated gastric epithelium 
 
Thus far, I have focused primarily on the dramatic changes that take place in intestinal 
epithelium at E16.5. As mentioned above, dramatic changes in the intestinal 
transcriptome appear to promote intestinal identity, but a similar large change in the 
stomach transcriptome does not occur. However, concomitant with the intestinalization 
event described in Chapter II, gastric Sox2 expression regresses anteriorly, such that at 
E18.5 it is excluded from the future glandular epithelium of the stomach [19]. Prior to 
E16.5, mutually repressive interactions between Cdx2 and Sox2 form a soft boundary 
between presumptive intestinal and gastric epithelium at the pylorus. However, Cdx2 
expression does not expand anteriorly with Sox2 at E16.5; rather, its anterior expression 
boundary remains at the pylorus, where a single cell-thick boundary forms between 
intestinal and gastric epithelium (i.e., the epithelial pyloric border) ([20]; unpublished 
data from our laboratory). What then accounts for the anterior regression of Sox2 between 
E14.5 and E18.5? 
 
One possibility is that Sox2 expression is regulated directly by specific signaling 
pathways, and changes in activity levels of these pathways along the A-P axis of the 
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stomach influence the Sox2 expression domain. In this respect, it is interesting to note 
that inhibition of Wnt signaling plays an important role in epithelial patterning of the 
stomach, and that interference with inhibition of Wnt signaling (Barx1 null mice) shows 
an anterior shift of Cdx2 expression [21, 22]. However, these foregut phenotypes are 
apparent prior to intestinalization, as early as E11.5 [21]. Furthermore, in Chapter II, I 
reported that there is no gradient of canonical Wnt pathway activity between the antrum 
and duodenum at E16.5. This suggests that inhibition of Wnt signaling in the stomach 
may have an indirect rather than direct effect on Sox2 and Cdx2 expression boundaries. 
 
Besides Wnt, other signaling pathways (i.e., BMP and Fgf) may control Sox2 and Cdx2 
expression domains in the posterior foregut. Loss of Bapx1, for example, is associated 
with epithelial patterning defects in the antrum [23]. Bapx1 is expressed in posterior 
stomach mesenchyme, where it prevents the activation of Bmp4 by endodermal Hh 
signaling in this region of the stomach [24]. In the chicken, epithelial patterning of the 
pylorus is controlled by the Bmp antagonist gremlin [25]. Intriguingly, in Chapter II, I 
showed that at E16.5 the pyloric epithelium expresses nephrocan, an inhibitor of TGF- 
signaling. These data suggest that inhibition of TGF- superfamily signaling may 
regulate epithelial patterning in the distal stomach and/or pylorus by directly repressing 
Sox2. Thus, it would be interesting to determine whether sustained, ectopic expression of 
TGF- superfamily ligands (i.e., Bmp4) prevents Sox2 regression.  
 
Abnormal Fgf signaling also disrupts normal stomach development [26]. Fgf10 is 
expressed throughout the mesenchyme of the glandular stomach and signals to fibroblast 
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growth factor receptor 2 (Fgfr2) in antral epithelium. Forced expression of Fgf10 in the 
Pdx1-positive epithelial domain of the posterior foregut alters the epithelial architecture 
and relative distribution of enteroendocrine cell types; it is also associated with decreased 
levels of Sox2 gene expression. Interestingly, in Chapter II, I reported that the 
intracellular Fgf inhibitor sprouty-related, EVH1 domain containing 2 (Spred2) is 
specifically enriched in pyloric tissue at E16.5. This suggests that inhibition of Fgf 
signaling may control epithelial patterning at the pylorus, while perhaps Fgf10 is required 
to downregulate Sox2 in the distal stomach. It would be interesting to determine whether 
endoderm-specific loss of Fgfr2 prevents Sox2 regression. 
 
Another possibility is that an unknown transcriptional repressor of Sox2 is activated in 
the future epithelial domain of the glandular stomach, and intriguingly, this repressor may 
also be involved in limiting the anterior expression of Cdx2 to the epithelial pyloric 
border. The data I presented in Chapter II raises the possibility that transcription factors 
are enriched specifically in the glandular epithelium of the stomach at E16.5. In this 
respect the expression of Sox21, a transcriptional repressor, is noteworthy. Sox2 and 
Sox21 are expressed in overlapping domains of chicken foregut endoderm and have 
antagonistic, counterbalancing roles in neurogenesis [27, 28]. While Sox2 expression in 
undifferentiated neural cells suppresses neurogenesis, forced Sox21 expression promotes 
neurogenesis [27]. In addition, Sox21 expression at the midbrain-hindbrain boundary is 
dependent on Fgf signaling [29]. I have not investigated the expression pattern of Sox21 
during intestinalization in these studies, and furthermore, it is unclear whether Sox21 can 
directly regulate Sox2 expression. However, it is tempting to speculate that Sox21 is 
174 
downstream of Fgf10 signaling and may be involved in establishing the future domain of 
gastric epithelium, perhaps by repressing Sox2. It would be interesting to examine Sox21 
null mice for defects in epithelial patterning of the stomach. 
 
Cdx2 and Sox2 are excluded from the epithelium of the glandular stomach in mice. This 
suggests that they may be actively repressed in stomach epithelial cells, and furthermore, 
that this repression may be critical for gastric epithelial homeostasis. Intestinal metaplasia 
(IM) of the stomach, which is an intermediate step in the pathogenesis of some types of 
gastric cancer, involves the patchy conversion of gastric epithelium to an intestine-like 
epithelium [30]. Ectopic expression of Cdx2 is associated with IM of the stomach in 
humans, and forced expression of Cdx2 in gastric epithelium (FoxA3-Cdx2) in mice 
upregulates intestinal epithelial genes [31, 32]. Interestingly, in Chapter II, I identified 
several transcription factors that are upregulated specifically in duodenal epithelium 
during the intestinalization event at E16.5. In particular, it would be interesting to 
determine whether, similar to Cdx2, forced expression of Tcfec or Hnf4 in gastric 
epithelium is able to activate intestinal gene expression. 
 
While Sox2 expression is clearly restricted from glandular stomach epithelium in mice, it 
may be expressed in normal gastric mucosa of humans and downregulated in IM of the 
stomach [33, 34]. This suggests that a novel Sox2-independent mechanism of stomach 
epithelial differentiation may have evolved specifically in rodents after the split from 
primates. To examine whether this species-specific difference is functionally relevant, it 
would be interesting to ectopically express Sox2 throughout the endoderm. This 
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experiment would provide data for two key questions. Does ectopic Sox2 expression in 
the glandular epithelium of the stomach prevent the establishment of gastric epithelial 
identity? What is the consequence of Cdx2 and Sox2 co-expression for epithelial identity 
in the intestine? The expectation is that ectopic Sox2 would be sufficient to drive 
esophageal identity in the glandular stomach. 
 
V.3. Is the pylorus a tissue organizer? 
 
The pylorus is a unique structure in the posterior foregut of the GI tract: the posterior 
foregut is the source for hepatic, pancreatic and splenic precursors; the pylorus forms a 
complex smooth muscle sphincter; and after intestinalization, the pylorus is the site of the 
epithelial pyloric border, a one cell-thick boundary between duodenal and antral 
epithelium. How does such a small region contribute to so many diverse structures across 
a number of embryonic time points? One hypothesis is that the pylorus is a tissue 
organizer. In Chapter II, I describe a novel domain of epithelial and mesenchymal gene 
expression at the pylorus at E14.5 and E16.5. Interestingly, the epithelial pyloric border 
exists within this unique expression domain, which for some genes extends into both the 
antrum and the duodenum (i.e., Pdx1 and nephrocan). In this way, the pylorus is 
strikingly similar to another border between two organs, the isthmus between the 
midbrain and hindbrain. The parallels here are interesting and worth a few paragraphs of 
further explanation, since the isthmus is known to have organizer properties. 
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During development, the brain is divided into three primary vesicles (from anterior to 
posterior): prosencephalon (forebrain), mesencephalon (midbrain), and rhombencephalon 
(hindbrain). The midbrain region eventually forms the tectum, while the hindbrain 
domain becomes the cerebellum. The isthmus is a region of unique gene expression that 
contains a one cell-thick boundary (i.e., the isthmic border) separating the midbrain and 
hindbrain territories [35, 36]. Expression of the homeodomain transcription factors 
engrailed 1 (En1) and En2 extends across the isthmic border in a decreasing P-A gradient 
(expression is highest posteriorly and lowest anteriorly). Within this En1/2 expression 
domain, two other homeodomain transcription factors, orthodenticle homolog 2 
(Drosophila) (Otx2) and gastrulation brain homeobox 2 (Gbx2), pre-pattern the midbrain 
and hindbrain; Otx2 is expressed in the midbrain, while Gbx2 is expressed in the 
hindbrain. The expression domains of Otx2 and Gbx2 initially overlap at the isthmic 
border. However, subsequent mutual repressive interactions refine the expression 
domains, such that they abut but no longer overlap. In addition, the isthmus secretes Fgf8, 
which via activation of the Ras-Erk signaling pathway both stimulates En1/2 expression 
and restricts Otx2 expression anteriorly, to position the isthmic border. 
 
Transplantation experiments have demonstrated that the isthmus itself is a tissue 
organizer [35, 36]. When isthmic tissue is transplanted either anteriorly, into the 
forebrain, or posteriorly, into the hindbrain, it retains its normal fate. In contrast, when 
forebrain tissue is transplanted next to the isthmus, the transplanted tissue changes fate 
according to its position relative to the isthmus. These are the classic properties of a 
tissue organizer [37]. Interestingly, exogenous application of Fgf8-coated beads to 
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forebrain tissue replicates the consequences of isthmus transplantation, which strongly 
suggests that Fgf8 is a primary organizing molecule at the isthmus [38]. 
 
Interestingly, as a tissue organizer, the isthmus is essential for its own development, as 
well as proper patterning of the tissue surrounding it. Germline loss of Otx2 is associated 
with aberrant forebrain, midbrain, and anterior hindbrain structures, while loss of Gbx2 
leads to abnormal development of the midbrain and anterior hindbrain; loss of either gene 
altered the expression domain of Fgf8 at the isthmus [39, 40]. As expected, Fgf8 
hypomorphs show substantial defects in midbrain-hindbrain patterning [41]. However, 
targeted inactivation of Fgf8 also eliminated Gbx2 expression, indicating the feedback 
regulatory role of the isthmic organizer [42]. 
 
Many similarities exist between the pylorus and the isthmus: (1) Transcription factors 
that specify distinct tissues (i.e., Otx2/Gbx2, Cdx2/Sox2) are initially expressed in 
overlapping domainsl; (2) the expression overlap eventually resolves into a one-cell-thick 
tissue boundary via mutually repressive interactions; and (3) signaling factors are 
uniquely expressed within a narrow domain that includes the tissue boundary. This 
suggests that the pylorus may be a tissue organizer. Transplantation studies, analogous to 
those performed in the brain, have not been conducted in the GI tract to determine the 
tissue organizing potential of the mouse pylorus. Here, I will explore some of these 
experiments and the expected outcomes. The most straightforward approach would be 
tissue transplantation between cultured gut explants in vivo. Tissue from E10.5 to E14.5 
ROSA26 (i.e., -gal-marked) embryos could be transplanted into stage-matched wild 
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type guts, in order to lineage trace the cells from the transplanted tissue. These explants 
could then be cultured together for several days before analysis (developmental growth 
slows down in culture). 
 
First, after the pylorus is removed from a wild type gut, the antrum and duodenum could 
be placed together and cultured without an intervening pylorus. Would the Sox2/Cdx2 
pattern be perturbed? Would an epithelial pyloric border form? Would Nkx2-5 and Gata3 
expression be lost? Would a pyloric sphincter develop? If the pylorus is a tissue 
organizer, the expectation is that the epithelial pyloric border would not form without it. 
Similarly, unless pyloric sphincter morphogenesis was independent of the organizing 
activity of the pylorus, it would be unlikely for the gut to develop a pyloric sphincter if 
the pyloric region was extirpated. 
 
Second, a narrow region of pyloric tissue could be transplanted in the opposite 
orientation, such that Sox2-positive cells are posterior to Cdx2-positive cells at the 
pylorus. Where would the epithelial pyloric border form? Would there be more than one 
border? If the pylorus is a tissue organizer, the expectation may be that the Cdx2- and 
Sox2-positive cells resolve by themselves into a single epithelial pyloric border, similar to 
anterior and posterior compartment cells in the D. melanogaster larval imaginal wing 
disc [43]. In that case, it would be interesting to examine what happens to the cells that 
were formerly Sox2-positive. Would they die? Would they stop expressing Sox2 and 
upregulate Cdx2? Would they migrate anteriorly past the Cdx2-positive cells? The 
questions of Sox2-positive cell lineages could be examined with transplanted tissue from 
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a Sox2-Cre and ROSA26R intercross. Alternatively, based on the mutual repressive 
interactions between Sox2 and Cdx2, it is possible that three borders may form in this 
experiment, such that there are reciprocal, isolated Sox2- and Cdx2-positive domains. In 
that case, it would be interesting to determine what types of epithelial cells were specified 
between them. For example, would Sox2-positive cells between two Cdx2-positive 
domains become stomach, esophagus, etc? In that case, the expectation is that the Sox2-
positive cells would become esophagus. 
 
Third, that same region of pyloric tissue could be transplanted at increasing posterior 
distance from the pylorus, in the correct orientation. Would there be extra epithelial 
pyloric borders? Would another pyloric sphincter develop? Is there a posterior limit to 
either border formation or sphincter development? If the pylorus is a tissue organizer, the 
expectation is that multiple epithelial pyloric borders and an extra pyloric sphincter 
would be formed from the transplanted tissue. Will there be a posterior limit to the 
organizing activity of the pylorus (a region of competency to conform to organizer 
instructions)? 
 
Finally, in lieu of tissue transplantation, gut explants could be cultured with beads soaked 
in signaling ligands (i.e., Bmp and Fgf) and/or infected with viral expression vectors for 
intracellular transcription factors (i.e., Nkx2-5). After removal of the pylorus, would 
exogenous Bmp4 and/or Nkx2-5 be sufficient for border formation and sphincter 
development? What about in the posterior intestine? Does Fgf8 have organizing activity 
in the GI tract?  If the pylorus is a tissue organizer, the expectation is that some 
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combination of exogenous ligand and forced transcription factor expression should be 
able to recapitulate its organizing activity and generate of epithelial pyloric border and 
sphincter. 
 
V.4. Transcriptional control of pyloric Nkx2-5 and Gata3 expression 
 
Thus far, I have focused primarily on the descriptive analysis of Nkx2-5 and Gata3 
expression at the pylorus. However, elucidating the regulatory relationships of these 
factors is necessary to more fully understand the function of Gata3 during pylorus 
morphogenesis. This includes knowledge of how Gata3 and Nkx2-5 interact with one 
another, in addition to how each factor relates to the other genes of the pylorus 
developmental network (see Chapter I.3). An impediment to this goal, however, is the 
lack of a rigorous descriptive analysis of cell populations within the posterior foregut. In 
Chapter III, I described the immunohistological analysis of pyloric smooth muscle cell 
populations, and then I investigated the co-localization of Nkx2-5 and Gata3 with these 
cells. However, there are a variety of other cell types at the pylorus, and few previous 
studies of pylorus development have focused on defining cell type-specific expression 
patterns for pyloric genes. With this caveat in mind, I will describe the potential 
regulatory relationships for Gata3 and Nkx2-5 at the pylorus. 
 
Given its early onset and narrow domain, the pyloric expression of Nkx2-5 is likely to be 
tightly regulated by a combination of transcription factors, including Hox proteins, and 
Bmp signaling from the surrounding tissues. Given this, the expression of the related 
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gene Nkx2-3 is interesting. Nkx2-3 is expressed throughout the loose mesenchyme of the 
intestine. At its anterior expression boundary, which lies just short of the pylorus, it abuts 
the Nkx2-5 expression domain [44]. This observation raises the possibility of a regulatory 
relationship between Nkx2-3 and Nkx2-5. Intriguingly, misexpression of a synthetic 
Nkx2-5 fusion protein carrying a strong repressor domain downregulates endogenous 
Nkx2-5 expression at the pylorus and shifts the Nkx2-3/Nkx2-5 expression boundary 
anteriorly [45]. This suggests that Nkx2-5 may be able to autoregulate its own expression 
and, additionally, that the boundaries of the Nkx2-3 domain may be set by Nkx2-5. Does 
Nkx2-5 control Nkx2-3 expression? Does Nkx2-3 regulate Nkx2-5 expression? To probe 
these potential regulatory relationships, it would be interestingly to examine Nkx2-5 
expression in Nkx2-3 null embryos (and vice versa). In the absence of Nkx2-3, what is the 
posterior boundary of Nkx2-5 expression? Will the anterior boundary of Nkx2-3 
expression shift anteriorly without Nkx2-5, as suggested by the Smith study? 
Alternatively, it would be interesting to explore the consequences of ectopic Nkx2-3 
expression at the pylorus. Would Nkx2-5 expression be extinguished?  
 
It is not clear what factors may limit the Nkx2-5 domain on the stomach side. Loss of 
either Bapx1 or Six2 results in the absence of the pyloric constriction, which places these 
factors near the top of the hierarchy of pylorus development. Bapx1 and Six2 are 
expressed in apparently overlapping domains with Nkx2-5 at the pylorus [46, 47]. In 
contrast to Nkx2-5, the expression of Six2 and Bapx1 extends anteriorly into the posterior 
stomach mesenchyme [2, 46, 47]. These patterns suggest that Bapx1 and/or Six2 may 
specify a zone for pylorus development in the posterior foregut. Interestingly, Bapx1 and 
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Six2 inhibit Bmp4 expression in the posterior stomach [24, 46]. Thus, in contrast to 
surrounding tissue, part of the Bapx1/Six2 expression domain does not express Bmp4. 
Instead, it contains cells that are competent to respond to Bmp4 signals and activate 
Nkx2-5 [45, 48]. Intriguingly, neither the loss of Bapx1 nor Six2 extinguishes the 
expression of Nkx2-5 [23, 46, 47]. These results are surprising because the pyloric 
phenotype of Bapx1 and Six2 null embryos is not due to a complete loss of Nkx2-5 
expression. As discussed in Chapter III, these observations may reflect an effect on 
Gata3, downstream of Nkx2-5. Alternatively, it raises the possibility that Bapx1 and Six2 
are partially functionally redundant. It would be interesting to examine pylorus 
development and Nkx2-5 expression in Bapx1/Six2 compound null embryos. What is the 
pyloric phenotype of these embryos? Would Nkx2-5 expression be extinguished? How is 
the expression of Bmp4 affected? 
 
In Chapter III, I presented several lines of circumstantial evidence for a regulatory 
relationship between Gata3 and Nkx2-5. The expression patterns of these genes are 
highly similar, with only small differences in the timing of onset (i.e., Nkx2-5 is earlier) 
and breadth of expression domain (i.e., Nkx2-5 is broader). Gata3 and Nkx2-5 are both 
expressed in specific smooth muscles at the pylorus, including the outer longitudinal 
muscle, dorsal nodule, and ventral pyloric cords. I showed that Gata3 is not epistatic to 
Nkx2-5, but that Nkx2-5 co-localizes with active transcription from the endogenous 
Gata3 locus. Taken together, these data strongly suggest that Nkx2-5 is epistatic to 
Gata3. Germline Nkx2-5 null embryos die prior to Gata3 expression at the pylorus, but it 
would be interesting to examine pylorus development and Gata3 expression after 
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conditional inactivation of Nkx2-5 [49]. What is the pyloric phenotype? Would Gata3 
expression be extinguished? 
 
In Chapter III, I also noted that a large number of Nkx2-5-positive cells do not co-express 
Gata3. It seems likely, therefore, that Nkx2-5 functions coordinately with other 
regulatory inputs to control Gata3 expression. As discussed in Chapter III, Bmp4 
signaling may also have direct regulatory input on Gata3 expression. However, if Gata3 
and Nkx2-5 are both direct targets of Bmp4 signaling, it is unlikely that Bmp4 signaling 
alone can account for the differences in their expression patterns. Another potential input 
on Gata3 expression is Sox9, which is expressed in a similar domain to Nkx2-5 and 
Gata3 at the pylorus [25, 46, 50]. Interestingly, while Bmp4 signaling directly activates 
Sox9 expression, it does so independently of Nkx2-5 [25]. Although the cell type-specific 
expression of Sox9 has not been examined, it’s tempting to speculate that Sox9 could 
restrict Gata3 expression by actively repressing its transcription in a subset of Nkx2-5-
positive cells. It would be interesting to examine the co-localization of Nkx2-5, Sox9, and 
Gata3 at the pylorus. Are Gata3 and Sox9 co-expressed? Are Nkx2-5 and Sox9 co-
expressed? Alternatively, it would be interesting to explore the consequences of ectopic 
Nkx2-5 expression in posterior foregut mesenchyme. Can Nkx2-5 activate Gata3 
expression in other mesenchymal domains? Finally, while germline Sox9 null embryos 
die prior to Gata3 expression at the pylorus, it would be interesting to examine pylorus 
development and Gata3 expression after conditional inactivation of Sox9 [51]. What is 
the pyloric phenotype? Would Nkx2-5 expressed be altered? Would Gata3 expression be 
affected? 
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The most significant difference between Nkx2-5 and Gata3 pyloric expression involves 
splenic precursor cells (SPCs). Between E12.5 and E14.5, SPCs migrate anteriorly from 
the pylorus to populate the spleen [47]. Nkx2-5, but not Gata3, is expressed in these 
migrating cells. That pyloric Gata3 expression begins at approximately the same time as 
SPC migration might suggest that Gata3 acts as a lineage determination factor (i.e., 
switch) between SPCs and smooth muscle cells of the pylorus (i.e., Nkx2-5
+
/Gata3
neg
 
cells become SPCs, while Nkx2-5
+
/Gata3
+
 cells become pyloric smooth muscle). This 
hypothesis predicts that loss of Gata3 increases SPCs at the expense of smooth muscle 
cells, which may lead to an abnormally large spleen. However, I observed no obvious 
gross morphological changes in the spleen of Gata3 null embryos. Another possibility 
that would be interesting to explore is that Gata3 must be excluded from SPCs. In that 
case, persistent, ectopic Gata3 expression in Nkx2-5-positive cells may disrupt spleen 
morphogenesis. 
 
V.5. Evolution of Gli/Ci binding sites and identifying Hh-regulated enhancers 
 
In Chapter IV, I identified novel Hh-regulated enhancers in silico by examining the 
conservation of relative Gli/Ci binding site clustering between divergent Drosophila 
species. Unlike previous computational methods for identifying Hh regulated enhancers 
in vertebrates, our method, Topo-TX, does not limit the area searched to regions of high 
inter-species sequence conservation, nor does it impose restrictions on the number, 
arrangement, or relative affinity of transcription factor binding sites [52, 53]. There are 
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only two requirements for binding sites in Topo-TX: they must have a minimum 
predicted affinity; and they must show significant clustering relative to other sites (on a 
genome-wide level). In this way, Topo-TX is very tolerant to variations in binding site 
number, spacing, and relative affinity within enhancer sequences. Given the nature of 
binding site evolution, this tolerance may increase the sensitivity of Topo-TX predictions 
[54]. However, even with these permissive standards, our method is likely to miss some 
Hh-regulated enhancers. Since relative clustering with other sites is a prerequisite for 
Topo-TX, enhancers that contain a single, non-clustered binding site will not be detected. 
In addition, enhancers with many low affinity sites may not be identified. The advent of 
chromatin immunoprecipitation (ChIP) strategies to study Hh enhancers provides another 
method to survey for transcription factor binding sites [53, 55, 56]. The merging of Topo-
TX and ChIP data is likely to help us isolate and functionally dissect a large number of 
enhancers in the near future. This will undoubtedly teach us much about the rules by 
which enhancers function and evolve.  
 
The selection of transcription factor binding sites has a significant impact on any in silico 
binding site analysis. In Chapter IV, I used a mono-nucleotide distribution matrix that 
was derived from in vitro DNA binding data for recombinant Ci protein [52, 57]. The 
data for this matrix was obtained from measurements of competitive protein-DNA 
binding reactions between oligomers containing the optimal consensus Gli/Ci site 
(GACCACCCA) and a similar site carrying n nucleotide substitution (n = 1-9). While for 
Gli/Ci there are 262,144 total 9-mers that could be tested in vitro, only oligomers with a 
single nucleotide substitution were examined (there are 28 unique mono-nucleotide 
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substitutions for Gli/Ci) [52, 57, 58]. The most significant advantage of using this matrix 
is that it is based on experimental binding data. However, it is unclear how well in vitro 
DNA binding of short oligomers with single nucleotide substitutions translates to in vivo 
DNA binding. For example, some proteins have preferences for specific di-nucleotide 
combinations in a binding site [58]. Thus, it would be interesting to determine Ci in vitro 
DNA binding affinity for di-nucleotide-substituted oligomers (there 121 unique di-
nucleotide substitutions for Gli/Ci). The di-nucleotide distribution matrix derived from 
these data may allow more precision in distinguishing between 9-mers that bind or do not 
bind Ci protein in vivo. This, in turn, may improve the sensitivity and/or specificity of 
Topo-Tx predictions. Of course, other issues not considered in such an analysis include 
the possible contribution of nucleotides outside of the 9-mer core to binding affinity and 
the contribution of surrounding (cooperative) binding interactions. Modeling of these 
parameters will be assisted by the identification and functional analysis of additional 
enhancers. 
 
The Drosophila genus has a well-developed set of phylogenomic resources for 
evolutionary analysis. In addition to D. melanogaster, the genomes of eleven related 
species in the Drosophila genus have been sequenced [59]. These twelve species 
(including D. melanogaster) can be organized into several phylogeny groups, spanning 
different evolutionary time periods (million years ago; MYA) [60]: melanogaster 
subgroup (6-15 MYA), Sophophora subgenus group (20-30 MYA), and Drosophila 
genus group (~40 MYA). Thus, the genomes of these species represent a comprehensive 
sample of evolution within the Drosophila genus, allowing assessment of both closely 
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and distantly related Drosophila species. As discussed below, while most extant tools for 
the identification of functional enhancers in genomic DNA utilize these rich genomic 
resources to extract and analyze areas of sequence conservation, other considerations 
(e.g., binding site clustering, binding site affinity and binding cooperativity) may be 
equally important.  
 
As fundamental units of enhancers, binding sites for transcription factors are a primary 
source of both stability and change during evolution [54]. Indeed, evolutionary change 
within an enhancer can affect several properties of transcription factor binding sites: total 
number, spatial arrangement, and protein binding affinity. Previous studies have 
examined the evolution of transcription factor binding sites in related species of yeast 
(Saccharomyces) and Drosophila [61, 62]. In yeast, functionally important positions 
within a binding site had lower rates of evolution, while in Drosophila, there was 
substantial loss and gain (i.e., turnover) of binding sites, even between closely related 
extant species. Interestingly, despite significant changes in genomic composition and 
structure, gene expression patterns are often preserved between divergent Drosophila 
species [54]. This suggests that the function, but perhaps not the exact sequence, of many 
cell-specific enhancers are under positive selective pressure during evolution.  
Unpublished data from Dr. Scott Barolo’s laboratory (Department of Cell and 
Developmental Biology, University of Michigan) indicates that the predicted protein 
binding affinities of sites within an enhancer are critical for its correct spatiotemporal 
expression domain, and for some sites, the relative affinity is preserved among related 
species. Importantly, maintenance of binding affinity does not require strict maintenance 
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of sequence. It is instructive, therefore, to examine known enhancers to determine 
whether indeed sequence conservation is a characteristic of most functional enhancers. 
 
In studies not described in Chapter IV, I investigated the conservation of Gli/Ci binding 
site sequence in the context of four known Hh-regulated enhancers: ptc, dpp, wg, and 
hairy [63-66]. Fifty percent (4/8) of the binding sites in these enhancers were sequence 
conserved across the Drosophila genus group, 75% (6/8) were conserved across the 
Sophophora subgenus group, and 100% (8/8) were conserved across the melanogaster 
subgroup. If this analysis is extended to the rdx and inv enhancers identified in Chapter 
IV, the percentages of sequence conserved sites are: 30% (6/20) across the Drosophila 
genus group, 50% (10/20) across the Sophophora subgenus group, and 90% (18/20) 
across the melanogaster subgroup. In addition, each of these individual enhancers is 
associated with at least one Gli/Ci sites that is sequence conserved across the 
melanogaster subgroup. Although this is a small sample size of sequences, these 
preliminary results suggest that Gli/Ci binding sites in Hh-regulated enhancers are nearly 
always sequence conserved across the melanogaster subgroup and are often sequence 
conserved across the Sophophora sub-genus or Drosophila genus groups. This analysis 
suggests that sequence conservation of Gli/Ci binding sites across the melanogaster 
subgroup may be a useful filter for Topo-TX results.  
 
While the use of sequence conservation as a single criterion across the entire genus may 
miss 70% of the functional enhancers, it is nevertheless of great interest to examine the 
sites that can be detected by such a strict filter. Genome-wide in D. melanogaster, there 
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are 154 sites that are sequence conserved across the Drosophila genus group. Use of the 
Topo-TX tool will allow us to determine which of these sites are associated with 
significant relative clustering; such an analysis is ongoing.  
 
Thus far, I have focused on the application of Topo-TX to identifying Hh-regulated 
enhancers in D. melanogaster. However, our original impetus for developing this method 
was to identify direct targets of Hh signaling in the mouse intestine. The most significant 
obstacle for applying Topo-TX to the mouse genome, in the manner described in Chapter 
IV, is the lack of appropriate phylogenomic resources. The nearest evolutionary species 
with a sequenced genome is the rat, and the split between the Rodentia and Primates 
orders was about 80 MYA [67]. On the other hand, there are rich genomic resources for 
human and the rest of the order Primates: the Great Apes (15-20 MYA), the Old World 
Monkeys (25-30 MYA), and the New World Monkeys (~40 MYA) [68]. It would be 
interesting to compare the relative clustering of Gli/Ci binding sites in each of these 
Primate genomes to identify orthologus regions of significant Gli/Ci sites clustering. 
These putative Hh-regulated enhancers could then be tested for reporter activity in 
transgenic mice. Would these regions correspond to functional enhancers in vivo? Are 
direct Hh targets in primates also direct Hh targets in rodents? It is clear that the further 
exploration of all of these questions would provide an interesting and exciting chapter to 
future theses on cell-specific genes expression in GI development and homeostasis.
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V.6. Attribution 
The first draft of this chapter was written entirely by Aaron Udager. The text was revised 
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